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Abstract
This project investigated a series of shift schedules (14-Days, 14-Nights, 7-Night,7-Days, 
and 7-Days,7-Nights,) to determine circadian status (using the rhythm of urnary 6- 
sulphatoxymelatonin), sleep (by actigraphy) and selected metabolic parameters, in the 
offshore petrochemical industry, which operates a range of schedules with uncertair impact 
on biological rhythms and health.
No circadian adaptation was observed in the 14-Days schedule. All subjects adapted to the 
14-Nights schedule by circadian phase delay, and to the night shift of 7-Days,7-Niglts by 
phase advance. On the 7-Nights,7-Days schedule the majority of subjects also adapted to the 
night shift by delay, but most did not re-adapt back to dayshift. The novel parameter 
‘Desynchrony Load’ (cumulated deviation from ideal circadian timing, in hours) was usei as 
a quantitative indicator of disruption. The 7-Nights,7-Days schedule gave the highest score 
(61.7h), 14-Nights, 7-days,7-nights and 14-Days gave 31.5, 26.2 and 13.9h respectively. Tie 
timing of light exposure in relation to circadian phase was identified as a major influence in 
adaptation.
The 7-Nights,7-Days and 7-Days,7-Nights schedules impacted negatively on sleep, as the 
night after the swing-shift had the shortest sleep (shortest duration and longest latency). Sleep 
efficiency was significantly improved after the 7-Nights,7-Days rollover suggesting that 
returning to normal clock-time was associated with better sleep despite the desynchrony.
There was no significant difference in overall macronutrient or energy intake between day 
and night shifts, despite a temporal redistribution of meal times. Postprandial TAG on night 2 
(desynchronised) was raised compared with night 6 (adapted) of night shifts (14-Nights and 
nights of 7-Nights,7-Days). Similar trends were seen in postprandial cholesterol and insulin, 
but not in glucose. The improved TAG on night-6 seen in adapting subjects was still seen as a 
trend in non-adapters, suggesting that metabolic recoveiy may occur independently of, or 
faster than, the central circadian clock.
In conclusion, the raised postprandial TAG on night-2 is evidence that shiftwork desynchrony 
may contribute to CVD risk via disturbance to normal metabolic processes. Finally, when 
night work is essential, the 14-Nights schedule is preferable to the schedules that impose a 
double desynchronisation.
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1 INTRODUCTION
1.1 G en e r a l  In tr o d uc tio n
The Earth’s rotation in orbit around the sun provides a 24-hour light/dark cycle 
that was influencing life on the planet long before Man arrived. Light is one of 
the most fundamental environmental variables that affect most organisms. 
Rhythmicity is a highly conserved evolutionary characteristic and organisms that 
demonstrated a physiological ability to respond to this rhythmic pattern of light 
following darkness, from primitive algae to sophisticated mammals, had an 
evolutionary edge over those that did not. Thus physiological or behavioural 
adaptation to environmental change conferred a selective advantage on the 
organism. In the light of this evolutionary advantage, it is clear that Man has 
evolved to be alert during the light period to hunt and harvest, i.e. to work. Being 
human is a 24-hour operation, our daily routines are by definition cyclic with a 
24-hour period. This pattern: to be sleepy when it is dark so that we can rest, to 
rise refreshed for a new day, is no accident.
Circadian (Latin: circa-diem, about a day) rhythms are generated by a central 
biological clock within the brain. They act in such a way as to maintain a 
physiological and behavioural periodicity of around 24 hours to coincide with the 
solar day. Circadian rhythms are disrupted when the 24-hour work-rest routine is 
altered from diurnal to nocturnal such as in night shift work.
The continuing economic development in our society demands that a percentage 
of the workforce undertake their duties during the hours of darkness. Numerous 
publications discuss the detrimental effects on health associated with shift work, 
particularly with regard to fatigue, sleep disturbances and risk of heart disease 
(Costa, 1996; Nicholson and D’Auria, 1999; Boggild and Knutsson, 1999; 
Rajaratnam and Arendt, 2001) and some attribute these conditions at least, in 
part, to the disrupted circadian rhythms of the shiftworker (Costa, 1997).
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This review of the background information and relevant literature will cover an 
introduction to the circadian system, the control of circadian rhythms and the 
disturbances that occur in shiftworkers. This will be followed by a review of the 
consequences of shiftwork on health and a more specifically on risk factors for 
heart disease. Current strategies for enhancing circadian adaptation or 
minimising its consequences are considered and finally the hypothesis and aims 
of the current research are presented.
1.2 THE ORCADIAN SYSTEM
1.2.1 Biological rhythms
1.2.1.1 Rhythmicity and circadian evolution
Rhythmic behaviour in response to environment is a fundamental characteristic 
present across animal and plant species. This rhythmicity is known to be 
associated with a number of biological functions including the production and 
secretion of biologically active compounds such as the hormone melatonin. 
Melatonin, the hormone of the pineal gland in humans, is produced almost 
universally across animal species. It is produced in the dark phase in unicellular 
algae (Poggeler et al, 1991; Arendt, 1995) and is even present in some higher 
plants. Furthermore both invertebrate and vertebrate species have been shown to 
demonstrate activity rhythms that are entrained by light to coincide with cycles of 
light and darkness (Rusak and Zucker, 1979). The pineal, a gland present across 
vertebrate species, has a photoreceptive function in fish and amphibians, while in 
birds it has retained photoreceptor properties combined with a secretory function. 
In mammals the pineal is the principal secretory organ of the hormone melatonin 
and has lost its direct photoreceptive function (Arendt, 1995).
Early in the 20th century Richter (1922) reported the persistence of activity 
rhythms in rats housed in constant darkness, thus questioning the popular belief 
that daily rhythms were in response to light and dark. Johnson (1939) reported 
periodicity in activity rhythms of animals in constant darkness, which was 
dissociated from the clock time dark period, suggesting that a ‘self regulating
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physiological clock’ was operating in the absence of environmental light/dark 
cues. With Pittendrigh’s concept of a biological clock and its function 
concerning daily rhythmicity (1954, 1960) the idea of an internal biological clock 
became accepted.
1.2.1.2 Mammalian rhythmicity
Mammalian, and most interestingly human, physiology and behaviour is strongly 
influenced, even controlled, by biological rhythms, which may vary in periodicity 
from ultradian rhythms of minutes or hours, to infradian rhythms lasting days or 
months. These include rhythms of circulating hormones, together with 
physiological and behavioural parameters such as body temperature and cognitive 
performance. Rhythmicity is an essential component of, for example, 
reproduction, performance and sleep (Rajaratnam and Arendt, 2001; Dijk and 
Lockley, 2002; Dunlap et al, 2003), and endocrine and metabolic parameters 
(Van Cauter et al, 1991, 1997; Gibson et al, 1975; Romon et al, 1997; Morgan et 
al, 2003).
1.2.1.3 Circadian rhythms
When daily biological rhythms persist independently of environmental or 
exogenous cues such as light and dark, continuing to hold their cyclic pattern and 
duration, they are truly circadian rather than simply diel rhythms that occur in 
response to the external time cues. In a time-free environment intrinsic circadian 
periodicity is not exactly 24 hours. The natural tendency of the human circadian 
clock, when light and other cues are removed, is to ‘free run’ to a period usually 
of more than 24 hours. Wever et al (1983) reported that human tau (free running 
rhythm duration) was 24.9 ±0.2 hours, however recently revised figures of 24.17 
(Czeisler et al, 1999) and 24.3 hours have been reported (Middleton et al, 1996). 
As the period of these endogenously generated rhythms varies between 
individuals, i.e. it may be slightly shorter or longer than 24 hours, there have to 
be controlling factors to maintain synchronisation to the 24-hour day.
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1.2.1.4 Clock genes
More recently human periodicity has been attributed to genes, with the discovery 
that the exact period, or tau, of the endogenously generated rhythms is genetic in 
origin. Clock genes were first identified in fruit flies and fungi when single gene 
mutations altering rhythm duration (e.g. sleep/activity period length) were 
reported (reveiwed in Takahashi and Zatz, 1982). Later clock genes were 
identified in mammals, first in rodents and then in humans. Subsequently Toh et 
al (2001) reported the occurrence of a clock gene (Per2) polymorphism in a 
familial sleep disorder, associated with a shorter than average tau causing an 
advance in the sleep phase.
Diurnal preference, the tendency toward momingness or eveningness, has until 
recently been assessed subjectively (Home & Ostberg, 1976). However a recent 
analysis of clock genes and Home-Ostberg scores has established grounds for a 
genetic basis for momingness and eveningness (Archer et al, 2003) providing an 
explanation of why some people are predisposed to be either ‘morning’ or 
‘evening’ people.
Clock genes continue to be identified and this area of research currently evokes 
intense interest as the molecular mechanisms of the circadian system are shown 
to have roles in peripheral tissues, and clock gene polymorphisms are being 
associated with human health. For a recent review of the molecular aspects of 
circadian biology see Cermakian and Boivin (2003).
1.2.2 Circadian physiology
1.2.2.1 Components of the circadian system
Current understanding of a circadian system generating physiological rhythms is 
that it contains three fundamental components: an entrainment mechanism, an 
oscillator and a rhythm output parameter, coupled via neural and humoral 
pathways (the anatomy and physiology of the mammalian, and specifically 
human, system is reported in several texts; Takahashi and Zatz, 1982; Dunlap et 
al, 2003).
5
Introduction - 1
The fundamental components of the human circadian system consist of the eye, 
providing photoreceptors for light entrainment, the suprachiasmatic nuclei (SCN, 
the central pacemaker or oscillator) and output parameters, of which pineal 
melatonin synthesis is one. These are schematically represented in Figure 1-1.
?
PINEAL 
MELATONIN 
RHYTHM j
SCG
EYE
REPRODUCTION
SLEEP-WAKE TEMPERATURE 
AND OTHER RHYTHMIC FUNCTIONS
Figure 1-1 Schematic of components of the circadian system. Reproduced from 
Arendt, 1995.
1.2.2.2 The eye and photoreception
Circadian photoreception in humans is via the eye. Retinal photoreceptor cells 
transmit light information via neurotransmitters along a non-visual neural 
pathway, the retinohypothalamic tract (RHT), to the suprachiasmaticnuclei 
(SCN). This system relays illuminance information from the environment to the 
SCN, enabling entrainment of the inherently rhythmic SCN output to the light- 
dark cycle.
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1.2.2.3 The SCN and rhythm generation
The SCN, positioned in the anterior region of the hypothalamus, consists of two 
bilaterally paired nuclei sited just above the optic chiasm. Mammalian circadian 
rhythms are generated and controlled in the SCN, where clock gene expression 
produces an inherent endogenous rhythmic activity. Hence the rhythms 
generated from this pacemaker are circadian in nature, i.e. they will persist in the 
absence of entraining factors.
A series of clock genes (e.g. Clock, Bmall, Perl, Per2, Per3, Cryl, Cry2), 
collectively contribute to the generation of rhythms and to their circadian nature 
(Okamura et al, 2002). They are expressed at different times of the circadian 
phase and the positive and negative effects on SCN signalling result in the 
rhythmic output. The pulsatile expression of clock genes is generated by 
feedback loops as raised expression product levels inhibit transcription and 
degradation of expression products removes this inhibition (Okamura et al, 
2002). Thus the tau (duration) of the rhythm is determined by a cycle of clock 
gene processes including the accumulation of mRNAs, then the accumulation and 
interaction of the resulting proteins, the feedback to suppress transcription, and a 
period of degradation before transcription begins again. The complex molecular 
mechanisms of the circadian clock are reviewed in detail in Reppert and Weaver 
(2002).
The phase of the circadian oscillation is entrained to synchronise with the light 
dark cycle via photic sensitivity. The are numerous inputs to the SCN, photic and 
neural, the most important for the entrainment of the circadian rhythm is from the 
RHT, via which SCN neurones receive photic input from the retina. Circadian 
photoreception has been shown to depend on specialised melanopsin positive 
retinal ganglion cells that are directly light responsive and project directly to the 
SCN (Reppert and Weaver 2002).
SCN neural output signals are transmitted via multisynaptic pathways. For 
example, SCN signals to the pineal gland are transmitted via the paraventricular 
nucleus (PVN), the spinal cord and the superior cervical ganglion (SCG) and
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noradrenergic postganglionic fibres (Kalsbeek and Buijs, 2002, Perreau-Lenz et 
al, 2003). The circadian rhythmicity of the signals (and associated noradrenergic 
recepters) results in rhythmic output, in the case of the pineal gland this is the 
synthesis of melatonin. Via rhythmic outputs of neural and hormonal circadian 
signals, the SCN controls peripheral clock mechanisms throughout the body 
(Reppert and Weaver, 2002; Kalsbeek and Buijs, 2002).
1.2.2.4 Peripheral output and peripheral clocks
SCN neural efferents reach endocrine and autonomic neurones within the 
hypothalamus and other brain areas and thus transmit clock messages to 
peripheral target tissues such as endocrine and reproductive organs (Kalsbeek and 
Buijs, 2002).
Clock genes are expressed not only in the clock control regions of the brain, but 
in peripheral tissues throughout the body that show rhythmic activity such as the 
liver and kidney (Reppert and Weaver, 2002). Reppert and Weaver’s review of 
the co-ordination of circadian timing in mammals (2002) suggest these peripheral 
clock genes maintain tissue specific rhythms such as the bile production in liver. 
The peripheral rhythms are expressed with a delay from the central clock timing 
suggesting they are normally entrained by centrally expressed clock-gene 
products. Furthermore Stokkan showed that liver oscillators could be entrained 
rapidly and ahead of the SCN (Stokkan et al, 2001), and Damiola also reported 
independent peripheral entrainment in response to feeding (Damiola et al, 2001).
The peripheral clock mechanisms are thereby under the control of the central 
clock, but can become uncoupled if the external influences on the peripheral 
oscillators, such as activity and feeding, conflict with the light dark cycle that is 
the major time keeper of the central clock.
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1.2.2.5 The pineal gland
The pineal gland is a small secretory organ in mammals, sited in humans 
centrally beneath the brain, that contains and synthesises a number of biologically 
active compounds and peptides, and its primary function is the synthesis and 
secretion of melatonin. It is the major, but not sole producer of the hormone and 
it is in the pinealocyte that the rate limiting control of the rhythmic production of 
melatonin occurs.
At the pinealocyte membrane noradrenaline, released from superior cervical 
ganglion (SCG) noradrenergic postganglionic fibres, binds to beta-adrenergic 
receptors and triggers an increase in pinealocyte c-AMP, which then upregulates 
the expression of N-acetlytransferase. This enzyme is the rate-limiting step in the 
synthesis of pineal melatonin, in humans (Klein and Moore, 1979; Arendt, 1995).
The light dark cycle sets the timing of the SCN output signal. Light induces an 
inhibition of firing in the postganglionic fibres, thus supressing the stimulus for 
melatonin synthesis. Hence melatonin, secreted in the absence of light and 
therefore mainly at night, is often referred to as the hormone of darkness. Thus it 
is by a combined mechanism of the inherently circadian rhythmic signal and the 
entraining power of the light dark cycle, the rhythm remains synchronised to the 
local light dark conditions (for a review see Ganguly et al, 2002).
1.2.3 Melatonin -  Rhythm and Role
1.2.3.1 Synthesis pathway and Structure
Melatonin is the name given to the planar molecule 5-methoxy-N- 
acetyltryptamine, synthesised from the amino acid tryptophan, by an enzyme 
catalysed reaction process represented in Figure 1.2. Tryptophan enters the 
pinealocyte, and is hydroxylated to 5-hydroxytryptophan, which is then converted 
by aromatic amino acid decarboxylase to 5-hydroxytryptamine (serotonin). The 
rate-limiting step is dependent on the expression, and therefore availability, of 
arylalkylamine-N-acetyltransferase (AA-NAT) to add an acetyl group, and
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convert 5-hydroxytryptamine to N-acetyl serotonin. Finally hydroxyindole-O- 
methyl transferase (HIOMT) catalyses the addition of a methyl group at carbon-5 
of the indole ring to produce the melatonin molecule, which is secreted into the 
vasculature of the pineal and to the bloodstream.
Tryptophan
Tryptophan hydroxylase
y
5-hydroxytryptophan
decarboxylase
T
5-hydroxytryptamine (serotonin)
aa-NAT
▼
N-acetylserotonin
HIOMT
V
5-Methoxy-N-acetyltryptamine (Melatonin)
Figure 1.2. The synthesis pathway for Melatonin.
Degradative metabolism of melatonin to inactive forms is via the liver. In humans 
the predominant metabolite is 6-sulphatoxymelatonin and is excreted via the 
kidneys.
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1.2.3.2 Sites of action
The physiological role of melatonin is as a local and peripheral messenger of the 
circadian system, synthesised primarily in the pineal, but targeting local and 
peripheral tissues throughout the body. Melatonin is also synthesised in other 
tissues in much smaller amounts. For example photoreceptor cells of the retina 
produce melatonin that does not contribute to circulating levels (Tosini and 
Fukuhara, 2003), and is therefore most likely to have a localised action.
The daily melatonin production profile is influenced by seasonal day-length due 
to the synchronisation of the rhythm to 24-hours by the light dark cycle, a change 
that represents an essential physiological role in the reproductive physiology of 
photoperiodic species (Arendt, 1995; Arendt, 2003). As a hormone produced in 
darkness it is a physiological signal for dark period activity or behaviour to occur, 
such as (in humans) the decline in body temperature and activity associated with 
sleep (reviewed in Arendt, 2003). It may also signal other physiological 
responses in peripheral tissues such as the circadian rhythms found metabolic 
parameters (NEFA, TAG and glucose tolerance) reported by Morgan et al (1998) 
and Hampton et al (1996). Furthermore, Stehle et al (2003) suggested that 
melatonin was a central circadian clock control signal for maintaining peripheral 
clock gene expression, or entraining the peripheral rhythms to the dark period.
The physiological activity of melatonin with respect to biological rhythms are 
manifested in tissues equipped with specific receptors. The SCN is rich in 
melatonin receptors, as is the pars tuberalis of the pituitary making them highly 
sensitive to melatonin, for feedback and for transmission of clock signals to the 
periphery. Many peripheral tissues including smooth muscle tissue and the 
vascular endothelium also have melatonin receptors, making them targets for 
circadian clock influence (Stehle et al, 2003). Three major melatonin receptors 
have been identified, and are expressed in a wide variety of tissues aside from the 
SCN and the retina, including cardiac tissues, arterial endothelial cells, muscle 
and intestinal cells, as well as organ tissues, lung heart kidney (for a review see 
Witt-Enderby et al, 2003).
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The roles of melatonin are by no means limited to the circadian system or the 
influence of sleep and activity rhythms. It is reported to have antioxidant 
properties (Beyer et al, 1998) and may regulate inflammatory response in the 
microvasculature, which has interesting implications for health and heart disease.
1.2.3.3 Melatonin as rhythm marker
Large individual variation is seen in daily plasma melatonin, however the average 
daily production was reported to be 28.8wg/day (Lane and Moss, 1985). The 
peak levels of aMT6s in urine occur approximately 2 hours after plasma level 
peaks, reflecting its rapid metabolism and resulting in over 70% of the total 24- 
hour production normally being excreted in the overnight urine sample (Arendt, 
1995). When correlated with hourly samples, aMT6s from 4-hourly and 
overnight urine sampling has predicted melatonin rhythm production and 
acrophase time with reproducible accuracy (Ross et al, 1995; Naidoo, 1998). An 
example of a 24-hour profile of 6-sulphatoxymelatonin from 4-hourly samples 
(8h overnight) is shown against hourly plasma and salivary melatonin in Figure 
1-3.
$
i '  r f  t
Time (h)
Figure 1-3 A 24h profile of urinary aMT6s excretion (ng/h) in 4-hourly (8h 
overnight) samples, shown with hourly plasma melatonin (A) and salivary 
melatonin (■). Reproduced from Arendt (1995).
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Although there is variation between individuals, given a constant environment, 
levels are similar within each person from day to day (Bojkowski et al, 1987), 
thus making melatonin a reliable rhythm marker. Plasma melatonin is 
representative of melatonin synthesis (Wilkinson et al, 1977), with an average 
maximum in plasma at peak of 60-70 pg/ml, while at the nadir of the production 
rhythm plasma melatonin concentrations are usually less than lOpg/ml 
(Arendt,1995). The major urinary metabolite of melatonin, 6- 
sulphatoxymelatonin (aMT6s), correlates well in both amplitude and timing with 
plasma levels (Bojkowski et al, 1987) and is often chosen as a marker in 
circadian field research as urine is less invasive and more practical to collect than 
plasma.
It is the inherent SCN circadian rhythmicity combined with the response to light 
that enables the system to adapt to a change in environmental conditions. When 
light inhibits noradrenaline release, the synthesis of melatonin is suppressed. 
Conversely when darkness is imposed the suppression is lifted, thus depending 
on the timing of the light exposure and darkness in relation to the inherent 
rhythm, the rhythm output will be phase shifted by delay (occurring later) or 
advance (occurring earlier).
Other rhythmic parameters are often used as experimental circadian rhythm 
markers. One of the most commonly used is the body temperature rhythm. Core 
body temperature reaches a low point (nadir) between 0400h and 0500h, and a 
peak (acrophase) in mid afternoon, this rhythm, like that of cortisol, is closely 
coupled to that of melatonin. In a recent report evaluating the variability of core 
body temperature (CBT), melatonin and cortisol as rhythm markers, melatonin 
was reported to be the least variable (Klerman et al, 2002). These rhythms can all 
be used in experimental conditions to assess circadian phase.
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1.2.4 Control of circadian rhythms
1.2.4.1 Zeitgebers
As illustrated in Figure 1-1, the circadian component of rhythms is generated 
internally, but there are controlling factors such as the effects of exercise on core 
body temperature and the ability of light to suppress the melatonin rhythm, in 
order to maintain the synchronisation of the internal rhythm to the external 
environment.
This synchronisation or ‘entrainment’ is effected by external time cues called 
zeitgebers (German, meaning time-giver/keeper). There are many zeitgebers that 
influence the body clock, the strongest and most important to the human 
circadian system being the Earth’s light dark cycle. Artificial fight can also be a 
strong entrainment tool, the use and effects of which are discussed in section
1.2.4.3.
Other environmental and social cues; working hours, clock time, exercise, and 
the routines of home and social fife may also influence the body clock. 
Melatonin itself, when administered exogenously, acts as a zeitgeber capable of 
inducing phase shifts (Arendt et al, 1985; Deacon and Arendt, 1995; Arendt et al, 
1997).
1.2.4.2 Phase shifts
Whether these time-keepers cause the circadian rhythm to extend (phase delay) or 
shorten its cycle (phase advance) depends on the stage of the circadian cycle that 
the exposure occurs. The magnitude and direction of the induced phase shift 
depicted as a function of the administration time of the zeitgeber, can be 
represented by a phase response curve (PRC). The phase response curve of 
circadian melatonin rhythm to light was first presented by Lewy et al (1984), but 
has since been improved upon and presented for other zeitgebers. The PRC 
shown in Figure 1-4 represents the curve for the effect of fight on endogenous 
plasma melatonin and the converse curve for the effect of exogenous melatonin, 
taken from a meta-analysis of several studies (Burgess et al, 2002).
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Figure 1-4 A schematic of a phase response curve (PRC) of the human plasma 
melatonin rhythm to light (dark line) and to exogenous melatonin (dashed line).
The Y axis shows the relative magnitude of the phase shifts of the melatonin rhythm 
by advance or delay, induced by the treatments. The clock time is shown on the X- 
axis and the time of treatment in relation to the dim light melatonin onset is shown 
in the lower x-axis. (reproduced from Burgess et al, 2002)
1.2.4.3 Light
The complete suppression of melatonin by bright light was demonstrated by 
Lewy, who showed that light (2500 lux), equivalent to that of indirect bright 
sunlight, when administered between 0200h and 0400h suppressed nocturnal 
melatonin secretion to near day-time levels, whereas domestic bright light was of 
insufficient intensity to achieve this (Lewy et al, 1980).
More recently even quite low intensity broad spectrum white light has been 
shown to suppress melatonin (Bojkowski et al, 1987; Boivin et al, 1996). 
Broadway in 1987 showed that bright light (2500 lux) administered daily over a 
six week period during the Antarctic winter (darkness) advanced the timing of the 
melatonin rhythm by 2 hours, to be the same as that in the Antarctic summer 
(Broadway et al, 1987). Moderate bright light has been shown to be sufficient to 
phase shift circadian rhythms of melatonin and core body temperature (Deacon 
and Arendt, 1994; Martin and Eastman, 1998) and Buresova et al (1991) reported
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that a single dose of bright light (3000 lux) administered in the early morning, 
0300h to 0900h could induce a phase advance of the evening melatonin rise.
The timing of light intervention is crucial to the magnitude and direction of the 
phase shift (Czeisler et al, 1986; Czeisler et al, 1989; Van Cauter et al, 1993; 
Jewett et al, 1991; Khalsa et al, 2003). Buresova’s light treatment was of 6 hours 
duration and administered during the early to mid morning, i.e. timed to the phase 
advance portion of the PRC to light (Buresova et al, 1991). Van Cauter found 
that a single 3-hour bright light ‘pulse’, administered at the time of the 
temperature minimum, brought about a phase advance, but the same treatment 
given 3 hours prior to the temperature minimum resulted in phase delays of 1-2 
hours (Van Cauter et al, 1993). This suggests that carefully timed light exposure 
or treatment could be used to encourage the circadian system to phase shift in 
order to synchronise with a given time schedule, such as in trans-meridian travel, 
or night shift work. This has been demonstrated in experimental and field 
conditions (Shanahan and Czeisler, 1991; Bjorvatnet al, 1998, 1999).
Lewy’s work also suggested that the effect of light was intensity dependent as 
light exposure at an intermediate intensity (1500 lux) produced a melatonin 
suppression between that of domestic light and bright light (Lewy et al, 1980). 
This intensity-dependant dose response was confirmed by Bojkowski et al 
(1987).
Furthermore, Boivin et al (1996) reported increasing phase advance of the 
circadian system with increasing intensity in light exposure, with light as low as 
180 lux inducing a phase shift. However, if it were the just intensity of the light 
that determined the suppression of melatonin or the phase shift of the circadian 
system, then it would be expected that light exposures of equal photons would 
induce a similar response. However Thapan et al (2001) and Brainard et al (2001) 
have shown conclusively that short wavelength light is the most effective for 
melatonin suppression. Moreover Warman et al (2003) and Lockley et al (2003) 
have demonstrated a similar wavelength dependence for phase shifting.
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Light is without doubt a potent zeitgeber for the circadian system. Despite the 
enormous variation in daily light exposure and other zeitgebers, and the 
heterogenicity of the human tau, we still remain entrained to the solar day and re- 
entrain after a period of desynchronisation. These recent findings suggest that the 
treatment needed to adjust rhythms might not need to be so bright, just 
appropriately timed and possibly of a wavelength attuned to circadian 
photoreceptors.
1.2.4.4 Exercise
Evidence to support exercise as a circadian zeitgeber is conflicting; some studies 
have reported exercise induced phase delays when exercise is undertaken during 
the evening or night (Schmidt, 1992; Van Reeth et al, 1994), while others have 
been inconclusive or found no effect (Van Cauter et al, 1993; Baehr et al, 1999). 
Schmidt et al (1992) suggested that if there is an effect of exercise it is weaker 
than light and can be negated by morning light exposure.
Buxton has consistently observed a dual effect of exercise on the circadian 
system. Firstly an acute effect on melatonin secretion; during evening and night­
time exercise secretion increased with exercise intensity. Secondly and 
independently of that, Buxton found a phase shifting effect on the next melatonin 
rise following exercise (Buxton et al, 1997).
The mechanism by which exercise can cause a phase shift is not clear, but the 
complex relationships between circadian rhythms in temperature, hormones and 
activity may be involved. It is a difficult zeitgeber to measure as there is usually a 
concurrent light exposure, change in posture and associated increase in body 
temperature, all o f which will contribute to effects on the circadian system. Work 
oriented activity could encourage adaptation, especially where sufficiently 
strenuous and undertaken during a susceptible circadian phase, however Barnes 
et al (1998a) did not find a difference in circadian phase shift between offshore 
installation drill workers (high physical activity) and control room operators (low 
activity levels).
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1.2.4.5 Exogenous Melatonin
The potential use of melatonin administration for phase shifting circadian 
rhythms has been investigated and reported since the 1980’s (Arendt et al, 1985). 
It can even act as a zeitgeber on its own endogenous secretion (Arendt et al, 
1985; Lewy et al, 1992, 1996; Zaidan et al, 1994). Taken orally in 
pharmacological doses melatonin can induce sleepiness and phase advances or 
delays in the circadian system, depending on the timing of the administration 
(Lewy et al, 1998). The extent of phase shifting ability of melatonin is dose 
dependant over a range of 0.05 to 5mg, and takes effect over the following 
24hours, with an acute effect on sleepiness and performance for up to 1.5 hours 
after administration (Deacon and Arendt, 1995). This limited period of efficacy 
probably reflects the rapid metabolism and elimination of melatonin.
1.2.4.6 Social and environment cues
Daily routines also contain cues to entrain the circadian clock. Imposed sleep 
schedules have been shown to lead to larger phase shifts when combined with 
light treatment than when either treatment is applied alone (Mitchell et al, 1997; 
Horowitz et al, 2001).
Family life and household noise levels cause disturbances to day-time sleep that 
might interrupt and impair the adaptation process in shiftworkers. In fact day­
time napping in itself may phase shift the human melatonin rhythm (Buxton et al, 
2000), although in Buxton’s experiment naps were taken in darkness, so the 
phase shift found could not be attributed to the nap alone, as light exclusion is 
also likely to have contributed. Thus as with other zeitgeber treatments, timing of 
the nap may also be a factor.
Eating and meal timing is an important social cue, certainly foods consumed at 
night will have an effect on metabolic parameters with a circadian component. 
Krauchi et al (2002) found a phase advance effect of a morning carbohydrate rich 
meal on the rhythms of core body temperature and heart rate, but no phase shift 
on melatonin, suggesting that food may entrain peripheral oscillators, but have no 
effect on the central or master clock, the SCN. Waterhouse et al, also recently
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compared the effects of morning and evening meals on the circadian rhythm 
parameters and found that rhythm amplitude in temperature and heart rate were 
higher at night after the p.m. meal, but no phase shift in melatonin rhythm 
occurred (Waterhouse et al, 2004). However the normal day-time light exposure 
would most likely override any phase shift, masking the meal effect. Additionally 
the effects on temperature and heart rate might be accounted for by diet induced 
thermogenesis. It is difficult to evaluate the effect of feeding on human phase 
shifting because, although it has been controlled in the study of other zeitgebers, 
it has not been studied in the their absence.
The effect of night-meals, or meals consumed during a period of 
desynchronisation, on metabolic parameters is interesting in terms of health and 
is discussed in section 1.5.6.
1.2.4.7 Masking factors
One of the difficulties of circadian rhythm studies is controlling for the effect of 
zeitgebers. Environmental factors can influence the duration and amplitude of 
circadian rhythms, so that the purest research must be undertaken in constant 
conditions. In field research conditions this is expensive and impractical as 
constant conditions do not reflect the interactions between zeitgebers that occur 
in real situations. It is important to consider these possible interactions to avoid 
masking the true effects of the research parameters, for example in a hypothetical 
study of the effects of exercise where the marker of circadian phase measured is 
temperature, the metabolic increase in temperature caused by the exercise would 
mask the temperature rhythm. Additionally the phase delaying effect of exercise 
at night could be inaccurately interpreted if there is also moderately bright light 
during the study.
To obtain unmasked results constant routine protocols, where a constant 
condition of all non-test parameters is maintained to allow test parameters to be 
measured without masking, are frequently designed in circadian rhythm research 
(Duffy and Dijk 2002). In an experimental or simulated environment a constant 
routine is achievable through protocol design and controlled environment, 
however in the reality of a field research working environment such control may
19
unreasonably intrude on the demands of the workplace and it necessitates greater 
reliance on the compliance of subjects. It is hard to completely remove all 
masking factors; moreover in an industrial field setting it would be impractical to 
do so.
1.2.5 Disturbances to Normal Circadian Rhythms
1.2.5.1 Types of disturbance
There are several circumstances in which normal circadian rhythms can be 
disturbed, such disturbances are manifested in measurable effects on rhythm 
parameters, such as the rhythm in melatonin and the associated sleep pattern. 
They may have a genetic origin, such as the disorder of Smith-Magenis syndrome 
where a gene mutation causes disturbance to the timing of melatonin synthesis, 
and sleep phase disorders where the melatonin production rhythm is mal- 
synchronised with the dark period (reviewed in Cermakian and Boivin 2003). 
Circadian disturbance may also be of a physical nature such as blindness that 
reduces or removes light perception so that no entrainment by light can occur 
(Lockley et al, 1999) or have an environmental basis as in jet lag and shift work 
where the desynchrony is imposed by a change in subjective clock time.
1.2.5.2 Sleep disorders
A number of sleep disorders are associated with disturbed or misaligned circadian 
rhythm, for example, delayed sleep phase syndrome, sleep onset insomnia, 
advanced sleep phase syndrome, early morning awakening and non-24-hour 
sleep-wake syndrome (Arendt, 1998). Delayed sleep phase syndrome causes 
increased sleep latency and the entire sleep phase is delayed resulting in late 
awakening as well. In advanced sleep phase syndrome the desire for sleep occurs 
very early and subjects awaken long before dawn. Sleep onset insomnia and early 
morning awakening are the two opposite expressions of shortened sleep phase.
All of these syndromes are disruptive to lifestyle and can result in a chronic state 
of sleep deprivation, although the acuteness with which the subject is affected 
will vary. As these conditions can be familial (Jones et al, 1999) the altered sleep 
phase can be at least partly attributed to clock genes. A mutation of the per2 gene
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has been linked to an advance in the rhythm or a shortened tau (Toh et al, 2001). 
Inter-individual differences in diurnal preference have also been linked to 
heterogenicity in human clock genes (Archer et al, 2003).
Sleep disturbances are not all necessarily due to circadian disorders, but can 
manifest as a secondary effect of imposed circadian rhythm disturbances i.e. 
where the circadian phase becomes misaligned by a change in environmental 
conditions, such as in transmeridian travel or night shift work.
1.2.5.3 Blindness
Non-24-hour sleep-wake syndrome is rare in sighted people, but common in the 
blind especially where there is little or no light perception allowing the 
endogenous circadian rhythm to free run to its natural tau. This results in the 
biological rhythms, including sleepiness, alertness, temperature etc, becoming 
desynchronised from clock time, thus the blind person’s sleep becomes 
dissociated from night-time. The syndrome results in poor night-time sleep and 
increased daytime napping, however where there is some light perception, 
strongly enforced social or activity zeitgebers or where melatonin is used as a 
treatment, the circadian rhythm of a blind person can be entrained to a maintain a 
24-hour oscillation (Lockley et al, 1999; Lockley et al, 2000; Hack et al, 2003).
1.2.5.4 Phase shift disturbances
1.2.5.4.1 Shift work and Jet lag
The desynchronisation of the human circadian system and its ability to adapt has 
been felt by many of us when we travel across time zones. The associated 
symptoms of fatigue, disturbed sleep pattern and sometimes digestive malaise are 
collectively accepted as ‘jet-lag’; defined as “A general feeling of fatigue and 
disorientation felt by travellers by jet aircraft who cross several time zones in 
relatively few hours” (Dictionary definition, Harper-Collins, 1996).
Trans-meridian travel and night shift work both force a de-synchrony between 
clock time and circadian time, so that as the circadian rhythm of sleepiness 
reaches its peak we are expected to work or interact, and then at the peak of
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alertness we are expected to sleep. After a number of days in a new time zone the 
circadian rhythm and sleep wake cycle realign to the new time and the symptoms 
desist. Thus phase shifting the body clock to suit the environment is the cure for 
the symptoms of misalignment.
Shift work and jet lag both bring about an immediate desynchronisation of the 
circadian clock and real time. Shift work, unlike jet lag, does not usually cause 
an adjustment in circadian phase as the change in environmental zeitgebers is 
never as complete as it is when travelling to an entirely different environment, 
consequently the symptoms may persist or re-occur at each shift change.
1.2.5.4.2 Seasonal affective disorder
Seasonal affective disorder (SAD) or ‘winter depression’, first described in 1984, 
is reported as a phase shift disorder as sufferers' phase alignment to the light-dark 
cycle drifts in winter due to the reduced light levels (Lewy et al, 1987, 2002). The 
disorder, reported to arise from a circadian phase delay caused by the long winter 
nights, results in increased sleep duration in winter and effects appetite. The 
phase delay can be reversed by bright light treatment which is used as a therapy 
for SAD (Magnusson and Boivin, 2003), and the rhythm usually entrains by 
natural light during the longer days of the summer months, thus relieving the 
depression.
1.2.5.5 Effects of circadian disturbance
There are short term and long term physiological effects that occur in response to 
desynchrony. The immediate effect of desynchrony of clock time from circadian 
time is the change in exposure to environmental variables such as light, thus the 
activity all of physiological rhythms that respond to light will occur out of phase 
with the sleep wake cycle. The result is a myriad of symptoms that can include 
reduced alertness during work time, inappropriate timing of sleepiness, altered 
mood and appetite, disturbances to digestive function and metabolism. These 
symptoms can present an immediate risk where alertness impacts on performance 
or safety, such as when driving or operating machinery. In addition there is a 
longer-term issue where the effects impact on individuals’ health and well being.
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The effects of shiftwork, which take into account circadian disturbance, on health 
are discussed further in section 1.5.
1.3 C ir c a d ia n  d isr u ptio n  in  Sh ift w o r k
1.3.1.1 Defining Shift work
Approximately 25% of the working population undertakes some form of shift 
work (Akerstedt, 1990). This figure may be an underestimation given the rise in 
demand for a 24-hour society over the last decade. In 2003 15% of the UK 
population reported having an occupation that involved shift work or non 
standard hours, and European statistics indicate that 18.8% of the workforce are 
employed in shift work that includes night work whilst 7% of the workforce, with 
a definite bias towards men, permanently work night shifts. Akerstedt defined 
shift work as ‘an arrangement of work hours which employs two or more teams 
(shifts) of workers in order to extend the hours of operation beyond that of 
conventional office hours’ (Akerstedt, 1990). Mostly shift schedules seem to 
divide into fast rotating schedules (these include a rota of early morning shifts, 
afternoon shifts and evening or night shifts), slow rotations of days alternating 
with nights over a longer period, i.e. 5 days or more, and permanent night shift 
work.
1.3.2 Circadian de-synchrony in shift work
1.3.2.1 Desynchrony and shift type
The physiological desynchrony of the circadian system that occurs in shiftwork 
and the symptomatic effects that this induces have been introduced in section
1.2.5.4. However as shift schedules are highly varied, so the physiological 
response to them is also diverse. A night shift causes the body to attempt to make 
physiological adjustments in order to phase shift the circadian clock to re-align 
with the new working hours. In most night-shiftwork situations there are still 
environmental time cues associated with normal day/night living conditions 
exerting effects on the circadian system. These environmental cues (clock time, 
social interaction, meal times, exercise and light exposure), that can entrain a
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rhythm to a new schedule, can also prevent the circadian rhythm from realigning 
and in many circumstances no adaptation to the night shift takes place.
The common fast rotating shift schedules, where workers undertake a shift 
rotation of early mornings, late days, night shifts and days off, rarely result in 
significant circadian phase shift (Burgess et al, 2002; Akerstedt 2003), as the fast 
rotation and environmental cues interact so that there are neither the conditions 
nor sufficient time to adjust before another change in schedule is imposed. Even 
working permanent night shifts may not induce an adaptive phase shift if the day­
time zeitgebers are still present to maintain the entrainment of the circadian 
melatonin and sleep rhythms to the light dark cycle.
Exogenous factors exist for both day and night workers but because they can be 
manipulated these become more important in shift workers whose schedule 
demands that they regularly change shift, or need to adapt. Given an 
environment where at least some zeitgebers are removed or controlled, such as 
offshore oil and gas platforms and the Hailey British Antarctic survey base, it is 
possible for night shift workers to advance or delay the timing of their circadian 
clock to coincide with the shift work schedule rather than clock time (Deacon and 
Arendt 1994; Barnes et al, 1998a; Gibbs et al, 2002a). In these isolated, 
controlled conditions although the potential to adapt to a shift is present, actual 
achievement of adaptation seems to depend on the relationship in timing of the 
shift and any number of zeitgebers. During an adaptation period, these shift 
workers are exposed to the same factors, potentially deleterious to their health 
and well being, as a non-adapted shift worker, and in a working environment 
such factors have consequences for safety as well as for health.
1.3.3 Resynchronisation in shiftwork
1.3.3.1 Defining adaptation
Adaptation of the circadian system has been studied extensively (Burgess et al, 
2002 for a review), but without a widely accepted definition of what constitutes
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adaptation. Any measurable and sustained phase shift (a movement in the timiag 
of the rhythm) of the circadian system from a baseline measure could be 
considered to be an adaptation. The first point at which this occurs, or at which 
there is a significant change from the starting point, presents options foi 
adaptation criteria to be defined. However in terms of jet lag or shiftwork a 
person could be considered adapted when a sufficient movement of the rhythm is 
achieved to resynchronise with the imposed shift or sleep/wake schedule (Martin 
and Eastman 1998; Burgess et al, 2002). Adaptation must therefore be 
quantified, this is generally done by the phase shift of a circadian rhythm marker 
e.g. melatonin, cortisol or temperature rhythm and, with less certitude, by 
objective/subjective measures of parameters affected by synchrony and de­
synchrony, such as performance, fatigue, and sleep.
1.3.3.2 Phase shifting to adapt to shift work
In a shift work environment exposure to a complex combination of zeitgebers at 
all times of the waking and working day can both encourage and hinder a shift of 
the circadian phase. Phase shifts in shift workers have been extensively reported 
(Midwinter and Arendt, 1991; Sack et al, 1992; Boivin and James, 2002; or for 
reviews see Ahasan et al, 2001; Burgess et al, 2002) and attributed to a number of 
factors, with light emerging as the most robust adaptation factor (Koller et al, 
1994; Eastman, 1992, 1995; Bougrine et al, 1995). The change in the timing of 
zeitgeber exposure, i.e. changing to nocturnal work from normal day time 
activity, in relation to the circadian rhythm is paramount in the result being an 
‘adaptation’ (Eastman 1992). Bougrine et al (1995) suggested that the phase shift 
achieved over the first three nights of night shift was durable as the adaptation 
was maintained throughout the remainder of the schedule.
Partial adaptation by phase advance occurs in some permanent hospital night 
workers. After two to five night shifts an advance in the melatonin acrophase 
timing in comparison to control subjects was found by Sack et al (1992), but this 
phase shift was insufficient to synchronise the acrophase with the sleep period. 
However in the isolated conditions of the Antarctic, adaptation to night shift was 
reported by Midwinter and Arendt (1991), who demonstrated phase shifts in the
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rhythm of 6-sulphatoxymelatonin that were greater than nine hours in summer 
time (continuous light) night shift workers and still more than five hours in winter 
(continuous dark) night workers. This adaptation occurred over one week of night 
shift work and demonstrates that complete adaptation can occur, with and without 
natural bright light.
1.3.3.3 Non zeitgeber factors affecting adjustment
The zeitgebers and environmental factors that influence the extent and direction 
of adaptation have been introduced and discussed -  however the variation in 
adjustment that is seen cannot be accounted for entirely by these factors, as even 
when they are controlled there are differences within individuals (Gibbs et al, 
2002a). That individual differences in adaptation or shift work tolerance might 
be attributed, at least in part, to diurnal preference, has not yet been elucidated 
but it is an interesting speculation. Recent findings have shown that diurnal 
preference is associated with a polymorphism in the per3 clock gene, with the 
long allele being more associated with momingness and the short allele more 
with eveningness (Archer et al, 2003). It is also known that the diurnal 
preference for momingness is associated with shorter tau, earlier pattern of 
melatonin production, and selected sleep period (Duffy et al, 2001). This 
indicates a heterogeneity in the timing of individuals' circadian phase, and 
therefore also in the timing of zeitgeber exposure in relation to circadian phase, 
which has consequences for shift work adaptation. It may in part explain the 
individual variation.
There is disagreement over the effect of age on adjustment, as Honma et al 
(1992) found no effect, but Harma et al (1992) reported that older shiftworkers do 
not adapt (subjectively) as rapidly as younger workers and suffer worse sleep and 
alertness on consecutive nights than their younger colleagues. The preference 
towards momingness increases with age (Duffy et al, 2001, Archer et al, 2003) so 
it is possible to speculate that older workers would find it harder to recover and 
sleep after a night shift, but could preferentially select an early morning shift. 
The ‘healthy worker effect’ may mask the true extent of the effect of age on
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tolerance to shift work as workers may deselect shift work as tolerance decreases. 
Diurnal preference may be a factor in selection or deselection of shiftwork.
Honma et al (1992) reported other non environmental factors that affect an 
individuars ability to adapt, and suggested that sleep performance, mood on 
waking and the number/frequency of health problems would all increase the time 
required to adapt.
1.3.4 Resynchronisation in offshore work
1.3.4.1 Diversity in offshore shiftwork schedules
The complexity of designing shift schedules requires consideration of factors 
other than simply those most appropriate for circadian adaptation. Operational 
constraints, such as helicopter schedules and crew change arrangements, further 
complicate decisions about shift rotation schedules. Thus the current diversity of 
shift patterns operated offshore has developed over the life of the industry with a 
basis in logistical factors and, the safety of a schedule. More recently, circadian 
disturbances and health consequences have been considered.
The range of shift schedules worked offshore is extensive, with tour length 
varying from one week to four weeks, and shift combinations including straight 
days, straight nights or swing shifts combining days and nights in a number of 
ways. Additionally shifts commence and finish at different times, running from 
0600hto 1800h, 0700hto 1900h, 0800hto 2000h, or 1200 to 2400h. Commonly 
operated schedules include 14-21 days or nights either continuously or rotating., 
and swing shifts where a week of nights is followed by a ‘swing shift day’ in 
which the worker has two short rest periods and one short work shift in order to 
change the time of their working period for the following week. The swing shift 
can also be reversed to be a ‘days to nights swing schedule’ or extend to 21 days 
combining a rotation of nights and days.
1.3.4.2 Adaptation to shifts offshore
Most of the research into shift work and health has focussed on rotating shift 
patterns in onshore industries with little work offshore. Only recently has it been
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highlighted that offshore oil and gas installation workers have different shift 
patterns and environmental factors to consider, producing different physiological 
responses particularly with regard to circadian adaptation to night shifts. The shift 
schedules operated offshore are usually different from those operated in onshore 
industries and the offshore oil installation provides an environment where some 
factors can be controlled. Thus the offshore environment presents an opportunity 
for circadian adaptation to night shift work, but brings other problems into the 
equation, such as cumulative fatigue, and the necessity to resynchronise to day 
life on return to shore.
The offshore oil and gas industry schedules work tours of 12-hour shifts for 7, 14, 
or 21 continuous days, permanent nights or combined nights and days. The 
schedules include managed meal times, segregated shifts and day-time darkness 
for night workers. These workers follow regular rotating shifts and night shifts. 
While it has been shown that offshore shift workers on certain schedules can 
physiologically adapt to a specific night shift (Barnes et al, 1998b), the process 
takes days, so they may be working a significant percentage of their tour in an 
unadapted state on both the day and night shifts. If it becomes apparent from the 
present research that working, eating and sleeping in this environment has health 
consequences, specific advice and guidelines for offshore working may be 
required, for both employers and shift workers, to minimise the effects.
Adaptation to night shift on North Sea oilrigs has been investigated, using the 
rhythmic production of the hormone melatonin, assessed via its urinary 
metabolite 6-sulphatoxymelatonin. The research indicated that on a 14 day tour 
of 12 hour night shift, 1800-0600h, subjects are ‘out of phase’ for at least the first 
4-5 days of the night shift (Barnes et al, 1998a) and so would also be out of phase 
for 4-5 days on returning home. Based on this ability to adapt, for a 7-night, 7- 
day sequence starting with night shift (1800-0600h), subjects would be out of 
phase for at least 4-5 days on night shift, followed by 4-5 days out of phase on 
day shift. Thus on a swing schedule of nights followed by days optimally adapted 
working conditions might only be achieved for 4-6 days of a 14 day period 
offshore.
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For a 14-day sequence starting with day shift (1200-2400h, 7 days) then 
switching to night shift (2400-1200h) the majority of crew do not adapt to night 
shift (Barnes et al, 1998b). Barnes found that some shift patterns lead to variable 
circadian adjustment with strong seasonal effects (Barnes 1998b), probably due 
to lack of synchronisation with daylight and long summer/winter day length 
effects in the northern North Sea.
1.3.5 Recovery from shift work
Although Barnes et al, showed a significant advantage of the 14D/14N rotation 
patterns in assessments of sleep, alertness, mood, and cognitive performance 
(Barnes et al, 1998a), a survey of workers showed a marked preference for the 
7N+7D pattern as this allowed adjustment to a normal routine before going on 
leave (Parkes et al, 1997). This worker preference for the 7N7D schedule appears 
to be due to the adaptation period felling within company time, not personal time.
The time required for recovery between periods of shift work is as affected by 
circadian phase and zeitgebers as is adaptation. If the worker has not adapted to 
any schedule then recovery may simply occur with sufficient rest. However if a 
phase shift adaptation has occurred the re-adaptation period is complicated by the 
conditions and phase position of the worker’s circadian rhythm. Totterdell et al, 
(1995) suggested that two days rest before night work was better for night shift 
performance than one rest day, but that four days rest resulted in slower reactions 
indicating reduced alertness. However as this was measured in slow rotation shift 
workers and circadian phase was not measured, it is not possible to take 
maladjustment into consideration.
In the Antarctic summer adapted night workers took a week to re-adjust to day 
time schedules, while in the winter, when natural light exposure is nil, night 
workers took three weeks to realign their circadian rhythm to daytime (Midwinter 
and Arendt, 1991). The re-adaptation was hastened by light treatment to one 
week, the equivalent of the summertime recovery period (Midwinter and Arendt 
1991). The use of light treatment in readjustment after shift work was reported
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by Bougrine et al (1995) who used light to hasten adjustment during night shift 
work and during the sequential recovery days. Light treatment during re­
adjustment has also been investigated in offshore workers returning to home: a 
faster improvement in cognitive performance and sleep recovery was seen with 
than without the light treatment (Bjorvatn et al, 1999).
1.4 SHIFT WORK AND HEALTH
1.4.1 Why work shifts?
Shift work is primarily driven by economics; businesses need to utilise their idle 
resources, and people require income and sometimes need to exploit the night 
time hours. Shift work is becoming more and more a necessary part of working 
life as the demand for a 24 hour society increases, yet it introduces some 
concerns for the health and safety of the worker.
Health is not likely to be a factor in choosing to undertake shiftwork, but it may 
be a factor in de-selecting it; in a study of consequences of shiftwork ‘health 
impact’ was the most reported disadvantage (Ohayon et al, 2002).
1.4.2 Health and shiftwork
1.4.2.1 Associations with health and well-being
In a review of health and shiftwork Nicholson and D’Auria (1999) found no 
statistical increase in morbidity in shift workers, however they and many other 
studies show increased incidence or risk of ill-health amongst shift workers. 
Reported associations between shift work and health include fatigue, reduced 
sleep quality, headaches, muscular-skeletal pains, gastrointestinal disorders and 
an increase in heart disease risk factors, altered bowel habits, stress and 
irritability, and possibly with asthma, epilepsy, and chronic fatigue syndrome 
(Nicholson and D’Auria, 1999; Boggild and Knutsson, 1999; Tenkanen et al, 
1998; Costa, 1997; Parkes, 1999; Mohren et al, 2002).
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In addition to shiftworkers suffering more from respiratory and gastrointestinal 
infections than their day work counterparts, they also attribute more blame to 
their work for general discontent (Mohren et al, 2002). Stresses in home life add 
to the woe of shift workers as their partners report that shiftwork impacts on their 
family life too (Smith and Folkard, 1993).
The only study of offshore shift workers and effects on specific health parameters 
demonstrated that sleep related health was associated with shiftwork, and external 
conditions, such as cold and weather conditions, were felt more severely by night 
shift (Parkes, 1999). However many of the other recorded health symptoms were 
attributed to job type when controlled for shiftwork, for example administrators 
suffered more headaches and drillers suffered more back pain (Parkes, 1999).
The effects of shiftwork on sleep and sleep on health are discussed further in 
section 1.4.3.
In addition to long term health issues, when the working environment 
incorporates dangerous activity, fatigue and reduced alertness present a more 
immediate health and safety risk. The risks to health and safety are elaborated in 
section 1.4.4. Two aspects of health recently associated with shiftwork drawing 
public attention are the increased risks of heart disease and of cancer:
1.4.2.2 Shiftwork and heart disease
Shift work has been associated with several independent risk factors for heart 
disease, including increased incidence of diabetes, hypertension, IR and impaired 
lipid metabolism (Boggild and Knutsson, 1999; Nicholson and D’Auria; 1999, 
Karlsson et al, 2001; Hampton et al, 1996). Altered diet in shiftwork may be 
implicated in well being, and the simple fact that shiftworkers eat at night when 
metabolic efficiency is at its lowest, may be a factor in shiftworkers’ heart 
disease risk. Shiftwork and CVD is further discussed in section 1.5.
1.4.2.3 Shiftwork and cancer
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The association between shiftwork and cancer is relatively new, Stevens first 
reported the link between the incidence of breast cancer and night shift light 
exposure (Stevens, 1987). Stevens proposed the melatonin hypothesis as the 
causative link, whereby the suppression of melatonin by the night time light over 
the peak melatonin production period, results in an overall reduction in melatonin 
amplitude (Stevens and Davis, 1996; Stevens, 2005). The theory hinges on the 
oncostatic (and possibly apoptotic) properties of melatonin (Davis et al, 2001; 
Schernhammer et al, 2001; Schemhammer and Shulmeister, 2004), thus the 
reduced levels of melatonin would result in reduced protection. Lissoni et al 
(2003) presents three possible mechanisms for an association between melatonin 
and cancer: anti-proliferative, immunostimulatory, and protective antioxidant 
effects and reported beneficial melatonin therapy (although not specifically in 
shiftwork related cancer). Other cancer and night work associations have since 
been made in a number of different work types (see Swerdlow, 2003 for a 
review).
1.4.3 Shift work and Sleep
1.4.3.1 Sleep mechanisms
Ultimately there are two factors that bring on sleep; one being fatigue - the 
physical need to rest, the other being the biological circadian signal that it is time 
to sleep (Dijk and Lockley, 2002). So although sleep propensity has other factors 
such as fatigue, the activity and sleep rhythm of the body is tied to the circadian 
clock. The circadian rhythm of body temperature, particularly the fall in body 
temperature following melatonin rise, is a predictor of rapid sleep onset, 
Cajochen et al (2003).
Melatonin per se is not correlated with sleep (subjects with a very low melatonin 
secretion can still sleep), it is the rhythm of melatonin that is associated with 
sleep. The rise in melatonin (or an exogenously given dose when endogenous 
melatonin is low) increases sleepiness (Cajochen et al, 2003), and wakefulness 
follows the fall in melatonin and associated rise in body temperature (Akerstedt, 
1990). Thus if the time period designated for sleep becomes desynchronised from 
the circadian rhythms of temperature and melatonin, then sleep may suffer.
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1.4.3.2 Sleep in shiftworkers
Sleep is undoubtedly disturbed by shift work. The enforced desynchrony between 
the body clocks sleep signal and the time in which sleep is scheduled is in itself a 
disturbance, which impacts profoundly on sleep parameters such as sleep latency 
(the time taken to fall asleep), and difficulty of wakening, and overall sleep 
quality. Disturbance of sleep associated with shift work, loss of sleep and sleep 
quality, is the most frequently reported ill-effect and one of the reasons for 
discontinuation of shift work (Ohayon et al, 2002; Akerstedt, 1990). Certainly the 
unadapted shiftworker will have a melatonin output desynchronised from his/her 
sleep-wake cycle and therefore will feel the effects in terms of body temperature, 
alertness and sleepiness at inappropriate times. Akerstedt (1984, 1990), reported 
reduced sleep duration and sleep quality as the most common symptoms, and that 
sleep duration is reduced by 1-4 hours in night and early morning shifts. It is 
related to the extension of sleep latency in early morning shifts -  these workers 
often go to bed early in order to wake early for their work shift, so they are 
attempting to sleep before melatonin is sufficiently risen to induce sleepiness. 
Ohayon (2002) found that sleep duration is shortest in night shift workers over 
rotating and day shift workers, but that the greatest variation in sleep disturbances 
occurred in the rotating shift workers.
Offshore workers are reported to have better sleep quality on night-shift than day 
shift, but no significant difference in the sleep duration (Parkes, 1994), whereas 
in onshore work the reverse is true, and in addition the day workers have longer 
sleep duration. The reasons for improved night shift sleep quality offshore might 
be that there are no family or lifestyle disturbances offshore and sleep 
interruptions are avoided. Home and family duties may also explain why day­
time sleep is reduced in onshore night shift workers; offshore there is less to do in 
free time and so more time may be spent in sleep.
1.4.3.3 Sleep, desynchrony and mood
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The association between mood and fatigue is undeniable; every parent recognises 
tiredness in their child even when they do not appear to be sleepy. Boivin et al 
(1997) showed that not only is mood associated with the duration of prior 
wakefulness, but also with circadian phase. Thus desynchrony of the sleep-wake 
cycle can have a dual effect on mood via time-since-sleep and circadian phase. 
This has an acute effect in jet lag, and may manifest more chronically in seasonal 
affective disorder where it is not until the longer days of spring and summer 
provide relief via the synchronising effects of daylight (Lewy et al, 2002). In 
shift work where circadian desynchrony occurs, there might be acute effects on 
mood due to fatigue, but also chronic effects depending on the shift schedule, 
rotation and duration as well as season.
1.4.3.4 Sleep loss and health
Disturbance to the circadian rhythm usually results in a loss of sleep via a 
shortened sleep duration that results in acute sleep deprivation, the effect of 
which is sleepiness and reduced alertness; this can often be made up in the 
following nights’ sleep. If however the disturbance is continuous or repeated, the 
sleep deprivation will become chronic (Akerstedt et al, 1994), adding symptoms 
of altered mood and appetite, and digestive complaints to the sleepiness and loss 
of performance. Additionally there is evidence to show that sleep debt impacts on 
the immune system (Dinges et al, 1995) and endocrine function (Spiegel et al, 
1999), causing effects on carbohydrate metabolism and glucose tolerance which 
are suggestive of metabolic syndrome and increased risk o f cardiovascular 
disease.
Studies into sleep deprivation and immune parameters in healthy people are 
agreed that there is an effect, but report different immune parameter findings 
(Dinges et al, 1995; Bom and Lange, 2002). There is an association between 
sleep and immune function as sleep, via circadian rhythms, generates a hormonal 
environment that is supportive of immune cell function and lymphocyte 
synthesis. This association may be two-way in that sleep allows daily restitution 
for the immune system, and in acute immune response to infection the increase in
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cytokines, (e.g. 11-6, IFN-alpha and TNF) is associated with increased sleepiness 
and can induce a greater propensity to sleep (Bom and Lange 2002).
Dinges et al (1995) concluded that sleep deprivation increases the non-specific 
immune responses such as phagocyte and NK cell activity and has immuno 
suppressive effects via reduced lymphocyte blastogenesis and reduced synthesis 
of T-cell activity. More recently Dinges (2002) suggested that sleep loss may 
promote inflammatory responses, as pro-inflammatory monocyte derived 
cytokines increase in a dose response relationship with sleep loss. These same 
cytokines stimulate the hepatic synthesis of the inflammatory marker C-reactive 
protein (CRP) that is a reliable predictor of subsequent cardiovascular disease 
events (Dinges 2002). Furthermore Meier-Ewert et al (2004) demonstrated raised 
CRP in sleep deprived subjects. Although no acute health impact of impaired 
immune function following sleep deprivation has been reported, this pro- 
inflammatory effect may provide a mechanistic link to the elevated CHD risk 
associated with sleep loss and shift work.
1.4.4 Shiftwork health and safety
1.4.4.1 Fatigue and performance
The effects of shiftwork on performance, safety and well being have been widely 
studied (Monk et al, 1996; Folkard and Tucker, 2003). Where sleep is impaired 
there will be a compounded effect on cognitive performance as the circadian 
disruption effects are combined with lowered mood and compromised alertness. 
Costa (1997) suggested that performance efficiency may parallel the circadian 
rhythm of body temperature and discusses the desynchronisation of circadian 
rhythms as a probable factor in decreased work efficiency and vulnerability to 
human error during night work.
Parkes (1999) has shown that shift patterns, job types and installation 
characteristics were significant predictors of safety, work and health measures. 
Evidence that offshore workers on night shift schedules undergo physiological 
adjustment in circadian rhythms (Midwinter and Arendt, 1991; Barnes et al, 
1998a) is supported by the data on cognitive performance, which showed that
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performance plateaued after three to four days on a night shift before falling 
sharply after a “swing” shift (Parkes, 1997). Parkes’ data suggests that there is an 
improvement in, or at least a recovery of performance associated with the night 
shift adaptation.
Reduced performance and increased errors are related to sleepiness and fatigue in 
shiftworkers (Akerstedt, 1990; Monk et al, 1996), with the suggestion that the 
impairment may be equal to that of moderate alcohol consumption (Akerstedt, 
1990; Haraldsson and Akerstedt, 2001).
1.4.4.2 Injuries and accidents
The requirement for sleep is an irresistible biological need, and maintaining 
wakefulness through the nadir of the activity rhythm is difficult, resulting in 
reduced alertness, and sometimes unavoidable lapses into unscheduled or 
involuntary sleep (Akerstedt, 2003). Such lapses in concentration, if they occur 
in the workplace or while driving home, present a risk to safety that is additional 
to and acutely more dangerous than the risk that sleep deprivation presents to 
health.
Monk suggested five areas of concern for performance and safety in shift 
workers: Errors, sleep and fatigue problems, mood related disruptions, absences, 
and off work accidents (Monk et al, 1996). Monk presented the following 2X2 
classification of the relationship between nightshift work error and the danger it 
represents (Monk et al, 1996):
Error Vs Failure to respond
X
Danger to society Vs Danger to self
Monk’s model is highly applicable to the offshore environment, whether fatigue 
causes error or sleepiness causes failure to respond, the outcome can represent a 
danger to the individual. In an industrial or commercial environment the same
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level of fatigue in a worker brings about a danger to the immediate population 
that is out of all proportion to the scale of the initial error/failure to respond. 
Given the dangerous nature of the offshore environment, fatigue and performance 
of all workers are critical issues in offshore safety that are complicated by the 
possibility of maladaptation, and consequently increased fatigue, in day shift as 
well as night shift workers.
Some of the most serious industrial accidents have occurred during the night 
shift, yet the relationship between accidents/incidents and night shift is not yet 
clear. The work so far is limited in that it is mostly observational studies with no 
interventions, and only a limited range of industrial settings (Frank, 2000). In a 
review of the literature reporting industrial injuries related to shift work, Frank 
found disagreement between the publications, some reported a higher risk of 
injury in rotating shift work that on fixed shifts, while others found no significant 
difference in the rate or severity of injuries between shift and non-shift workers. 
Frank concluded that there was a greater risk of injury in those schedules that 
rotated more frequently than weekly and when there increased distraction, such as 
immediately before a shift end or break, but that there seemed to be no greater 
hazard from a longer, i.e. 10-12 hour, working day.
However Akerstedt reported a peak in errors during night shift (Akerstedt, 1990) 
and Smith et al (1994) reported an overall increased incidence of injuries in 
nightshift, and in self-paced (rather than automated) work the reported injuries 
are more serious on night shift than in the morning or afternoon.
1.4.5 Shift work and diet
1.4.5.1 Circadian aspects of eating.
Food intake has a diurnal rhythm; as humans are diurnal we eat mostly during the 
day to provide energy for our most active period. The urge to eat is triggered by 
hunger signals, a complex process of metabolic activity and hormone fluctuations 
that are switched off when appetite is satisfied and switched on again when that 
fuel has been depleted. However Reinberg et al (1979) suggested that
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appetite/food intake has a circadian component on the basis that in isolated 
conditions without time cues a rhythm in timing, frequency, quality and quantity 
of food intake was maintained. This is in contrast with Waterhouse et al (2004) 
who reported a lack of evidence for a circadian signal for eating, during a forced 
desynchrony study. Shiftwork, via the desynchrony from clock time and routine 
forces a change in the timing of food intake that may be dissociated from 
appetite, this does not appear to significantly alter the total energy intake, but 
alters and timing of foods consumed (Reinberg et al, 1979, Lennernas et al, 
1994).
1.4.5.2 Diet and performance
It is also possible that food choice could affect performance. This may be partly 
job specific as foods providing the nutrients most necessary for cognitive 
function are different from those required for physical exertion, the brain utilises 
glucose as fuel and muscles preferentially use lipid once glycogen is depleted. 
Lowden et al (2004b) reported that a high fat diet reduced overnight hunger to a 
greater extent than a high carbohydrate diet and resulted in better night time 
performance. In a study comparing high carbohydrate, high protein and a normal 
diet with cho:pro ratio of 3:1, Paz and Berry (1997) found the best performance 
resulted from the ‘normal’ diet.
A less disputed dietary effect is that of carbohydrate on increased sleepiness, (Paz 
and Berry, 1997). This occurs as a high carbohydrate and low protein intake 
induces a change in the tryptophanrneutral amino acid ratio, so that there is less 
competition for tryptophan uptake in the brain, this increases the tryptophan 
available for serotonin, and subsequently melatonin synthesis (Wurtman, 1979).
The sleepiness-inducing effect of carbohydrate foods may be offset by the initial 
energy rush provided by a simple (sugary) carbohydrate food. In a review of 
macronutrient intake and performance, Dye et al (2000) concluded that a 
carbohydrate meal increases performance in memory and attention skills (which 
may be explained by the increase in glucose utilisation during learning and 
frontal lobe activity), but is also associated with feelings of fatigue. In contrast, a
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high protein intake increased performance in accuracy tests. Dye’s findings also 
suggested that high saturated fat intakes were associated with poor cognitive 
function and learning, although it was uncertain if a high fat intake was beneficial 
or detrimental to reaction time tests. This suggests that certain foods may be more 
beneficial prior to different activities, and a high fat intake should be avoided on 
a night shift where cognitive function in important.
1.4.5.3 Dietary intake in shift workers
The dietary provision for shift workers is likely to vary enormously within 
industry environments and the availability of prepared foods will impact on the 
food choice of the workers (Stewart and Wahlqvist, 1985). For example distance 
drivers are likely to rely on snacks and road side services, industry workers may 
have anything from vending machine meals, kitchen facilities or cafeteria service, 
while lone night workers may have to provide their own food. Dietary provision 
on offshore installations has not previously been investigated, however as the 
workforce live on site, and the industry is highly geared to a 24h operation, it 
generally offers a frilly catered service to all shifts.
The eating habits of shift workers differ from those of day workers for a variety 
of reasons. Certain determinants of food choice (e.g. taste, appearance, cost and 
nutritional value) may be foregone in favour of food availability and 
convenience, and the alteration in routine and meal time may also affect eating 
habit. Early studies of night shift eating revealed a pattern of increased ‘nibbling’ 
on carbohydrate based foods (Reinberg et al, 1979), i.e. greater intake from 
snacking and less from balanced meals. This resulted in a lower percentage of 
energy being derived from fat intake, than that seen in day time food intake in the 
same workers. Reinberg concluded that night shift workers were ‘grazers’ and 
day workers ate more regular meals.
Lennernas et al (1995) found that although patterns of eating were altered in shift 
workers along with a temporal change in energy intake, there were no significant 
differences in the total daily energy, carbohydrate, or fat intakes. However 
Lennernas (1994) also showed that night-time intakes of total energy were
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correlated with lipid profiles, suggesting that consuming a greater percentage of 
total energy during the night has consequences for lipid metabolism that are not 
present in normal day time intake. The differences between the studies are 
probably heavily influenced by the demographics of the shift work groups studied 
for example gender, industry/job type, hours worked, marital status and local 
food provision can all influence food choice and availability.
It is well established that diet, in particular the total amount and type of fat in the 
diet, is an important factor in the development of CVD (Office of Health 
Economics, 1991; Griffin and Zampelas, 1995; Lovejoy, 2002) thus if night shift 
eating or food choice alters dietary fat intake it will have a slow and silent impact 
on shift-workers’ cardiovascular health.
Knutsson et al (1990) reported that fibre intake in shift workers is reduced and 
correlates with unfavourably altered apolipoprotein ratios that are a risk factor for 
cardiovascular disease. The role of dietary fats in the etiology of atherosclerosis 
and CVD risk is elucidated further in section 1.5.5.3. while the impact of 
shiftwork on diet and the effect of night time eating on metabolic responses are 
further discussed within section 1.5.6.
Offshore workers in particular consume no alcohol during their work tour as the 
installations have a no alcohol policy, however they are also anecdotally reputed 
to consume an excess of alcohol when leaving the installation at the end of a tour, 
evidence to support the actual alcohol intake of shiftworkers is lacking.
1.5 Sh ift w o r k  and  c a r d io v a sc u l a r  disease
1.5.1 Cardiovascular disease
1.5.1.1 Cardiovascular disease incidence and etiology
According to the British Heart Foundation statistics database, CVD is the major 
cause of mortality in the UK and accounts for 39% of UK deaths (Peterson et al, 
2004) and for 29% of global deaths (WHO 2003). Although Peterson reported a
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fall in UK death rates, he also reported an increase in treatment costs and 
morbidity, suggesting the fall in mortality rate is due to an improvement in 
treatment rather than a decline in incidence. CVD has no boundaries of 
geography or socio-economic status, and incidence is rising in the developing 
countries, making it the world’s greatest cause of mortality. Risk factors include, 
hyperlipidaemia, dyslipidaemia, obesity, hypertension, smoking, lack of physical 
activity, family history of the disease, and non insulin dependant diabetes 
(NIDDM). Recent years have advanced current understanding of the disease’s 
etiology via atherosclerosis, insulin resistance (IR) syndrome and endothelial 
dysfunction and highlighted further likely risk factors (reviews include Ferns and 
Lamb 2001; Bloomgarten 2003a, 2003b; Bonetti et al, 2003). The association 
between shiftwork and CVD is discussed in section 1.5.6.
Coronary artery disease (CAD) and coronary heart disease (CHD) are diseases of 
the cardiovascular system, but the literature also refers to findings and risk factors 
in terms of CHD risk, CHD mortality and CVD risk. However as the risk factors 
apply more generically to cardiovascular disease (CVD) it is probably more 
accurate to describe the overall risk as one of CVD than specifically CHD. The 
term CHD is used here where it is specifically referred to, in individual literature.
While some CVD risk factors act independently to increase the risk of disease, 
they commonly act together to produce a compounded risk and increased disease 
progression, thus development of the disease usually has a multifactorial 
etiology. There is a predisposed risk associated with genetic makeup that is non- 
modifiable, however there also interactions between risk factors, that may 
exacerbate or reduce CVD risk. Keys et al (1984) recognised the importance of 
using risk as a predictor of mortality only in the population in which the risk data 
was collected, as in his seven countries study mortality rates in Northern Europe 
did not predict mortality in a matched population in Southern Europe.
CVD develops as one or more factors cause atherosclerotic damage and reduction 
in arterial endothelial function: Circulating lipoproteins become sequestered into 
the endothelial wall where they become trapped, thus thickening the arterial wall, 
and are prone to oxidative damage. The result is a reduced arterial elasticity,
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lumen capacity and impaired endothelial function which lead to an increase in 
blood pressure, further endothelial damage, and greater risk of thrombosis or 
occlusion.
The risk factors and atherosclerotic process are reviewed in greater depth in the 
following section. In order to explore the relationships between metabolic 
dysfunction risk factors and etiology, there is first a review of normal 
metabolism.
1.5.2 Postprandial metabolism
1.5.2.1 Insulin
Dietary carbohydrates and proteins are hydrolysed to glucose and amino acids 
respectively, and rapidly absorbed into the bloodstream A rise in blood glucose 
can be detected within minutes of eating and results in the increased secretion of 
the anabolic hormone insulin from the y£-cells o f the pancreas.
Insulin exerts fine control over the circulating levels and cellular uptake of 
glucose. Glucose is taken up by cells via membrane transporters, for example in 
muscle where glucose uptake is the major regulator of postprandial glucose 
levels, a receptor on the cell membrane is activated by insulin and triggers the 
translocation of the Glut4 transporter to the membrane surface. Insulin stimulates 
glycolysis and the utilisation of glucose and, in the liver, blocks the 
gluconeogenesis pathway thereby reducing hepatic glucose output. Glucose is 
converted to glycogen as a metabolic fuel reserve in muscle (and in liver), 
although muscle cells demonstrate a preference for lipid as a metabolic fuel, 
small amounts may be utilised for energy.
In addition to the control of blood-glucose concentration, insulin is active in a 
number of other metabolic pathways. Suppression of HSL by insulin in adipose 
tissues regulates the flux of NEFA, and via the stimulation of lipoprotein lipase 
insulin regulates the catabolism and clearance of CM-TAG and the delipidation 
of VLDL. Insulin clearance is predominantly via the liver, as signalling
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molecules trigger receptor mediated insulin endocytosis and subsequent 
degradation (Najjar, 2002).
1.5.2.2 Normal lipid metabolism
Dietary fats are transported in the circulation as Chylomicrons (CM), lipid rich 
particles with a triacylglycerol (TAG) core. CM are delipidated, the TAG 
hydrolysed by lipoprotein lipase (LPL) and the liberated NEFA utilised as a 
metabolic fuel in muscle tissue, or taken up by adipose tissue for storage. CM 
also lose TAG via neutral lipid exchange (NLE) with cholesterol esters from high 
density lipoproteins (HDL), under the mediation of cholesterol ester transfer 
protein (CETP). CM-remnants carrying the cholesterol esters and any remaining 
TAG are transported to the liver, where the remaining TAG is packaged into very 
low density lipoprotein (VLDLi and VLDL2 depending on the fatty acid 
composition and overall concentration of the TAG, see section 1.5.5.3). VLDL 
enters the circulation and this also undergoes delipidation by LPL or via further 
NLE with other lipoproteins. The VLDLi are reduced to remnants, removed from 
the circulation via endothelial membrane receptors, or reduced in size to become 
the smaller and more dense VLDL2 . VLDL2 become intermediate density 
lipoproteins (IDL), and are further delipidated by endothelial or hepatic lipases to 
LDL, the composition of which varies with the origin of their dietary fatty acids. 
For further detail of postprandial lipid metabolism see Griffin and Zampelas 
(1995), Ebenbichler et al (1995), Frayn (1992), Frayn and Coppack (1992) and 
Frayn et al (1995).
1.5.3 Compromised postprandial metabolism
1.5.3.1 Insulin resistance
Resistance to insulin mediated glucose uptake, is a condition where the 
effectiveness of circulating insulin is reduced. There is reduced cellular 
sensitivity to insulin so that a greater amount of insulin is needed in order to 
achieve the required metabolic outcome, resulting in an over production of the 
hormone. The elevated insulin combined with resistance to action at the cell
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alters the direction of several metabolic pathways. (Reviews: Reaven, 1988; 
Bloomgarten, 2003a, 2003b).
The gold standard for measurement of IR is via the euglyeaemic, 
hyperinsulinaemic glucose clamp (EGC) technique, where dual catheters are 
inserted for the infusion of a constant insulin dose, a variable glucose dose and 
the withdrawal of samples to measure glucose clearance. However this is an 
invasive and costly method. Other simpler techniques have usually provided less 
accurate or precise results as for example the oral glucose tolerance test (OGTT) 
which measure glucose and insulin responses to a 75g oral glucose load, does not 
take into account hepatic glucose output or measure /2-cell function. Hermans et
al (1999) compared numerous methods and reported the CIGMA (continuous 
infusion of glucose with model assessment) method to bear the closest correlation 
to the EGC. CIGMA measures glucose-insulin interaction in a low dose 
continuous infusion of glucose which stimulates glucose metabolism and insulin 
response in a similar fashion to the postprandial state, thus reflects both the beta 
cell function and insulin sensitivity. Recently, Soonthompun et al, (2003) 
published a mathematical model for insulin sensitivity index derived from the 
oral glucose tolerance test, but by using the area above the curve of glucose 
response, rather than area under the curve the hepatic glucose output was 
accounted for.
IR may be defined and measured by the impairment of glucose metabolism, but it 
impacts equally significantly on lipid metabolism. The routes by which the 
impaired insulin sensitivity can interfere with glucose and lipid metabolism are 
outlined below based on the normal actions of insulin.
Plasma glucose is usually tightly maintained between 3.5 and 5.5 mmol/1, 
however if resistance to insulin stimulated glucose uptake develops, glucose may 
remain postprandially elevated for longer (Reaven, 1988). The reduced glucose 
clearance results in a subsequent compensatory increase in insulin secretion.
44
The reduced sensitivity to insulin may result in lower activity of LPL, reducing 
the lipolysis of TAG from CM and increasing TAG availability in the liver for 
VLDL synthesis. Increased VLDL particle number alongside diminished LPL 
forces increased NLE, promoting TAG rich HDL and LDL (Frayn and Coppack, 
1992, Frayn, 1993). The maximal capacity of GETP is rate limiting on NLE 
(Eibenbichler, 1995), the rate-limiting threshold of CETP will be rapidly 
overwhelmed by excess TAG, resulting in extended and raised postprandial 
hypertryacylglycerolaemia. When the resulting TAG enriched lipoprotein 
particles are delipidated they form small dense HDL and LDL. The result of these 
two processes is a predominance of the more atherosclerotic small dense LDL 
and an increased duration in which these particles may be sequestered into the 
endothelial membrane space (Griffin and Zempelas, 1995; Griffin, 1999).
In the circulation, diet derived NEFA will fell as the LPL activation is impaired 
and in adipose tissue the resistance means that HSL is not effectively suppressed, 
thus NEFA is liberated from adipose cells, increasing NEFA flux and potentially, 
fatty acid oxidation (Frayn, 1998). The net effect however is higher circulating 
NEFA in IR.
In the liver the resistance to insulin dampens the pathways for glycogenesis and 
glycolysis, this and the increased supply of fatty acid promotes gluconeogenesis 
(GNG), so hepatic glucose output rises, thus further increasing the blood glucose 
level. This aspect in particular creates a vicious circle as the normal tight control 
of glucose and insulin is impaired, resulting in hyperglycaemia and 
hyperinsulinaemia.
Frayn proposed that there may be reduced hepatic insulin clearance (Frayn and 
Coppack, 1992), which is supported by Najjar’s suggestion of reduced activity o f 
receptors for insulin downregulation/degradation (Najjar, 2002), thus the eventual 
compensatory hyperinsulinaemia may be exacerbated by a reduced insulin 
clearance. Although most IR is downstream from the insulin receptor, molecular 
mechanisms for IR via mutations of the insulin receptor gene(s) have been 
suggested, causing impaired receptor synthesis, functionally altered binding 
regions, increased degradation of receptors (Scott, 2003), and it is not unrealistic
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to suppose that efficacy of the receptors for insulin degradation might also 
attenuated by a gene mutation.
IR occurs in most cases of NIDDM, the syndrome is now accepted as a 
fundamental factor in the etiology of non-insulin dependant diabetes as y&cell
compensation cannot be maintained indefinitely. As the resistance to insulin 
increases the postprandially raised glucose will impact on fasting insulin, and 
lead to a diagnosis of non-insulin dependant diabetes (NIDDM). As the y&cell
function fails this is likely to develop into insulin dependant diabetes (IDDM) 
(Reaven, 1998; Hagstrom-Toft et al, 1997).
IR also accounts for the impaired glucose tolerance that occurs in obesity, but it is 
not present in all cases. Zammit suggests that the effects of IR on lipid 
metabolism lead to the presence of metabolic syndrome long before the resistance 
compromises glucose metabolism sufficiently for a diagnosis of NIDDM, or 
overweight has reached obesity (Zammit et al, 2001).
Hypertension occurs in most IR subjects as hyperinsulinaemia results in a 
stimulation to the sympathetic nervous system, the resulting vasoconstriction and 
increased cardiac output cause the rise in pressure (Reaven, 1998; Scott, 2003).
1.5.3.2 Hyperlipidaemia and CVD risk
Hyperlipidaemia, a raised level o f circulating lipids, covers a number of different 
clinical parameters, combined with genetic, metabolic and dietary etiologies.
Hypercholesterolaemia is long established as a cardiovascular risk factor, as 
raised total cholesterol is correlated with CHD mortality (Stamler et al, 1986), 
however alone it does not adequately predict CVD, which can occur when 
cholesterol is normal, and may be absent when cholesterol is high. Other 
components of the lipid profile have since been shown to be independently 
associated with CHD risk: triacylglycerol (TAG) and the lipoproteins (VLDL, 
LDL and HDL) that transport TAG and cholesterol (Hobbs et al, 1995; Assman 
et al, 1999; Griffin, 1999).
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The status of TAG as an independent risk factor for CHD was uncertain until the 
early 1990’s as the incidence of heart disease where TAG was not significantly 
raised suggested that it did not reliably predict the disease (Austin et al, 1998). 
Hobbs et al (1995) demonstrated an association of CAD with TAG-rich LDL 
particles and Assman et al (1999) reported that TAG >2.3mmol/l was associated 
with a 1.6 increase in risk of cardiovascular events in o f middle aged men. A 
fasting triacylglycerol level >1.5mmol/l is considered the atherogenic threshold.
Hyperapoproteinaemia, as identified by an excess of apolipoprotein B, is a useful 
indicator of atherosclerotic risk when LDL is within normal range as it provides 
an indication of increased LDL particle number. There is a single apo-B on each 
LDL particle to act as a binding ligand for membrane receptors, when apo-B is 
high and LDL levels remain normal it suggests raised levels of small dense LDL.
The outcome of the compromised metabolic pathways outlined above is a 
dyslipidaemia, that is dissociated from the hyperlipidaemia described in that it 
does not necessarily raise lipid, especially LDL, levels above the normal range. 
The dyslipidaemia of IR may be exacerbated by dietary fatty acid, obesity and 
lack of exercise, to further impact on TAG and small dense LDL. The overall 
circulating level of the lipid components, and the size, density and ratio of 
lipoproteins along with the physiological ability to control them mediates the 
atherosclerotic and lipid oxidative damage to the vasculature (for reviews see 
Griffin and Zampelas, 1995; Ferns and Lamb, 2001).
1.5.4 Atherosclerosis and endothelial dysfunction
1.5.4.1 Atherosclerosis
It seems likely that the metabolic and haemodynamic situation that results from 
IR triggers atherosclerosis and endothelial dysfunction concurrently and that 
atherosclerosis adds to the dysfunction as it progresses.
The atherogenicity of small dense LDL is attributed in part to the conformity of 
the small particle’s apo-B which has a reduced binding affinity for LDL
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receptors, reducing LDL clearance and in part its susceptibility to oxidation. The 
extended duration in circulation and small size increase the chances of 
endothelialisation, and once inside the sub endothelial space the particle becomes 
trapped there.
LDL is susceptible to macrophage scavenging, and the subsequent formation of 
‘foam cells’, which develop into fatty lesions in the arterial wall. Intimal 
lymphocyte activity will increase inflammation, cytokine release and reactive 
oxygen species, producing a pro-oxidative environment, while macrophages 
release platelet-derived-growth-factor (PDGF), which stimulates smooth muscle 
cell proliferation in the lesion. Macrophage degradation can cause lesions to 
destabilise and become prone to rupture (George, 1998), indicated by dissociated 
endothelial cells in the circulation (George, 1992). Stable lesions contribute to the 
narrowing of the arterial lumen, while ruptured thrombotic particles promote 
further atherosclerotic damage, and can cause a CVD event by occlusion 
(Atherosclerotic etiology is reviewed in Ferns and Lamb, 2001; Griffin, 1999; 
Ebenbichler, 1999).
1.5.4.2 Endothelial function and dysfunction
The arterial endothelium has in built anti-atherogenic protective mechanisms that 
include antioxidant, anti-inflammatory, and anticoagulant factors as well as 
vasodilators to protect against oxidative and hypertensive damage. It also 
inhibits leukocyte and platelet adhesion and smooth muscle cell proliferation as 
protection against formation of the atherogenic fibrous lesions (Bonetti et al,
2003).
However IR associated increases in insulin, LDL, NEFA and TAG disturb and 
overwhelm these protective mechanisms: The insulin reduces nitric oxide (NO, 
an endothelial vasodilator) production by suppression of endothelial nitric-oxide 
synthase (eNOS), thereby raising hypertension (Bonetti et al, 2003; Ferns and 
Lamb, 2001).
In addition to the atherogenic effect and oxidative effect of LDL, other lipid 
components were recently proposed to contribute to IR mediated endothelial
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dysfunction. Postprandially raised free fatty acid, due to poor suppression by 
insulin, can enter endothelial cells and be stored as TAG in the same way as in 
muscle cells and adipocytes. McCarty (2003) proposed that it was the 
simultaneous exposure to raised NEFA and insulin that initiates this and that the 
endothelial TAG conferred a negative impact on endothelium dependant 
vasodilation.
Atherosclerosis further impacts on endothelial function, as cytokines and 
inflammatory factors CRP and TNF are released from the macrophages and 
lymphocytes, impacting on hypertension and a highly pro-oxidant environment.
As endothelial dysfunction is a marker that directly or indirectly reflects the 
impact of other atherosclerotic and CVD risk factors collectively and was shown 
by Bonetti et al (2003) to be an independent risk factor for cardiovascular events, 
it may be regarded as the ultimate CVD indicator.
1.5.5 Other cardiovascular disease risk factors
1.5.5.1 Obesity and CVD risk
Obesity has long been associated with CVD risk, and is widely accepted as a 
factor in the etiology of non-insulin dependant diabetes and hypertension and 
CVD (Wu, 1999; Abbasi et al, 2002, McLaughlin et al, 2004), both also 
independent risk factors for CVD. Body mass index (BMI) is a clinical measure 
of overweight and obesity, 18-25 kg/m2 defining the healthy range, 25-30 
indicating overweight and BMI>30 being the clinical cut-off for obesity. 
Centrally placed obesity, which correlates well with BMI values (Rexrode et al, 
2001) is associated with the CVD risk factor of raised TAG (Assman et al, 1999). 
McLaughlin et al (2004) recently demonstrated that a BMI >25 conferred 
increased CHD risk and that while IR was not dependant on obesity, escalating 
BMI was associated with increased IR. McLaughlin showed that the presence of 
both risk factors compounded the risk of CHD.
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1.5.5.2 Metabolic syndrome
Reaven (1988) suggested that where a number of dyslipidaemic and insulin 
resistant symptoms occurred together it constituted a syndrome -  a collection of 
factors that collectively contributed to the development of a further disease -  in 
this case a combination of factors occurring together to confer a cardiovascular 
health risk. It was given the name Syndrome X, Metabolic Syndrome or Reaven’s 
syndrome. The main factors initially considered to contribute were obesity 
(centrally placed), dyslipidaemia (normal or raised TAG and LDL with low 
HDL), and hypertension (Reaven, 1988; Shen et al, 2003; Miller, 2003). While 
Reaven (1988) included IR as one of the factors of the syndrome, others have 
since proposed it as the underlying cause (Griffin and Zampelas, 1995; Griffin, 
1998; Shen, 2003; Bloomgarten, 2003a).
1.5.5.3 Dietary fats and hyperlipidaemia
Diet is a modifiable CVD risk factor and considered to contribute to heart disease 
risk predominantly via dietary fat intake. Saturated fat was first associated with 
serum cholesterol and CHD mortality by Keys (1970), and dietary advice to 
reduce saturated fat intake for patients with raised cholesterol ensued. The roles 
of fats and fatty acids in hyperlipidaemia and IR have since been elucidated 
(Lovejoy, 2002; Griffin and Zampelas, 1995) and Griffin (1999) suggested that 
while the amount of each type of fatty acid has a quantitative effect on lipaemia, 
the ratio of fatty acids has a qualitative effect that impacts on the subclasses and 
atherogenicity of the lipoproteins.
Saturated fatty acids (SFA’s) produce more saturated TAG, which forms smaller 
chylomicrons and the smaller subclass of VLDL particles (VLDL2), that are 
cleared more slowly than the larger VLDLi particles. The slower clearance is 
likely to be mediated by a suppression or downregulation of LDL receptors 
(Grundy and Denke, 1990), resulting in higher levels of LDL.
Fatty acids derived from saturated fats were shown by Hajduch et al (2003) to 
interfere with cellular glucose uptake and insulin signalling in muscle cells via
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increased synthesis of ceramide, thereby increasing IR. Ceramide may also 
induce damage in the insulin producing cells of the pancreas (Unger, 2003).
Polyunsaturated fatty acids (PUFA) are reported to contribute less to the dietary 
effect on CVD risk than SFA’s by reducing postprandial lipaemia and having a 
beneficial effect on lipoprotein subclasses; producing the larger, more rapidly 
cleared VLDLi particles and thus lower LDL (Shepherd and Packard, 1987). 
However where PUFA’s are incorporated into VLDL2 and LDL they will 
increase the oxidative susceptibility of the phospholipid. The more oxidative 
nature of the unsaturated fats may increase the atherosclerotic damage should it 
become sequestered into the arterial wall. A recent study in rats has 
demonstrated that a PUFA diet increases the oxidative stress in cardiac tissue 
over that of SFA’s or a low fat control diet (Diniz et al, 2004).
n3-PUFA has been shown to reduce TAG (Harris et al, 1988), mechanisms 
suggested for this (reviewed in Griffin and Zampelas, 1995) include; a reduction 
in liver or enterocyte TAG synthesis by lipogenic enzyme inhibition, competition 
between larger n3-PUFA rich chylomicrons and VLDL for degradation by LPL, 
and an increase in catabolism by upregulation of LPL expression and activity.
Dietary n3-PUFA is unlikely to significantly add to total fat intake, and more 
likely to alter the fatty acid ratios of the diet to an overall beneficial increase in 
PUFA:SFA ratio. Nevertheless the inclusion n3-PUFA are associated with higher 
LDL than N6-PUFA via the synthesis of VLDL2  over VLDLi (Harris, 1989). As 
N3-PUFA are associated with more rapidly cleared CM, they do not result in 
especially TAG-rich VLDL2  and are therefore less likely to form the atherogenic 
small dense LDL.
The effect mono unsaturated fatty acids (MUFA) on TAG is not fully clear. 
Ginsberg et al, (1990) and Berry et al, (1991) found no significant effect of 
MUFA rich diet compared to SFA and PUFA respectively, while Chan et al, 
(1991) found a reduction in TAG on a MUFA rich diet. MUFA may protect 
HDL levels via a sparing mechanism where increased apo48 on chylomicrons 
successfully competes with HDL for removal in the liver (Brouwer et al, 1993).
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The effect of MUFA on TAG may be minimal, but by displacement of dietary 
saturated fats and HDL sparing MUFA has a positive impact on lipoprotein 
profile.
Based on the various effects of dietary fatty acids it is likely that the greatest 
benefit on postprandial lipaemia will be found from a combination of N6-PUFA, 
N3-PUFA and MUFA dietary fatty acids, with a low intake of SFA’s in an 
overall lower fat diet. This is likely to result in lower TAG due to a lower fatty 
acid intake overall, smaller rapidly cleared CM and spared HDL via the MUFA, 
lower TAG and VLDL, with larger more rapidly cleared VLDL via PUFA, and 
less atherogenic LDL via N3-PUFA. This theory is supported by Wardlaw and 
Snook (1990) who reported lower TAG following a diet of mixed MUFA and 
PUFA than after a SFA rich diet.
1.5.5.4 Other dietary factors
Dietary lipids clearly have potential for positive and negative impact on CVD 
risk, this led to a debate on the role of diet in CVD as a ‘cause or therapy’ (Office 
of Health Economics, 1991). However lipids are not the only culprit, other 
dietary factors that demonstrate controversial effects are antioxidant nutrients/ 
polyphenols (Bonetti et al, 2003; Liu and Manson, 2001;) and carbohydrates 
(Davy and Melby, 2003) sparking the debate over high glycemic index foods. 
While Akerstedt reported that fibre intake was correlated with poor lipoprotein 
ratios (Akerstedt, 1990).
High carbohydrate, low fat diets have been the standard dietary recommendation 
for reducing CHD risk factors, especially hypercholesterolaemia. Recently 
carbohydrate has been on the receiving end of a much criticism, suggesting that a 
carbohydrate rich diet increased blood glucose and insulin, and could result in 
increased TAG and IR (Daly, 2003). carbohydrate in the form glucose/sucrose 
will initially increase the insulin response, and has been reported to induce IR in 
the longer term via a down regulation of insulin activity and thus reduced 
sensitivity following hyperinsulinaemia, however a recent review of sugars and 
insulin sensitivity failed to find a consistent effect (Daly, 2003). An excess of
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the ideal cardioprotective diet needs qualitative and quantitative correction. Davy 
and Melby (2003) reported that an increase in dietary fibre to produce a high 
carbohydrate, high fibre, low sugar and low fat diet would result in improved IR.
Dietary intakes that are high in antioxidant-rich foods, mainly fruits and 
vegetables, are associated with lower incidence of CHD, however intervention 
studies with antioxidant supplements fail to achieve the same results (reviewed in 
Liu and Manson, 2001). Thus it is unlikely to be these components alone that 
confer benefit, however the inclusion of antioxidant rich foods may have a 
displacement effect on other foods of greater calorific and poorer micronutrient 
value.
The cardiovascular risk or protection afforded by diet is most likely to be a 
combined effect, via the diet lipid profile, the fibre content, the antioxidant 
nutrients, and trace components such as polyphenols. Thus while diet is a 
contributor to CVD risk, it is a modifiable one with components that can also 
counter amassed risk.
1.5.5.5 Inflammatory factors
IR has been associated with increased inflammatory response and inflammatory 
factors TNF, CRP and NFkB have all been suggested as having a causative role 
in the resistance of cell membranes to insulin (Davy and Melby, 2003; Lui and 
Manson, 2001). This is supported by the reported IR seen where levels of 
inflammatory markers such as CRP and NFkB were raised, such as in acute 
infection, (Shoelson et al, 2003) and in obesity (Haffher 2003; McLaughlin et al,
2004) where a low level inflammatory state is present.
1.5.5.6 Genetic factors
There is a strong hereditary factor in CVD risk. Understanding of the genetic 
component of CVD risk had advanced rapidly and continues to do so as research 
identifies gene polymorphisms that control expression of, for example, regulatory 
enzymes and membrane receptors and apoprotein genotypes. Apoproteins, 
ligands to cellular lipoprotein receptors and regulatory proteins exhibit different
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alleles, resulting in a heterogenous population in terms of lipid metabolism. 
Apolipoprotein E for example, impacts on the efficiency of cholesterol absorption 
thus contributing to circulating LDL levels, and may influence cellular uptake of 
TAG thus altering circulating TAG and chylomicron remnant density (Wu, 1999; 
Griffin and Zampelas, 1995). Further, apoprotein E4 polymorphism demonstrates 
diet-gene interaction as a PUFA rich diet in Apo E4 subjects is associated with a 
reduction in LDL cholesterol (Griffin and Zampelas, 1995; Mantari et al, 1991). 
With a vast combination of possible genotypes (recent review in Bloomgarten, 
2003a), CVD risk could be highly individually timed.
1.5.5.7 Lifestyle factors and CVD risk
Lifestyle choices such as smoking and activity levels are modifiable risk factors 
and contribute to CVD risk. In smoking, the greatest single risk factor and the 
largest modifiable risk factor, this occurs via increases in oxidative stress and 
postprandial lipid intolerance (Neaton and Wentworth, 1992; Eliasson et al, 
1997). Inactivity promotes risk via a reduced utilisation of energy and metabolic 
capacity leading to slower clearance of TAG, this is often in association with 
excess bodyweight or obesity (Liu and Manson, 2001). Environmental factors 
that are not part of a selected lifestyle, for example where air pollution is heavy or 
where employment is sedentary in nature, could contribute via the same 
mechanisms.
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1.5.6 Shiftwork and CVD
1.5.6.1 Shift work and heart disease risk
Shift work has been linked with risk factors for heart disease such as lipid 
metabolism and hypertension (Nicholson and D’Auria, 1999; Boggild and 
Knutsson, 1999; Tenkanen et al, 1998; Hampton et al, 1996; Romon et al, 1992), 
conferring an overall increase in CHD risk associated with shift work of 1.4. 
Each risk factor present has a compounding effect on the risk; for example the 
relative risk for shift workers with obesity or who smoke are 1.7 and 2.7 
respectively (Nicholson and D’Auria, 1999; Tenkanen et al, 1998).
In order to consider the mechanisms by which shiftwork has a contribution to 
CVD risk we should acknowledge where shiftwork or the circadian system are 
likely to interact with the CVD risk factors. A number of mechanisms for the 
association between shiftwork and cardiovascular disease have been suggested. 
There may be changes in dietary intake or food choice having independent effects 
on hyperlipidaemic risk, and metabolic effects via timing of food intake during 
the night, a metabolically inefficient period (Lenneraas et al, 1994; Holmback et 
al, 2003; Morgan et al, 1998; Morgan et al, 2003; Ribeiro et al, 1998; Sopowski 
et al, 2001).
Knutsson and Boggild (2000) suggested the mechanisms for CVD development 
in shift work comprised the combined effect of lifestyle and dietary choices, work 
stress and sleep disturbances, and the desynchrony between timing of circadian 
rhythms and eating.
Shiftwork may have an additional effect that is as yet unaccounted for, via lost 
sleep (Knutsson and Boggild, 2000), increased stress (Peter et al, 1999) and 
increased infections (Dinges et al, 1995; Barton et al, 1995). It is not too great a 
jump to consider that shiftworkers, via increased stress, minor infections and lost 
sleep, could have a mild but persistently raised inflammatory response 
contributing to and accentuated by IR, and adding to the night time metabolic 
inefficiency.
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1.5.6.2 Circadian aspects of CVD
The circadian system has complex neurological and endocrine interactions with 
peripheral circadian oscillators to control rhythmic behaviours in other tissues 
and it is apparent that the circadian behaviour of the autonomic nervous system 
dictates a circadian rhythm in cardiovascular markers (Guo et al,2003). Recent 
reviews of the circadian system and on CVD identified circadian and diurnal 
rhythms in haemodynamic CVD markers that impact on risk (Guo et al, 2003; 
Hastings et al, 2003). Blood concentrations of catecholamines, major regulators 
of cardiovascular activity, demonstrate a circadian rhythm that rises from waking 
to a peak at midday. Heart rate, blood pressure and cardiac output demonstrate 
rhythmic activity that is low overnight and also rises around the time of waking. 
Thrombotic risk increases at this time via increased platelet aggregation (peak 
time around waking) and reduced thrombolytic activity. Endothelial function 
demonstrates an increased vasoconstrictor response in the morning. These 
rhythms can combine, resulting in an increased cardiovascular stress and 
therefore it is no surprise that cardiovascular events show a diurnal variation and 
occur most frequently during the morning (Selwyn et al, 1991).
The circadian hormone melatonin has been linked directly with heart disease, 
conferring a benefit, via reduced hypertension, and reduced LDL cholesterol 
(Sewerynek, 2002). Sewerynek suggested that melatonin synthesis is decreased in 
CHD, supported by reports of lower melatonin in CHD disease patients and an 
inverse correlation between melatonin production and heart disease progression.
1.5.6.3 Circadian aspects of postprandial metabolism
Diurnal rhythm in human glucose tolerance and insulin sensitivity was shown by 
Gibson et al (1975), whose subjects demonstrated a significantly higher glucose 
and insulin response after a 5pm meal than that of an 8am meal, and Van Cauter 
et al (1989) confirmed a reduced glucose tolerance at night. La Fleur et al (2001) 
demonstrated the SCN control of glucose rhythms in the rat where the diurnal 
rhythm of blood glucose was lost in SCN lesioned rats that remained glucose 
tolerant, thus the lesion only removed the rhythmic control.
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Hampton et al (1996) demonstrated a diurnal variation in postprandial metabolic 
efficiency following meals at 1300h, where one was after a 9-hour phase 
advance, thus simulating a meal at 2230h. Furthermore Romon et al (1997) 
administered meals at OlOOh and 1300h, and found a diurnal variation in TAG 
and VLDL that was high after the OlOOh meal. This study also reported that LDL 
and HDL were lower after the OlOOh meal. Romon suggested that this showed 
circadian effects on cholesterol transport, however if this were interpreted as 
insulin resistant dyslipidaemia, the lipid profile could be a reflection of delayed 
postprandial CM, TAG, and VLDL clearance, and the formation of small dense 
LDL and HDL. This is supported by the findings of a diurnal rhythm in insulin 
resistance, increasing resistance as the day progresses reaching a peak at night 
(Morgan et al, 1999) and a diurnal variation in lipoprotein lipase activity 
(Asaradnam et al, 2002). These two factors influence clearance of glucose and 
TAG from the circulation and the diurnal rhythms could be responsible for the 
raised postprandial metabolite levels found in response to nocturnal meals by 
Hampton et al (1996).
Morgan et al (1998) demonstrated a clear diurnal rhythm in TAG that could 
become dissociated from the control of the central circadian clock. In this study, 
the melatonin rhythm remained entrained to clock time while diurnal rhythm in 
TAG was de-synchronised from clock time following a 27h day phase shifting 
protocol. The TAG rhythm was more closely associated with the new sleep wake 
cycle, although the rhythm amplitude appears reduced. This suggests that 
peripheral oscillators of metabolic rhythms can be entrained independently o f the 
central clock, and may be susceptible to entrainment by feeding and sleep 
schedules. This situation could represent that of a shift worker whose circadian 
rhythm does not adapt yet the diurnal rhythms associated with daily routines 
remain allied with the shift schedule.
Clearly there is a circadian aspect to postprandial metabolism that will impact of 
the responses of nocturnal eating during shift work, for a review see Morgan et al 
(2003).
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1.5.6.4 Postprandial responses to night time meals
Metabolically we are designed to eat during the day and not eat at night, the 
endocrine system most effectively metabolises foods during daytime hours. In a 
shiftwork situation, where meals are consumed during the night, and the worker 
is day-adapted, the normal insulin related metabolic responses to meals are 
extended and plasma glucose and TAG clearance are delayed, demonstrated in 
simulated night shift studies by Hampton et al (1996) and Ribeiro et al (1998).
Hampton et al (1996) measured postprandial metabolic responses following a 
high fat pre-meal and a daytime (1300h) test meal on two occasions, one after a 
9h phase advance representing the effect of a late evening meal (simulated night 
shift, body clock time 22.30). The study showed that the normal postprandial 
metabolic responses are impaired following the ‘night shift’ meal; glucose, 
insulin and TAG clearance were impeded and the return to metabolic baseline 
was delayed.
Ribeiro et al (1998), using a similar phase advance protocol, tested the effect of a 
low fat pre-meal on the simulated night shift eating and found that the low fat- 
high carbohydrate pre meal prevented an impaired glucose and insulin response. 
The postprandial TAG was raised following the night shift meal and the NEFA 
baseline return was clearance was still delayed. A third pre and test meal was 
given 2 days later and the postprandial TAG showed a partial recovery. Ribeiro’s 
work suggests that a lower fat food choice may reduce the postprandial metabolic 
impairment seen in night shift eating studies, and that metabolic recovery occurs 
within days of returning to normal clock time. Consistent with Ribeiro’s 
findings, Holmback et al (2003), in studies of diets with different energy sources 
fed at varying times within 24-hours, showed that stronger circadian patterns 
were seen in lipid metabolism on the high fat diet than the high carbohydrate diet.
The diurnal rhythm in TAG and the delayed clearance following a simulated 
night shift meal was confirmed by Sopowski et al (2001), who additionally 
identified a gender difference in postprandial TAG. A significantly increased 
TAG was found in men following a low fat pre-meal and test meal given at
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01.30h, compared to the response in women, suggesting that male shiftworkers 
may be at greater risk from impaired metabolic responses their female co­
workers.
In confirmation of the above simulation studies, in a small group of real shift 
workers in Antarctica (Lund et al, 2001), circulating postprandial levels of 
glucose, insulin and triacylglycerol (TAG) were found to be significantly raised 
after an abrupt change in the timing of sleep and work.
Considering the disturbed postprandial metabolism and IR it seems likely that, 
via disturbances to the circadian system and the effect of night-time meals on a 
metabolic system that is increasingly insulin resistant over 24 hours, shiftwork 
presents a possible pathway increased CVD risk. Whether any benefit is found in 
normalising the postprandial metabolism by circadian resynchrony remains to be 
established.
1.6 A d a pt a t io n  t a c t ic s  a n d  th era py
1.6.1 Correcting circadian disruption
1.6.1.1 To adapt or not to adapt
The benefits of circadian adaptation can be felt in the same way as the symptoms 
of misalignment of the internal and external clock, when we adjust to jet lag; that 
is, the realignment of the circadian system coincides with an improved adherence 
to the new sleep schedule, an improvement in our sleep quality and a normalising 
of appetite and fatigue. Barton et al (1995) suggested that adaptation, via re­
synchrony to the ‘new time’, reduces the disruption to the circadian system, so 
that sleep duration and quality are improved and there is a resulting improvement 
in psychological health and reported symptoms of ill health. In shiftwork, 
environmental zeitgebers can be manipulated to hasten the phase shift into 
synchrony with the new imposed time schedule, i.e. to improve physiological 
adaptation of the circadian rhythm, during night shift work. This is clearly a 
benefit where the schedule is of long (greater than one week) duration and
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suggests that in offshore shift schedules, where night shifts run in a series of at 
least seven nights and frequently 14 or 21 nights, adapting to night work would 
benefit the sleep and health of the worker. Whether there is any benefit in not 
adapting is less certain. A worker who has not adapted to a night shift should not 
need to resynchronise back to normal time, resulting in fewer days of 
maladaptation in fast rotating shiftwork.
1.6.1.2 Adaptation and health benefits
Adaptation, or at least a phase shift of a circadian rhythm marker in simulated 
conditions, has been shown to confer improvements in a number of health or 
safety related parameters; improved sleep, quality o f life and alertness (Barton et 
al, 1995; Yoon et al, 2002; Dawson and Campbell, 1991). In fast-rotation 
shiftworkers, those who demonstrated at least partial circadian adaptation 
achieved performance scores of reaction time and memory test equal to that of 
day workers, while non-adapters showed reduced performance (Quera-Salva et 
al, 1997).
The improvement in postprandial TAG 2 days after a simulated night shift study 
reported by Ribeiro et al (1998, previously described in section 1.5.6.4) showed a 
partial recovery, but not a complete return to baseline, of metabolic responses to 
meals. Thus to what extent circadian adaptation contributes to normalising the 
health parameters disturbed by shift work, such as the metabolic responses to 
night-time meals, and how it is distinct from the effect on health conferred by 
environmental conditions (e.g. light) and behaviour (e.g. exercise) is not yet fully 
clear. This represents a potentially important line of inquiry as it may assist in 
identifying the schedules most appropriate for health and indicate the best use of 
adaptation as a coping strategy.
1.6.2 Light treatment and darkness
1.6.2.1 Light and adaptation
Light intervention has been investigated for encouraging phase adaptation in shift 
workers (Czeisler et al, 1990; Eastman, 1992; Eastman et al, 1994; Bougrine et 
al, 1995) and alleviating maladaptation to shift work (Horowitz et al, 2001).
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Following the early reports that light could phase shift circadian rhythms (section 
1.2.4.3), Eastman demonstrated the use of bright artificial light intervention in 
adapting circadian rhythms to accommodate 12-hour shifts over eight or more 
consecutive simulated night shifts (Eastman, 1992).
As light can act as a zeitgeber for circadian rhythmicity, so the appropriately 
timed absence of light, by restricting light exposure with the use of sunglasses, 
goggles or darkened day time sleep environments, can contribute to the 
adaptation process (Eastman et al, 1994, Czeisler et al, 1990, Horowitz et al, 
2001). The use of timed bright light during night shift, and imposing darkness 
for day time sleep, in simulated shift worker studies has been shown to phase 
shift the temperature rhythm to nadir within the imposed sleep schedule (Czeisler 
et al, 1990, Martin and Eastman, 1998, Eastman et al, 1994). Yoon et al (2002) 
tested the timed light and darkness theory in night shift workers by treating them 
with bright light (4000-6000 lux) or room light (100-500 lux) at night followed 
by one hour of bright light after the shift, or the same bright light treatment but 
with light attenuation, by wearing sunglasses, in the morning after the shift. Yoon 
found the largest improvements in daytime sleep, nocturnal alertness and 
performance were achieved by the bright light with morning light attenuation 
treatment.
1.6.2.2 Light treatment, sleep and performance
Light has been suggested as a treatment to alleviate the symptoms of 
maladaptation suffered by offshore shift workers, who have adapted while 
offshore, upon return to normal routine after a night shift tour. Bjorvatn et al 
(1999) reported reduced sleepiness and improved ‘quality of day’ with a 30- 
minute exposure to bright light, appropriately timed, on the first 4 days at home 
after night shift. Whether or not self administered light treatment at home can 
induce a phase shift to readapt shift workers to clock time has yet to be shown 
and is currently under study.
The phase shifting effects of bright light have been widely discussed and it is 
encouraging to find that the phase delay caused by bright light confers an
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improvement in alertness (Dawson and Campbell, 1991). The use of bright light 
treatment improves performance and alertness in simulated night shifts 
(Campbell and Dawson, 1990; Foret et al, 1998) and in real night workers (Costa, 
1997).
1.6.2.3 Treatment administration
The complex combinations of light intensity, wavelength, duration and timing as 
well as the absence of light, all taking effect on a system that has it’s own 
inherent rhythm, means that light used inappropriately (the wrong light at the 
wrong time) could have an undesired phase shifting effect. Thus inappropriately 
timed light or darkness may hamper adaptation by inducing a phase shift of the 
wrong direction (Mitchell et al, 1997).
1.6.3 Exercise
1.6.3.1 Exercise and adaptation
Like light, the strength of exercise as a zeitgeber depends very highly on the time 
the exercise is undertaken, and on the intensity of the exercise. Intense exercise 
when melatonin secretion is already high, normally at night/early morning, will 
stimulate melatonin secretion acutely, but moderate exercise, or timed during the 
afternoon (the melatonin ‘trough’), does not have that same effect (Buxton et al, 
1997). Exercise during the night induces a phase delay over the following day 
independently of any delay caused by light exposure at night (Buxton et al, 
1997). Thus it is feasible that exercise appropriately timed within the 24-hour 
period in relation to the circadian phase might assist nightshift workers in 
adapting to an imposed schedule.
1.6.3.2 Exercise, adaptation and health effects
Fossey (2002) suggested that physical training and fitness were associated with a 
faster resynchronisation of circadian rhythms in shift workers, and reported an 
increase in performance of memory-loaded tasks in women taking regular 
physical training. Harma also suggested that exercise should be encouraged in 
night workers as it has benefits on well being and reduced night shift fatigue and 
sleepiness even without circadian adaptation (Harma et al, 1995). Timing is still
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important as exercise around midnight on a night shift showed a greater effect on 
glucose lowering than at other times (Scheen et al, 1998).
1.6.4 Sleep scheduling/napping
1.6.4.1 Sleep scheduling and adaptation
The reasons for sleep disturbance among shift workers have been discussed 
(1.3.2) as circadian desynchrony and exposure to external interference to sleep. 
Humans naturally schedule their sleep as the circadian neurohormone melatonin 
rises to signal the sleep onset, the sleep period then ensues until the melatonin 
rhythm falls again. For a night shift worker this period must be spent in 
wakefulness, and the sleep scheduled for a time earlier or later. Horowitz et al 
(2001) showed that scheduling the sleep period and excluding light exposure after 
the night shift end was beneficial for adaptation and performance.
1.6.4.2 Napping
Taking a nap is a natural instinct in response to fatigue and provides a quick, if 
temporary, cure for the urge to sleep. Napping as a strategy to promote alertness 
during the early hours of night shift was investigated by Sallinen et al (1998). 
Comparing naps of 30 mins, 50 minutes and no nap, at OlOOh or 0400h they 
found that all naps improved visual performance tests later in the night 
suggesting that allowing naps during a night shift might improve alertness. 
However, there may be an optimum duration for napping during night shift 
before day time sleep is impaired, as Sallinen also reported that with longer 
duration nap there was a consequence of reduced slow wave sleep during the next 
daytime sleep period (Sallinen et al, 1998). They concluded that a short nap, 
around 30 minutes, early in the night shift would promote alertness without 
impairment of subsequent sleep period.
Buxton et al (2000) suggested that day-time naps may phase shift the circadian 
rhythm. These naps were taken in darkness, so the exclusion of light may have 
been the ultimate zeitgeber in this study, however it does suggest that a night shift 
nap might encourage adaptation if it is timed to attenuate light at the right time.
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1.6.5 Exogenous Melatonin
1.6.5.1 Melatonin and adaptation
Exogenous melatonin administered in pharmacological doses has phase shifting 
properties as discussed in section 1.2.5.5, and is widely used by travellers to 
alleviate jet lag. Although not currently available as an OTC treatment for 
disturbed rhythms in the UK, its use in travel and shift work adjustment and to 
aid sleep is widespread in countries where it is pharmaceutically accepted.
Dawson et al (1995) compared the use of light with therapeutic melatonin 
administration to treat maladaptation, finding that light was more effective at 
phase shifting and resulted in greater improvements in performance and sleep 
parameters. However Deacon and Arendt (1996) showed that when melatonin 
and bright light were administered at conflicting times, melatonin was the more 
effective zeitgeber and dictated the direction of a phase shift, thus melatonin may 
be a most useful strategy for aiding adaptation even when conflicting light cannot 
be completely excluded.
1.6.6 Dietary advice.
1.6.6.1 Dietary advice for shift workers and night time eating
Dietary advice devised specifically to aid shift workers in terms of health and 
wellbeing or in terms of adapting to their shift schedule does not at this stage 
exist. The few studies available investigating diet in shift workers are dietary 
intake studies, to my knowledge there are no intervention studies on diet intake 
and phase shift or health in shift workers.
There is an enormous volume of work to support the relationship between diet 
and lifestyle factors to cardiovascular health, thus dietary advice for improving 
the cardiovascular health risks in shift workers may be one of the most practical 
strategies to implement. However research has demonstrated that the different 
macronutrient balance of meals may induce a different response when consumed 
at night (Ribeiro et al, 1998; Holmback et al, 2003), this suggests that there is a 
need to identify if and when foods which induce a healthy or less healthy
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response are being consumed. Food choice at night clearly has a place in any 
advice that is devised for shift workers.
1.7 Pr o je c t  a im s  a n d  o bjec tiv es
The literature strongly points to circadian and metabolic consequences of 
shiftwork, which are not fully elucidated. It is not yet known on which shift 
schedules circadian adaptation occurs or if such adaptation confers any benefit to 
the worker.
The hypothesis for this project was that the current diversity of shift patterns 
being worked offshore is likely to allow differing levels of circadian adaptation 
between schedules and to have variable consequences on health.
The offshore oil and gas industry installations provided an ideal environment for 
the study of shiftworkers as the isolation and semi-controlled conditions would 
remove the influence of home life and individual routines. Onshore studies could 
potentially be confounded by these influences.
With the support of the industry regulator (Health and Safety Executive) and the 
UK petrochemical industry offshore operators, this project was established in 
order to investigate the relationships between the circadian and endocrine 
systems in shift workers on UK offshore oil and gas installations. The project 
proposed to determine circadian adaptation to different shift systems and in the 
same individuals to monitor sleep, diet and metabolic parameters to identify any 
associated effect between schedule, circadian status and health.
More specifically the objectives of the project were:
■ To identify schedule association with:
■ circadian disruption and resynchrony
■ light exposure
■ sleep parameters
■ postprandial metabolic and hormonal markers of CHD risk
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■ to compare the findings between schedules
■ to recommend strategies for coping with the effects of shift work and 
circadian disruption.
The unique and novel component of this project centred on the range of schedules 
studied and the concurrent investigation of circadian adaptation with the 
physiological, metabolic and dietary parameters.
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Chapter 2 : Materials 
and Methods
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2 MATERIALS AND METHODS
2.1 M a te r ia l s
2.1.1 Equipment sent offshore
Disposable pipettes 
Alpha Labs, Eastleigh, UK.
Vacutainer tubes, needles and holders 
Beckton Dickinson and Company, Oxford, UK.
Actiwatch-L,
Cambridge Neurotechnology, Cambridge, UK.
Freezers
Comet, Hull, UK.
Hereaus labofuge centrifuge, Centurion centrifuge 1020. 
Fisher scientific, Manchester, UK.
Urine collection bottles
Griffiths and Nielson, Billingshurst, UK.
Scintillation vials (Urine sample tubes)
Perkin-Elmer, Beaconsfield, UK.
2.1.2 Equipment at University of Surrey
Beckman J6 centrifuge 
Beckman-Coulter, High Wycombe , UK.
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Alphawasser SP-ACE Automated Spectophotmetric analyser, sample cups, 
cuvettes.
Randox Laboratories Ltd., Crumlin, County Antrim, UK
Cobas Mira Automated analyser, cuvettes.
Roche Products Ltd, Welwyn Garden City. UK.
Wallac 1470 Wizard automated gamma counter 
Wallac International, Finland.
2.1.3 Laboratory Disposables:
Disposable pipettes 
Alpha Labs, Eastleigh, UK.
LP3, LP4 tubes
Bibby-Sterilin, Staffordshire, UK.
Disposable gloves
Fisher Scientific, Loughborough, UK
2.1.4 Chemicals and Reagents
All chemicals used are of AnalaR grade unless otherwise stated.
Polyethylene glycol (PEG)
BDH Laboratory Supplies, UK
Di-Sodium hydrogen orthophosphate anhydrous salt (Na2HP0 4 )
Sodium dihydrogen orthophosphate hydrated form (NaHfePC  ^2 H2 O).
Fisher Scientific UK.
Bovine serum albumin (BSA)
Sigma Chemical Company Ltd, UK.
69
Reagent Kits: Randox glucose analysis kit, Randox TAG analysis kit, Randox 
Cholesterol analysis kit, Randox HDL analysis kit, Randox NEFA analysis kit. 
Alphawasser glucose analysis kit, Alphawasser TAG analysis kit, Alphawasser 
Cholesterol analysis kit. Alphawasser System diluent.
Randox Laboratories Ltd., Crumlin, County Antrim, UK
2.1.5 Sera/antisera
C-peptide antiserum, Normal sheep serum, donkey anti-sheep antiserum.
Insulin antiserum, normal guinea-pig serum, donkey anti-guinea pig antiserum. 
These were provided by Dr Shelagh Hampton, University of Surrey.
Charcoal stripped serum was supplied from frozen stock previously produced at 
the University of Surrey, prepared by the method described in 2.2.4.1.
aMT6s antiserum
Provided by Stockgrand Ltd, University of Surrey.
2.1.6 Radio labelled tracers
125I Insulin 
125I C-peptide
These were prepared and provided by Dr Shelagh Hampton, University o f Surrey. 
125I aMT6s
This was prepared and provided by Stockgrand Ltd, University of Surrey.
2.1.7 Specialist software 
Sleepwatch software.
Cambridge Neurotechnology, Cambridge, UK.
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Diet plan 5
Forestfield Software, Horsham, Sussex, UK 
RIAcalc
Wallac International, Finland.
2.2 M e th o d s
The methods described here are assay procedures and techniques that are 
common to more than one study. Any methodology that is specific to one study is 
described separately in the method section of the relevant chapter.
2.2.1 Study design
The fourteen-day study protocol was undertaken by sixty-three male offshore oil 
and gas installation workers on one of four 14 day (or 14 days of a 21 day 
offshore tour), 12-hour shift schedules: night-shift 1800h-0600h (14N), day-shift 
0600h-1800h (14D), night-day swing-shift of 7-nights 1800h-0600h and 7-days 
0600h-1800h (7N7D), day-night swing-shift of 7 days 1200h-2400h and 7 nights 
0000h-1200h (7D7N).
Offshore operators in the UK petrochemical industry were invited to participate 
in the research and nominated installations operating the appropriate shift 
schedules. Subjects were recruited from these installations via the OIM 
(Offshore Installation Manager) and/or installation medical officer.
Circadian adaptation to shift schedule was determined using the urinary circadian 
rhythm marker 6-sulphatoxymelatonin (aMT6s, a metabolite of melatonin). Light 
and activity/sleep data was recorded by Actiwatch-L (wrist worn activity 
monitor). Postprandial hormonal and metabolic markers of CVD (cardio-vascular 
disease) risk were assessed from blood samples taken when fasted and six hours 
following a meal. Subjects completed a dietary intake record and a diet/lifestyle 
questionnaire. All subjects participated voluntarily and gave informed consent.
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The study protocol was approved by the University of Surrey Advisory 
Committee on Ethics.
2.2.2 Assessment of circadian status via urinary 6-suIphatoxymelatonin
2.2.2.1 Sample collection
Circadian status and the direction and rate of adaptation of the internal clock to 
12 hour night and day shifts on each shift schedule was assessed using 
measurements of urinary 6-sulphatoxymelatonin. Urine was collected from all 
subjects every 3-4 hours and oversleep, the time and the total volume of the urine 
collection was recorded and a 3ml aliquot taken and frozen until analysis, using 
the urine collection protocol (see appendix i).
2.2.2.2 Radioimmunoassay for 6-Sulphatoxymelatonin (aMT6s)
The urinary melatonin metabolite aMT6s was measured by a specific 
radioimmunoassay technique (Aldous and Arendt, 1988, adapted from Arendt et 
al, 1985).
Assay principle
Urine samples are diluted and incubated with a specific polyclonal antiserum to 
aMT6s (raised in sheep), allowing the sample aMT6s to bind to the antibody. 
Then an 125I-aMT6s label is added. Since the number of antibody binding sites 
are limited the label competes with the sample or standard aMT6s for available 
sites. The amount of bound label is thus a function of the amount of sample or 
standard aMT6s competing for antibody sites. A dextran-coated charcoal 
suspension, permeable to small molecules is added to adsorb the free125I-aMT6s 
thus separating it from the antibody-bound fraction. The free 125I-aMT6s fraction 
(bound to charcoal) is sedimented by centrifugation and the radioactivity counted 
in a gamma counter. A standard curve is constructed at the same time from a 
range (0-100 pg/tube) of aMT6s standards made up in charcoal stripped urine. 
The gamma counter determines CPM (counts per minute) in each sample and 
constructs a standard curve from the known concentrations of the standards. The 
amount of radioactivity associated with the free antigen is proportional to the 
concentration of the test antigen, when measured against the standards.
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This assay was undertaken by Stockgrand Ltd, using the assay protocol in 
appendix ii.
2.2.2.3 Calculation of circadian status from 6-Sulphatoxymelatonin data
The rhythm of aMT6s production was calculated from the duration of each urine 
collection period and the sample aMT6s concentration. The rhythm was then 
analysed for timing (calculated peak time = acrophase) by cosinor analysis 
(programme written by Dr DS Minors, University of Manchester), which 
measures the rhythm of the metabolite concentration against a cosinor curve, 
using it as an ‘ideal’. The significance of the rhythm’s fit to the cosinor curve is 
an indicator of how close the measured rhythm is to the cosine curve. Thus the 
rhythm’s acrophase time can be calculated even in a phase shifting condition. 
Inconsistency or extended duration of the collection periods reduces the 
reliability of the data and its fit to the cosinor curve; the closer the fit, the more 
accurate the acrophase time is. Data points with less than 30% cosinor fit or p = 
>0.1 were rejected. Changes in timing of the acrophase were taken to indicate 
circadian phase shifts, indicating a physiological adaptation to the work schedule.
Adaptation of the circadian rhythm during a shift schedule was calculated as a 
significant phase shift from the mean acrophase position on day 2 of the 
schedule. For individuals, adaptation was considered to be a phase shift of 3 
hours or more from the individual’s phase position on day 2 of the schedule.
2.2.2.4 Calculation of desynchrony load
Desynchrony load is a novel quantitative measure of the impact of desynchrony 
calculated as the area under the curve of hours desynchronised from mean 
baseline (mean adapted acrophase or estimated ideal where no adapted mean is 
available), ie the hours of phase shift required to reach the ideal phase position 
for that shift.
The 14D ideal was calculated from the mean of all 14 days. The 14N and night 
shift of 7N7D was calculated from the mean of the adapted phase position on
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week 2 of the 14N schedule. The ideal on the day shift of the 7N7D and 7D7N 
was taken as being the same as the 14D. Insufficient data was available to 
calculate a mean adapted phase position of the 7D7N night shift, so an estimated 
ideal was calculated from the phase position that would be required for it to fall 
within the subjects sleep period. This was similar to the phase position achieved 
by night shift workers on the same schedule reported by Barnes et al (1998b).
2.2.3 Protocol for blood sampling
Blood samples were taken by the medical officer on board each offshore 
installation, the blood was separated and the plasma frozen according to the 
protocol in appendix iii.
The samples were stored offshore until the study was complete, when they were 
packed into a cold box and flown directly to the shore. The samples were than 
transferred to dry ice and transported to the University of Surrey by courier.
2.2.4 Measurement of plasma metabolites
2.2.4.1 Spectrophotometric analysis
Plasma metabolites were analysed by automated spectrophotometer. A specific 
reagent kit is used for each analyte, an aliquot of each sample is provided to the 
analyser, which performs the assay with automated precision. The analyser was 
calibrated at the start of each sequence of assays, and quality controls were 
included on each assay run to detect any assay drift. The analyser principle is as 
follows: Concentration of the metabolite in the sample is determined after an 
enzymic reaction releases hydrogen peroxide to form a dye with the pigment 
reagents. The colour intensity of the final product is measured at a specific 
wavelength and is directly proportional to the analyte concentration in the 
sample. These assays are linear within the range measured.
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2.2.4.2 Assay of plasma TAG
Triacylglycerol (TAG) was measured using an automated spectrophotometric 
analyser (Cobas Mira or Alphawasser SP-ACE), using specific TAG analysis kits 
for each analyser (Randox TAG analysis kit, or Alphawasser TAG analysis kit).
The method determines TAG concentration in plasma by enzymic hydrolysis and 
colorimetric measurement of the product. TAG in EDTA plasma was hydrolysed 
by lipase enzymes, quinoneimine was formed as an indicator in quantities 
directly proportional to the TAG concentration represented by the following 
equation:
lipases
TAG  ► glycerol + fatty acids
GK
Glycerol + ATP ------------ ► G-3-P + ADP
GPO
G-3-P + O2 ^  dihydroxyacetone-phosphate + H2O2
POD
2 H2O2 + 4 aminoantipyrin + 4 chlorophenol------------ ► quinoneimine
+ HCL + 4 H20
KEY:
GK - glycerol kinase
GPO - glycerol-3-phosphate oxidase
POD -peroxidase
The absorbance of the quinoneimine dye (measured bichromatically at 
505nm/692nm) is directly proportional to the TAG concentration in the sample.
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2.2.43 Assay of plasma NEFA
Non-esterified fatty acids (NEFA) were measured using an automated 
spectrophotometric analyser (Cobas Mira or Alphawasser SP-ACE) using Wako 
NEFA C analysis kit or Randox NEFA analysis kit (Wako Chemicals USA, Inc, 
Richmond VA, USA, Randox Laboratories Ltd., Crumlin, County Antrim, UK). 
NEFA in EDTA plasma was converted to acyl-CoA by an acyl-CoA synthase 
enzyme then oxidised. The hydrogen peroxide produced was then condensed and 
in a further reaction formed a quinoneimine indicator in quantities directly 
proportional to the NEFA concentration. The absorbance of the quinoneimine 
was measured (550nm).
Acyl Co a Synthase
NEFA+ATP+CoA ------------ ► Acyl Co A + AMP + PPi
Acyl CoA oxidase
AcylCoA +O 2  ------------ ► 2-3-trans-Enoyl-CoA + H2 O2
peroxidase
2 H2O2 + TOOS + 4-AAP ► purple adduct + 4 H2 O
KEY: 4-AAP = 4 aminoantipyrine
TOOS = N-ethyl-N-(2-hydroxy-3-sulphoproply)-m-toluidine
2.2.4.4 Assay of plasma glucose
Plasma glucose was determined using an automated spectrophotometric analyser 
(Cobas Mira or Alphawasser SP-ACE), using Randox glucose analysis kit or 
Alphawasser Glucose (GOD-PAP) analysis kit (Randox Laboratories Ltd., 
Crumlin, County Antrim, UK). Glucose in fluoride-oxalate plasma was oxidised 
by glucose oxidase forming hydrogen peroxide, which under catalysis o f 
peroxidase with phenol and 4aminophenazone forms a quinoneime dye. The dye 
is produced in direct proportion to the glucose concentration.
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Glucose oxidase
glucose + O2 + H2O ------------ ► gluconic acid + H2O2
Peroxidase
2 H2O2 + 4 aminophenazone + phenol------------ ► Quinineimine + H2 O
The absorbance is measured bichromatically at 505nm and 602 against a reagent 
blank and the glucose concentration calculated.
2.2.4.5 Assay of plasma cholesterol
Total cholesterol was measured using an automated spectrophotometric analyser 
(Cobas Mira or Alphawasser SP-ACE). Total cholesterol in EDTA plasma was 
hydrolysed by cholesterol esterase enzymes (Randox total cholesterol analysis kit 
Randox Laboratories Ltd., Crumlin, County Antrim, UK) and oxidised producing 
hydrogen peroxide. A quinoneimine dye was generated from the peroxide with 
phenol and 4-aminoantipyrine, by a peroxidase. The absorbance was measured 
bichromatically (505nm and 602nm) and is directly proportional to the 
cholesterol in the sample.
Cholesterol esterase
Cholesterol ester ------------ ► Cholesterol + fatty acids
(+ free cholesterol)
Cholesterol oxidase 
Cholesterol + O2  ; ► Cholestene-3-one + H2O2
Peroxidase
2 H2O2 + 4-aminantipyrine + phenol ------------ ► Quinoneimine + 4 H2 O
2.2.4.6 Assay of plasma high density lipoproteins
High density lipoproteins (HDL) were measured using an automated 
spectrophotometric analyser (Cobas Mira or Alphawasser SP-ACE).
HDL cholesterol in EDTA plasma was assayed in two distinct steps (Randox 
HDL analysis kit Randox Laboratories Ltd., Crumlin, County Antrim, UK). In 
the first step VLDL and LDL cholesterols and chylomicrons are eliminated by
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cholesterol esterase and oxidase to form hydrogen peroxide which is 
subsequently degraded by catalase enzymes. In the second step HDL cholesterol 
is released from the lipoprotein core by detergents, and is esterified and oxidised 
producing hydrogen peroxide that is able to form a quinoneimine dye as an 
indicator as the catalase from step one is inhibited by sodium azide in step 2.
STEP 1
Cholesterol esterase 
Cholesterol ester ------------ ► Cholesterol + fatty acids
Cholesterol oxidase 
Cholesterol + O2  ----------- ► Cholestenone + H2 O2
Catalase
2H20 2 2H20  + O 2
STEP 2
Cholesterol esterase 
Cholesterol ester ------------ ► Cholesterol + fatty acids
Cholesterol oxidase 
Cholesterol + O2 ► Cholestenone + H2 O2
Peroxidase
2 H2O2 + 4-aminantipyrine + HD AOS ------------ ► Quinoneimine + 4 H2 O
The quinoneimine was measured colourimetrically at 600nm against a reagent 
blank, and the colour intensity is directly proportional to the HDL cholesterol 
concentration.
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2.2.5 Measurement of plasma hormones
2.2.5.1 Radioimmunoassays for insulin and C-peptide
The insulin and C-peptide were assayed by specific radioimmunoassays 
developed at the University of Surrey (Hampton, 1983). These are sensitive and 
specific techniques for measuring hormones. They are both disequilibrium 
assays, where the sample antigen (insulin or c-peptide) and a specific antiserum 
are allowed to bind before a fixed amount of radiolabelled antigen is added. The 
labelled antigen then binds to remaining antibody. A second antibody is then 
added to form a matrix with the bound antibody-antigen complexes. The double 
antibody complexes are then sedimented and separated, and the supernatant 
containing any unbound labelled antigen is discarded. The amount of 
radioactivity (CPM counted by gamma counter) associated with pellet is 
inversely proportional to that of the unknown antigen. The gamma counter 
software calculates the concentration of the unknown sample from the activity of 
the pellet, when measured against the set of known standards.
2.2.5.2 Reagents for insulin and C-peptide RIA
Insulin and C-peptide phosphate buffer:
0.04M Phosphate buffer (pH 7.4)
4.6g Na2HP0 4  anhydrous salt 
1.2g NaH2P04.2H20  
Dissolved in 1L RO water and stored at 4°C.
Radioimmunoassay buffer:
0.04M Phosphate buffer with 0.1% bovine serum albumin (BSA) added.
Charcoal stripped serum:
Charcoal stripped serum was supplied from frozen stock previously produced at 
the university. 20 gms of Norit A charcoal per lOOmls serum was added to a 
serum pool collected from fasted volunteers and stirred for 24 hrs. at 4°C. The 
following day, the charcoal serum mixture was centrifuged, then the supernatant 
filtered through a Seitz Filter until all the charcoal was removed. Aliquots (5ml)
were frozen and stored at -20°C.
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Quality controls:
Quality control samples were supplied by Dr. S Hampton, University of Surrey. 
Normal, healthy volunteers provided blood samples after an overnight fast, 30 
minutes and 1 hour after a meal, to produce low, medium and high controls. The
samples were aliquoted into 0.5mls volumes and stored at (-20°C) until use in the 
assay.
Polyethylene glycol (PEG):
PEG is used to adsorb the water component and therefore allows the reagents to 
react a smaller volume. A 4% solution is made up in assay buffer.
2.2.6 Radioimmunoassay for Insulin
The method used to determine plasma insulin was developed by Dr S M 
Hampton, University of Surrey (Hampton and Withey 1993). Antiserum was 
raised in guinea pig injected with porcine insulin conjugated to egg albumin, the 
conjugate was prepared using a gluteraldehyde reaction. Separation of the 
antibody bound and free insulin is carried out by a second antibody (donkey anti­
guinea pig) plus polyethylene glycol method. 125 I insulin was produced ‘in 
house’ using a chloramine T method. The assay buffer (0.04M phosphate buffer 
containing 0.1% BSA) was used to dilute the label and antiserum. The assay was 
carried out on an ice tray (approx 4°C). The samples were defrosted, then 
assayed in duplicate and the assay included controls to detect assay drift and 
blanks for non-specific binding as well as specific binding.
2.2.6.1 Reagents specific to Insulin RIA 
Antiserum:
The insulin antiserum was provided by Dr. Shelagh Hampton, University of 
Surrey. The antiserum used in the assay is batch no. MF/GP/2 VILA and is 
diluted to 1:20,000 (each vial of this batch is made up to 20ml).
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Insulin standards:
The insulin standard used was supplied from National Institute of Biological 
Standard and Controls. Freeze dried vials containing 0.1ml of pre-diluted 
standard were provided from frozen stock. For use in the assay, lml of assay 
buffer was added to a freeze dried vial. This produced the top standard of 
1500pmol/L (200 mU/L). Standards containing 750, 375, 187, 94, 47 and 23 
pmol/L were produced by sequential double dilution with assay buffer.
125I-labelled Insulin:
The 125I-labelled Insulin was provided by Dr. Shelagh Hampton for use as a 
tracer, prepared using the Chloramine-T method. The label was stored frozen (- 
20°C) in lOpl and 20pl aliquots. After the iodination, the label is diluted to give 
10,000 cpm/tube with assay buffer, this dilution is used throughout the life of the 
label.
Double antibody:
Normal serum and the second antibody both bind to the antibody-antigen 
complexes formed during the incubation stages, they are required to produce a 
larger matrix which can then be separated from the unbound antigen by 
centrifugation. These reagents were provided by Dr. Shelagh Hampton. Normal 
guinea pig serum was diluted 1:200 (initial dilution) in assay buffer. Donkey anti­
guinea pig antiserum was diluted 1:16 in assay buffer.
2.2.6.2 Insulin assay procedure 
Day one:
The reagents are added in the order shown on the protocol table (Table 2.1) to 
assay tubes set up in duplicate, including sufficient controls and zeroes to detect 
any assay drift. The tubes were then vortex mixed and preincubated for 24hr at 
4°C.
Day two:
lOOjul labelled Insulin was added to all tubes, including two tubes as ‘totals’. The 
tubes were vortexed, then incubated for a further 24 hr at 4°C.
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Day three:
100 pi Normal guinea pig serum and double antibody, and 700 pi of 4% 
polyethylene glycol were added as in the protocol table. The tubes were 
vortexed and incubated for 2 hr at 4°C, then centrifuged at 2500 rpm for 30 
minutes at 4°C and the supernatant aspirated from all tubes except the 'totals'.
The radioactivity of the pellet containing the antibody-bound, labelled insulin 
was counted by an automated gamma counter (Wallac Wizard 1470, Wallac 
International, Finland). The gamma counter software calculates the insulin 
concentration of the sample from the activity of the pellet, in counts per minute, 
measured against the standard curve.
Sensitivity and Specificity
The limit of the detection, based on twice the standard deviation from zero 
binding, is 16 pmol/L. The assay has high specificity for human insulin, the 
Crossreactivities at 50% displacement of tracer are (data provided by Dr. S. 
Hampton, Insulin Assay protocol):
%Crossreactivity 
Human Biosynthetic Insulin 100%
Human Biosynthetic Proinsulin 42%
Des 64-65 Biosynthetic Proinsulin 76%
Des 31 -32 Biosynthetic Proinsulin 61 %
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Table 2-1 Insulin radioimmunoassay protocol
Reagents Tubes DAY 1
Totals NSB Zero
Standard
standards NSB
QC
QC NSB
unknown
unknown
pi pi p i pi Hi pi pi pi
Assay diluent - 350 250 250 350 250 350 250
Insulin standard - - - 50 - - - -
CSS - 50 50 - - - - -
QC plasma - - - - 50 50 - -
Sample - - - - - - 50 50
Antiserum - - 100 100 - 100 - 100
Vortex mix all tubes and incubate for 24 hours at 4°C
DAY 2
Insulin tracer 100 100 100 100 100 100 100 100
Vortex mix all tubes and incubate for 24 hours at 4°C
DAY 3
NGPS - 100 100 100 100 100 100 100
DAGP - 100 100 100 100 100 100 100
4 %PEG - 700 700 700 700 700 700 700
Vortex mix all tubes and incubate for 2 hours at 4°C
Representative Insulin Standard Curve.
100
80
60
40
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I n s u l i n  c o n c .  p m o l / L
Figure 2-1 Representative insulin standard curve. Reproduced from assay protocol.
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2.2.7 Radioimmunoassay for C-peptide
Plasma C-peptide was determined by radioimmunoassay. The method used was 
modified from the method of L.G.Heding, Novo Research Institute, Copenhagen, 
Denmark, (1975). The antiserum (provided by Dr. Shelagh Hampton, University 
of Surrey, batch No. HP/S/473 - 5.5.78) was raised in a Soay sheep injected with 
a synthetic human C peptide conjugated to Egg Albumin (conjugate was prepared 
using a glutaraldehyde reaction). No extraction of the sample is required. 
Separation of the assay is carried out by a double antibody plus polyethylene 
glycol method. The assay was carried out on an ice tray (approx 4°C). The 
samples were defrosted, then assayed in duplicate and for non specific binding as 
well as specific binding.
2.2.7.1 Reagents specific to the C-peptide RIA 
C-peptide standard
The C-peptide standard used was a synthetic 32 amino acid standard obtained 
from Hoechst, diluted in assay buffer and then freeze-dried in glass vials
containing 20ng of C-peptide and stored frozen (-20°C). The standard was 
diluted for use in the assay in charcoal-stripped serum (CSS as described in 
2.2.4.1) over the range: 18, 39, 77,154, 310, 620,1230 and 2460 pmol/L.
Quality control
Quality control samples were the same as for the insulin assay.
Antiserum
The antiserum (provided by Dr. Shelagh Hampton, University of Surrey, batch 
No. HP/S/473 - 5.5.78) was diluted to 1:1500 and stored neat at 4°C in 1ml 
aliquots for use in the assay.
125I-labelled antigen
125I-labelled C-peptide was prepared by Dr. Shelagh Hampton. Synthetic human 
tryosylated C-peptide was iodinated using iodogen. Purification is carried out
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using G25 Sephadex . The label was stored in lOpl and 20pl aliquots frozen (-
20°C). For use in the assay, the label is diluted with assay buffer to give 10,000 
cpm/tube.
Second antibody
Normal Sheep Serum (NSS) and Donkey anti-Sheep IgG antibody were provided 
by Dr. S. Hampton. The normal sheep serum (NSS) was diluted 1:1200 with 
assay buffer. Donkey anti-Sheep IgG antibody (Dab) was diluted 1:20 with assay 
buffer.
22.12 C-peptide assay procedure 
Day one
The reagents are added in the order shown on the protocol table to assay tubes set 
up in duplicate, including sufficient controls and zeroes to detect any drift in 
accuracy. The tubes are then vortex mixed and preincubated for 24hr at 4°C.
Day two
lOOpl labelled C-peptide was added to all tubes and the tubes vortexed. The 
tubes were then incubated for a further 48hr at 4°C.
Day four
lOOpl NSS and Dab were added as in the protocol table to all tubes except 
'totals'.
500 pi of 4% polyethylene glycol was added to all tubes except 'totals'.
The tubes were vortexed and incubated for 2 hrs. at 4°C, then centrifuged at 2500 
rpm for 30 minutes at 4°C and the supernatant aspirated from all tubes except the 
'totals'.
The radioactivity of the pellet containing the antibody bound C-peptide was 
counted by automated gamma counter (Wallac Wizardl470, Wallac International, 
Finland). The concentration of the C-peptide in the samples was calculated by 
RIAcalc.
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Table 2-1 C-peptide radioimmunoassay protocol
Reagents Tubes
DAY 1
totals NSB Zero
Standard
standards NSB
QC
QC NSB
unknown
unknown
pi pi pi pi pi pi pi pi
Assay diluent - 100 - - 100 - 100 -
C-pep standard - - - 100 - - - -
CSS - 100 100 - - - - -
QC plasma - - - - 100 100 - -
Sample - - - - - - 100 100
Antiserum - - 100 100 - 100 - 100
Vortex mix all tubes and incubate for 24 hours at 4°C
DAY 2
C-peptide label 100 100 100 100 100 100 100 100
Vortex mix all tubes and incubate for 48 hours at 4°C
DAY 4
NSS - 100 100 100 100 100 100 100
Dab - 100 100 100 100 100 100 100
4 %PEG - 500 cnnJ U U 500 500 500 500 500
Vortex mix all tubes and incubate for 2 hours at 4°C
Centrifuge all tubes at 250Qrpm, 4 °C for 30 min
Aspirate and discard supernatant, and count activity in pellet
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2.2.8 Assessment of dietary intake
2.2.8.1 Dietary record diary
A diet record sheet was designed in the form of a diary, to record all food and 
drink consumed, separating each eating occasion, including snacks and drinks, by 
time. A record of portion size was included, and pictorial food portion guide was 
designed to accompany the diary. The food pictures were selected from The 
MAFF food portions guide (MAFF, 1998) to represent the most commonly eaten 
foods, meals and food textures, with a range of food portions aimed at reducing 
the subjective component of food portion recall (diet diary see appendix iv). A 
record of dietary intake and portions consumed was made by the subjects at each 
mealtime, recording all food and drinks consumed at that meal and since the last 
meal. Dietary intake was recorded for four, nine or fourteen days depending on 
the study. The dietary records were returned by post to the University of Surrey 
for analysis.
2.2.8.2 Dietary record analysis
Dietary records were analysed using a recognised diet analysis program Diet Plan 
5 (Forestfield Software, Horsham, Sussex, UK) to establish 24 hour total energy 
intake, macro and micronutrient consumption, 24h patterns of dietary intake and 
differences in content and timing of food consumption on day and night shifts.
Where sufficient dietary data was available, analysis of the polyphenol content of 
the diet was undertaken by a supervised undergraduate student, using a database 
devised by Professor M. Clifford, University of Surrey.
2.2.9 Light and Actigraphy
2.2.9.1 Light and activity data collection
Light and activity data was collected using an Actiwatch-L (AWL, Cambridge 
Neurotechnology, Cambridge, UK). This wrist-worn watch-like device was worn 
by all subjects continuously on the non-dominant wrist outside the sleeves of the 
clothing for the duration of the study. Removal was allowed for short periods to 
allow for showering. Measures of movement and light exposure were taken at 
one minute epochs.
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Figure 2-2 Actiwatch-L, light and activity monitor, Cambridge Neurotechnology, 
UK
2.2.9.2 Analysis o f  light and activity data
The analysis software Sleepwatch 98 and Sleepwatch 2002 (Cambridge 
Neurotechnology, Cambridge, UK) was used to assess the light exposure and 
sleep quality o f  the subjects. Peak daily light levels, total 24-hour exposure, and 
2-hourly bins o f  light were calculated. Sleep periods were identified from the 
point at which active movement reduces following the light going out, and the 
point at which the lights and activity are resumed. Sleep latency is the period 
between the time the subject starts attempted sleep (lights out was used as the 
usual signal) and actual sleep, sleep duration (sleep start to wake up), sleep 
efficiency (the duration o f  sleep in relation to the duration o f  attempted sleep) and 
sleep fragmentation data (adjusted sleep efficiency taking into account latency 
and wake episodes) were calculated.
2.2.10 Statistical Analyses
Graphpad Instat, and Statistica were the software packages used for these 
statistical analyses.
Assessment o f  significant changes in circadian phase was by paired two tailed 
Student’s t-tests comparing the starting acrophase (day 2) and day 6 acrophase.
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The relationship between initial aMT6s acrophase time and rate of adaptation (in 
14N schedule study) was tested by Pearson correlation.
Desynchrony load was compared between schedules by two way repeated 
measures analysis of variance (RMANOVA, factors: day and schedule).
Changes in light exposure, and sleep parameters within tour were assessed by 
repeated measures one-factor analysis of variance (within subjects factor, time).
Relationships between shift schedule and sleep parameters (sleep latency, 
duration and efficiency) and light (24-hour light exposure) were assessed by two 
factor analysis of variance (within subjects factor, time, between subjects factor, 
schedule).
Plasma metabolites and hormones were compared between each sample day by 
paired two tailed Student’s t-tests, on absolute values and as a change from the 
fasting sample as a baseline. Changes in plasma metabolites over tour duration 
and between schedules were assessed by two factor analysis of variance (within 
subjects factor, time, between subjects factor, schedule).
Changes in dietary intake parameters were assessed by paired two-tailed t-test 
(day versus night shift), or repeated measures ANOVA (over the study duration).
P values of <0.05 were accepted as statistically significant.
2.2.11 Precision and reproducibility
Quality controls were included at the start and end of all assays to demonstrate 
precision. Inter-assay co-efficient of variation was calculated for each parameter 
and these are shown in appendix vii.
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Chapter 3:14-Night shift 
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3 CIRCADIAN AND METABOLIC CONSEQUENCES OF A
14-NIGHT SHIFT SCHEDULE
3.1 In tr o d u c t io n
3.1.1 The offshore environment
An offshore oil or gas installation is considered to be a hazardous environment, 
not purely because of the flammable nature of the raw materials that it handles, 
but also in terms of the physical nature of the installation. Metal walkways and 
stairways are open to the elements and have safe walking areas and emergency 
exit routes marked out on the ground. These must be negotiated in overalls and 
heavy protective footwear and hard hats are worn outside. There are railings 
everywhere, and rules about using them, to prevent injuries. There are warning 
signs for ignition, fire or electrical risk, with emergency call phones, fire fighting 
equipment and life jackets at every turn. This can be an isolated and harsh 
environment, accessible only by helicopter, and one arrives dressed in a 
cumbersome coldwater survival suit and life jacket with a water-triggered rescue 
beacon worn around the neck. The first task of a new arrival is a safety tour of the 
exits and lifeboats. If any doubts remain that this retreat is no holiday 
destination, there is the continuous loud hum of industrial noise.
There is a sense of community amongst the workforce. The crews are mostly 
male, two or more sharing a cabin and often on different shifts, so that they do 
not interrupt each other’s sleep. The cabins can be completely darkened and there 
are ‘quiet’ notices in the corridors to prevent daytime sleep disturbances. There is 
limited social activity as space is at a premium, however most installations have 
the facilities to show films and have a recreational area for television, and some 
also have computer games and a pool table. Fitness facilities are limited by 
space, but many have a small gym and offer circuit training.
The industry has a no alcohol policy so all installations are ‘dry zones’, however 
offshore installations are fully catered environments. All meals, drinks and 
snacks are provided and meal times are a major period of social interaction.
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Healthy eating is usually taken into consideration by the catering service, 
although the interpretation of ‘healthy eating’ varies between installations. In 
addition to the healthy options there are always fried breakfasts, chips and 
puddings on offer. How healthy dietary intake is, and thus the potential for 
health benefit or detriment that it confers, is ultimately the choice of the 
individual worker.
These isolated and controlled conditions create an environment that is conducive 
to research as all subjects are exposed to the same conditions and there is limited 
scope for variation.
3.1.2 Health and safety concerns
The offshore industry operates numerous shift patterns offshore as discussed in 
section 1.3.3. Considering the symptoms of fatigue, sleep disturbance and 
reduced alertness that are associated with the circadian desynchrony that occurs 
in night shift work (section 1.4.3) the industry is rightly concerned for the health 
and safety of its workforce.
As it is known that, given the appropriate conditions, offshore workers can 
resynchronise their circadian rhythms to a night shift (Barnes et al, 1998a, 
1998b), it is important to know if this is the case with the schedules currently 
operated by the UK offshore petrochemical industry.
The possibility of increased health risks associated with shiftwork has been 
established (section 1.4 and 1.5), however there is little information available on 
the consequences associated with specific schedules, and it is not clear whether 
there are benefits conferred by resynchronisation (adaptation) or not. The project 
aims to investigate this in a combination of day shift, night shift and mixed shift 
schedules. The present study focussed on the adaptation process in workers 
undertaking a 14-day tour of 12-hour night shifts, and the schedule’s 
consequences for sleep and postprandial metabolism.
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3.1.3 The 14-nights schedule
The 14-Nights (14N) shift schedule is one of the most commonly operated work 
schedules in the offshore petrochemical industry. The schedule is usually 
operated in rotation with a tour of 14 days, with 14 days of leave between each 
tour, so that the entire rotation takes 8 weeks to complete and the workers 
undertake one period of night shift during this time. A similar 21-day tour 
rotation is operated, so that the rotation is complete in 12 weeks. The schedule 
usually operates as a 12 hour night shift from 18:00h to 06:00h (or 19:00h to 
07:00h).
The 14-nights schedule was chosen for inclusion in this series of studies, as the 
circadian rhythm of the melatonin metabolite 6-sulphatoxymelatonin (aMT6s) 
shows adaptation (Barnes et al, 1998a). It is therefore perceived that there will be 
less overall disruption to sleep. However this schedule requires a period of 
readjustment after the tour, during leave time, it is unpopular in workers who are 
used to the 7-night, 7-day schedule.
A study was undertaken to measure the circadian adaptation, sleep, performance, 
dietary intake, hormonal and metabolic responses to meals during 14 nights 
offshore. The term ‘adaptation’ is taken to mean a physiological adaptation of 
the central internal clock and is measured by phase shift of the 6- 
sulphatoxymelatonin (aMT6s) output rhythm.
The aim was to confirm a phase shift of the circadian system on this night shift 
schedule in a population of offshore oil and gas installation workers and to 
monitor for consequences of the schedule with regard to sleep, hormones and 
metabolism.
3.2 M eth o d o lo g y
Prior to commencement of this study a pilot study was undertaken to establish the 
feasibility of measuring circadian adaptation concurrently with dietary records 
and metabolic parameters in the same subjects. The pilot protocol was augmented
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to include the use of the Actiwatch-L to record light exposure and sleep 
parameters. The protocol and methods used are summarised below, and detailed 
further in chapter 2. A cross reference to the relevant section is given for each 
method.
3.2.1 Subject Recruitment
Two offshore oil and gas operators provided access to installations in the North 
Sea (geographical latitude 60°N) and Morecombe Bay (54°N). The installations’ 
paramedical staff recruited subjects from their workforce, and co-ordinated the 
sample and data collection.
All subjects (n = 12) were studied over the first 14 night shifts (1800h-0600h) of 
a 14 or 21 night tour. Subjects were men, aged between 27 and 54 years (40.5 
years ±9.0 mean ±SD), with mean BMI of 27.6 kg/m2 (range 23-32kg/ m2). They 
were free of medications indicated in the protocol exclusion criteria, and gave 
informed consent.
3.2.2 Study Design
The study was designed to run in 14-day periods. Over the 14 days subjects were 
required to provide 3 to 4 hourly (and oversleep) sequential and complete urine 
collections, 4 blood samples, a record of their dietary intake and complete a 
questionnaire about diet and lifestyle onshore. They were required to wear an 
Actiwatch-L (wrist worn activity and light recorder, CNT, Cambridge, uk) This 
protocol is summarised in Table 3-1.
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Table 3-1 Study design for a schedule of 14 nights.
Day 1 2 3 4 5 6 7 8 9 10 11 12 13 14
Shift N N N N N N N N N N N N N N
Urine U U U U U U U U U U U U U U
Blood PA PA PA
FA
Diet D D D D D D D D D D D D D D
AWL L L L L L L L L L L L L L L
KEY
N = Night shift
U  = Urine collection (24h total in 3-4 hourly collections)
FA = Fasting blood sample 
PA =  6h Postprandial blood 
D = The dietary intake record
L = subjects wear an Actiwatch-L light and activity monitor
3.2.3 Determination of circadian phase & phase shift
Sequential urine collections were provided by all subjects at three to four hour 
intervals and oversleep as described in methods 2.2.2.1. The intervals between 
samples varied and subjects provided 3-7 samples per day. The subjects’ 
circadian status, direction and rate of adaptation of the internal clock to the 12 
hour night was assessed via the urinary melatonin metabolite aMT6s, measured 
by a specific radioimmunoassay technique (Aldous and Arendt, 1988), see 
method section 2.2.2.
The aMT6s acrophase time was calculated by cosinor analysis (Dr D.S. Minors,, 
University of Manchester) using 48h moving windows. The change of the aMT6s 
acrophase time was taken as an indicator of circadian phase shift. The rate of 
adaptation (expressed in hours of phase shift per day) was calculated on an 
individual basis, from the starting phase position on day 2 (the first complete 24h 
period of data) to the first day on which each subject met our adaptation criterion 
(see methods section 2.2.2.3).
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3.2.4 Assessment of actigraphy and light exposure
Light and actigraphy (activity monitoring provides data for sleep parameters) 
data was collected using an Actiwatch-L. The light exposure and actigraphy data 
were analysed using Sleepwatch 98 as described in methods section 2.5.
3.2.5 Measurement of hormonal & metabolic changes
3.2.5.1 Blood sample collection
The protocol allowed only one postprandial blood sample per day which was 
drawn six hours after the mid-shift (midnight or thereabouts) meal. The reason 
for this timing was that the 6h postprandial TAG response is an indicator of CVD 
risk, and has previously been shown to be altered at night. (Hampton et al, 1996; 
Ribeiro et al, 1998).
Blood samples were taken by the medical officer on board each offshore 
installation. 25ml venous blood samples were taken from each subject on four 
occasions over the tour. The plasma was separated by centrifugation and 
immediately aliquoted and frozen, according to the protocol in appendix vii. 
The samples were stored offshore until the study was complete, when they were 
packed into a cold box and flown directly to the shore. The samples were than 
transferred to dry ice and transported to the University by courier.
On the 14-Nights schedule a fasting sample was taken after an over-sleep fast of 
at least 8 hours on study day 13. Day 13 was selected as the most fully adapted 
day and the most likely to represent a ‘normal, non-shiftwork’ fasting sample. 
Samples 2, 3, and 4, postprandial samples, were taken 6 hours post consumption 
of a mid-shift main meal on nights 2, 6, and 13 as shown in table 3.1. Day 2 was 
the first full 24h period on night shift and represents the night when subjects are 
least adapted to night shift. Day 6 was selected as the day of tour by which 
adaptation should have occurred based on the phase shift data of Barnes et al 
(1998a) for this shift schedule. Day 13 was chosen for the final sample to 
ascertain any further effect through the tour.
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3.2.5.2 Plasma analysis
Plasma from fasting and 6h-postprandial samples was analysed for glucose, 
TAG, cholesterols and NEFA content by automated spectrophotometer, see 
methods section 2.2.3.
Plasma insulin and C-peptide were assayed by specific radioimmunoassays, see 
methods section 2.2.4 for full assay protocols.
3.2.6 Assessment of dietary intake
3.2.6.1 Dietary intake
Dietary intake was recorded at each mealtime, recording all food and drinks 
consumed at that meal and between meals, for all 14 days of the study as 
described in methods section 2. See appendix iv for the Diet diary.
Dietary records were analysed using a validated diet analysis program Diet Plan 
5, to establish 24-hour total energy intake, macronutrient consumption, 24h 
patterns of dietary intake and differences in content and timing of food 
consumption on day and night shifts.
3.2.7 Statistical methods
Statistical analyses were used to identify significant changes in phase shift, light, 
sleep and metabolic parameters through the course of the tour, the tests used are 
described in methods 2.6.
In addition, patterns of dietary intake across the period of the tour were assessed 
by repeated measures analysis of variance (within subjects factor, time (day of 
shift)).
P values of <0.05 were accepted as statistically significant.
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3.3 R esults
3.3.1 C ircadian adaptation
3.3.1.1 Circadian rhythm assessment
The rhythmic production o f  aMT6s in ng/h was established for each subject from 
the urine sample analysis and the urine collection data records o f  collection 
volume and duration. An example o f  the urinary aMT6s profile over the 14-night 
tour is shown in Figure 3-1.
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Figure 3-1 Profile of aMT6s rhythm, showing peaks at collection midpoint, 
over a 14-night tour.
The rhythmic production o f  aMT6s is clearly displayed, however the timing o f  
the rhythm peak is a function o f  the collection time and duration as it is the 
midpoint o f  each collection period that is plotted. Therefore the accuracy o f  the 
observed peak time depends on the number and timing o f  samples collected. 
Cosinor analysis allows a more precise calculation o f  the acrophase (time o f  the 
rhythm peak) as it fits the data to a curve, this also provides a measure o f  the 
rhythm amplitude.
O f the twelve subjects recruited, one was excluded from the adaptation analysis 
due to non-significant rhythm analysis. This was attributed to low and irregular 
aMT6s concentration, possibly caused by incomplete collections, preventing 
adequate rhythm analysis.
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3.3.1.2 Phase shifts in circadian status
The acrophase times for each subject on days 2 to 14 o f  the tour were calculated. 
Figure 3.2 shows the mean daily aMT6s acrophase time as assessed by 
measurement o f  urinary 6-sulphatoxymelatonin (aMT6s) in sequential samples 
throughout 14 night shifts (1800-0600h). Day two is the first day on which an 
acrophase can be calculated, and thus provides a starting acrophase, i.e. a starting 
point from which a phase shift can be measured.
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Figure 3-2 Circadian response to night shift; mean (+/- SEM, n = ll)  daily aMT6s 
acrophase time as assessed by urinary 6-sulphatoxymelatonin (aMT6s) in 
sequential samples throughout 14 night shifts (1800-0600h), showing change 
(adaptation) o f acrophase by delay.
There was a significant change in mean (n=l 1) aMT6s acrophase timing over the 
14 days (mean day 2 aMT6s acrophase 6.05h, mean day 14 aMT6s acrophase 
12.69h, total change 6.82 hours), with a significant phase shift by day 4 (mean 
change 4.11h, t-test p = 0.0005). After day 8 no further significant delay o f  
acrophase was seen in the group as a whole (mean change day 8 -  day 14, l . lh ,  
p>0.05). One subject showed only very small phase shifts o f  the aMT6s rhythm 
from a very late acrophase starting point o f  13.20h. This is unusually late and this 
subject appears to have been pre-adapted to the night shift, however there was no 
readily identifiable fault with his data or rhythm analysis and he was therefore 
included in the mean.
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Starting acrophase time was correlated with rate o f  adaptation in hours/day, 
(r=0.77, p = 0.015, n=9). This suggests that subjects with a late starting acrophase 
adapt more rapidly than subjects with an earlier starting acrophase. Two subjects 
were excluded due to inadequate cosinor fit o f  aMT6s data on day 2. The 
relationship is shown in Figure 3-3.
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Figure 3-3 The relationship between the acrophase time at the start of the 
tour and the rate of adaptation (hrs/d) of the aMT6s rhythm to night shift 
(n=9).
3.3.2 Actigraphy and light.
Actiwatch-L’s were worn by all subjects. Two were excluded from the data as the 
watch was removed at night, ten were analysed for actigraphy and light exposure.
3.3.2.1 Light
Figure 3-4 shows the total mean (± SEM, n=10) light exposure per day o f  the 
schedule, calculated from light records at one minute epochs, averaged for hourly 
data. There were no significant changes in total daily light exposure (p=0.14) or 
maximum daily light exposure (p=0.078) over the tour duration. These data
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confirm that the subjects were exposed to consistent overall light levels each 24h 
period.
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Figure 3-4 Total daily light exposure on 14N schedule (mean lux ±SEM, n = 
10)
3.3.2.2 Adaptation of acrophase with light and activity.
Figure 3-5 shows the mean acrophase position in relation to the light exposure 
and activity level over the tour duration. Each 24h period is divided into equal 
vertical bands, the acrophase time and amplitude is denoted by the vertical black 
line marker, and the pattern of light or activity is denoted by the red and blue 
lines respectively. The acrophase can clearly be seen to delay, initially occurring 
during a light phase when the subjects first commence the night shift tour, then 
moving into the dark phase (the dark phase is during the day because lights are 
switched off during sleep periods) as they adapt to the night shift. A similar 
relationship is seen with acrophase and activity, which drops each day during the 
sleep period.
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Figure 3-5 Graphs show the mean (n=9) acrophase position in relation to the 
pattern o f light exposure (top) and activity (below) over the 14-N tour. Days 1 to 13 
of the tour are represented in 13 vertical bands with the aMT6s acrophase position 
for each 24-hour period indicated by a vertical black line. The height o f the line 
indicates the amplitude o f the rhythm and the position o f the line within each day 
indicates the acrophase time.
 = light,  = activity.
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The graphs of phase position in relation to light/activity in two subjects, 
representing the extremes of the mean, are shown in figure 3-6. 3-6a shows a 
subject who adapts slowly to the shift, while 3-6b shows a subject who adapts 
rapidly. The subject that adapted rapidly had greater total light exposure over the 
duration of the tour (p=0.02) and received a greater proportion of daily light prior 
to the aMT6s acrophase than the slow adapter. This difference in the timing of 
individual light exposure in relation to the aMT6s acrophase may offer some 
explanation for the increased adaptation rate.
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Figure 3-6 Graphs show the aMT6s acrophase position in relation to the pattern o f  
light exposure over the 14-day tour o f two representative subjects. As in Figure 3-4 
each day of the tour is represented by 13 vertical bands with the aMT6s acrophase 
position for each 24-hour period indicated by a vertical black line. The height o f  the 
line indicates the amplitude o f the rhythm and the position o f the line within each 
day indicates the acrophase time. 3-6a is a slow adapter, 3-6b is a fast adapter.
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3.3.3 Sleep
Analysis of actigraphy data provided qualitative and quantitative measures of the 
subjects’ sleep for each night of the 14-night tour. Sleep duration is a measure of 
the total time asleep calculated from the point at which sleep is deemed to start to 
the point of waking. Sleep latency is the time between first attempting to sleep 
and actual sleep commencing. Sleep efficiency is the actual time asleep expressed 
as a percentage of the total time in bed attempting to sleep, until rising. Sleep 
fragmentation is a more qualitative marker as it takes into account the 
restlessness (wakenings and increased movements during sleep) over the sleep 
duration. The sleep of subjects on the 14-nights shift schedule is expressed as the 
four sleep parameters described above and shown in Figure 3-7.
There were no significant changes in sleep duration, sleep efficiency or sleep 
fragmentation over the period of the tour (ANOVA p>0.05). ANOVA indicated a 
difference in the sleep latency over the tour duration (p = 0.03), the Tukey- 
Kramer post hoc test identified the difference to be between day 3 (16 minutes, ± 
SD18) and day 13 (2 minutes ±SD1), suggesting an improvement over the tour. 
Examination of the error bars on sleep latency indicates that the between subject 
variance reduced as the tour progressed, suggesting that although there was no 
improvement in the mean, the extremes of variance between the subjects was 
improved.
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Figure 3-7 Mean sleep duration (hrs: minutes), efficiency (%), latency (minutes) and 
fragmentation (%), on 14-Nights schedule (± SEM, n=10).
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3.3.4 Consequences of night shift meals on postprandial metabolism
Blood samples were collected from all twelve subjects, one fasting sample and 
three postprandial on nights 2 (unadapted to night shift), night 6 (adapted to night 
shift) and night 13 (adapted to night shift).
Subjects were requested to standardise their diet prior to these blood samples by 
consuming the same meal on each occasion. The compliance with this request 
was poor, however in all but one subject the meals were of a similar nutritional 
content, in terms of fat, carbohydrate and energy, thus one subject was excluded 
from the analysis for non-compliant diet. A further 3 plasma results were 
excluded where the diet record identifies that a ‘snack’ was consumed between 
the test meal and the blood sample.
Results were not excluded for being more than two standard deviations from the 
mean, as it was considered inappropriate to do so in a subject group (night 
workers) that might be likely to give abnormal results.
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3.3.4.1 Plasma TAG
Figure 3-8 shows the mean (± SEM) plasma TAG. The postprandial plasma 
sample from night 2, when subjects were the most unadapted to night shift, had 
the highest mean TAG and was significantly higher (p= 0.047) than on day 6 
when the subjects’ circadian system has adapted to the night shift.
Triaclyglycerol (TAG)
3 1 
2.5 -
2 -
0  -j -------- T-----L------------T-----L—---- ------T-----■BMH-
D13F D2-pp D6-pp D13-pp 
sample day fasting or post prandial
Figure 3-8 Mean (n= 11 ±SEM) TAG in fasting and postprandial plasma following 
night time meals on the 14N schedule (p=0.047 D2 vs D6).
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3.3.4.2 Plasma cholesterol
Postprandial total cholesterol, shown in figure 3-9, was significantly raised on 
night two in comparison to night 6 (p = 0.04), this difference was not apparent in 
HDL or estimated LDL.
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Figure 3-9 Mean cholesterol (±SEM, n= 11) in fasting and postprandial 
plasma following night time meals on the 14N schedule.
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3.3.4.3 Plasma Glucose
No significant differences were found in the postprandial glucose samples 
although a visible trend is apparent for glucose to be higher on night 2 than at all 
other times. Glucose is shown in figure 3-10.
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Figure 3-10 Mean (±SEM, n= 11) glucose in fasting and postprandial plasma 
following night time meals on the 14N schedule.
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3 3 .4.4 Plasma NEFA
No significant differences were found between the postprandial NEFA samples, 
they are shown in figures 3-11.
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Figure 3-llMean (n= 11 ±SEM) NEFA in fasting and postprandial plasma 
following night time meals on the 14N schedule.
I l l
3.3.4.5 Plasma insulin and C-peptide
No significant differences were found between the insulin or C-peptide 
postprandial samples, they are shown in figure 3-12.
Insulin & C-peptide
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Figure 3-12Mean (±SEM, n= 11) plasma insulin and C-peptide in fasting and 
postprandial plasma following night time meals on the 14N schedule.
3.3.5 Dietaiy Intake
There was a temporal redistribution o f  food intake to an increase at night, 
aligning with the sleep-wake cycle. The daily total energy and macronutrient 
intake by subjects on the 14N schedule was determined and is shown in Table 3- 
2. The estimated average requirement (EAR) is shown as an indicator o f  the 
energy requirements for a population o f  adult males, and the reference nutrient 
intake (RNI) is given as the indicator o f  recommended macronutrient intake. The 
shift has been divided into days 1 to 5 and days 6 to 14 to compare the early and 
unadapted nights with the later adapted nights.
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Table 3-2 shows the mean (and SEM) energy and macronutrient (expressed as a % 
of energy) intake on days 1-5 and 6-14 of a 14 night shift schedule.
Mean 
nutrient intake
EAR*
/RNI
Nights 
1-5 of 14
SEM Nights 
6-14 of 14
SEM
Total energy (k- 2550* 1988 163 1939 53
cals)
CHO as % energy 50% 42.7 2.6 44 0.49
Fat as % energy <35% 40 0.36 39 0.57
Protein as % 15% 19 0.53 17 0.44
energy
There was a significant decrease in the percentage of energy consumed as protein 
from night 6 onward (P= 0.02) with a corresponding increase in carbohydrate 
consumption (P = 0.02). No further differences were found in macronutrient 
intake between the two periods within the tour and no significant changes in 
intake over the period of the tour.
3.4  D isc u ssio n
3.4.1 A daptation to shift schedule
An equivalent schedule has previously been studied for adaptation of the aMT6s 
rhythm (Barnes et al, 1998a). However it was considered important to revisit the 
schedule for concurrent determination of the circadian disruption and its 
consequences in parameters of sleep and metabolism, before the protocol was 
applied to other schedules.
The phase shift in aMT6s acrophase by day 4 of the schedule showed that the 
subjects adapted by delay of the circadian rhythm. This observation is consistent 
with the results reported by Barnes (1998a) in a group of offshore workers during 
both winter and summer. The adaptation was by a delay of the aMT6s rhythm in 
all subjects, most likely due to the timing of light exposure. Nightshift subjects 
get increased light exposure during the hours of darkness, starting before the
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melatonin peak, i.e. at a time when light delays the circadian clock. Light applied 
at a later time, during the fall of melatonin production, could have the reverse 
effect by suppressing the melatonin so that the rhythm falls earlier and the next 
rise in the rhythm is advanced (occurs earlier).
The correlation found between starting acrophase time and rate of individual 
adaptation (hours/day) suggests that the earlier the acrophase peak the more 
difficult the subject finds it to adapt their aMT6s rhythm. A late starting 
acrophase indicates that less adjustment of the rhythm may be needed to delay the 
acrophase so that it occurs during the dark phase, i.e. the sleep period, of the 
subjects’ day. Those with an early acrophase have to adapt their phase position 
further in order for it to occur during the daytime sleep period, however the early 
acrophase subjects also adapted at a slower rate. Mitchell et al (1997) also 
reported that subjects with a late circadian clock (evening preference) adapted 
more readily to night shift. The overnight and early morning light received in 
relation to individuals’ phase position is a major factor in the adaptation rate 
(Dumont et al, 2001; Gibbs et al, 2002b) as light that conflicts with the desired 
direction of adaptation would have the effect of slowing the adaptation rate.
The one subject who showed only slight adaptation of the aMT6s rhythm and 
who had a very late starting acrophase may naturally have an abnormally late 
acrophase. The subject could also have been pre-adapted to the night shift due to 
activities and sleep patterns during his on-shore leave, for example it would be 
possible to pre-adapt by a Tate to bed, late to rise’ routine. There are also 
anecdotal reports of workers moonlighting: this involves working a night shift 
during the two week onshore rest period. This practice is considered 
unacceptable in the offshore industry as it presents an increased risk o f fatigue 
and none of the subjects participating in this study admitted to the practice.
3.4.2 Light
The mean total light exposure across the shift did not change significantly, 
suggesting that subjects received a similar daily light exposure throughout their 
tour. The small increases in mean light seen on day 3 and day 8 can be explained
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by corresponding increase in maximum light measured on the same days, 
suggesting the local weather and light conditions are the cause. Differences 
between subjects are likely to reflect job type and personal routines.
The correlation between starting acrophase time and adaptation rate is attributable 
to the timing of light exposure in relation to the acrophase. Subjects with earlier 
acrophase times will receive light at different points in their circadian phase to 
those with a later acrophase time. Entrained phase (indicated by starting 
acrophase time or phi) is related to tau (the period of an individuals circadian 
rhythm). The later the phi, the longer the tau and the more likely the subject is to 
phase-delay faster (Czeisler, 1990; Mitchell et al, 1997).
Melatonin production, and therefore also the aMT6s acrophase, would normally 
occur during the dark phase (i.e. during the night/sleep). However during the 
early days of the night-shift tour the acrophase times initially occurred during a 
period of light (the night-time light being provided by artificial lighting). This 
night-time light exposure causes a phase delay in the circadian melatonin rhythm. 
The acrophase peak occurs later each day until it falls within the dark phase (the 
night shift workers’ sleep period). However subjects whose acrophase time is in 
the early part of the night will get some of the night-time light before their 
acrophase and some after. In this case the light is conflicting and the expected 
phase delay of the acrophase into the daytime sleep period is inhibited, thus the 
subject adapts more slowly. This demonstrates the relationship between the 
adaptation process and the timing of the light exposure and can be clearly seen in 
the Figure 3-5 which shows the light timing in relation to circadian phase, and 
how the circadian phase becomes later until the acrophase falls within the sleep 
period.
The period of free time for recreation between shift end and sleep was not 
scheduled and thus the duration of this period was the subjects’ choice. This 
provides an uncontrolled period where those subjects who postponed sleep had a 
longer period of wakefulness during daylight. Light at this time falls after the 
aMT6s acrophase, so inhibiting the phase delay required for adaptation to this 
schedule. Subjects whose choice was to sleep immediately after the shift end
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avoided the conflicting light. This suggests that scheduling the sleep period 
would improve adaptation and is supported by the literature on the use of timed 
light and light avoidance for night shift adaptation (Eastman et al, 1994; Eastman 
and Martin, 1999; Boivin and James, 2002). Confirmation of the efficacy of this 
strategy in offshore shiftworkers by a study of sleep scheduling is required.
The effects of light levels and timing of exposure in relation to the circadian 
system, are not folly known. Moreover individual sensitivity to light is a factor 
that has yet to be investigated and may influence the circadian adjustment.
3.4.3 Actigraphy and sleep parameters
A fourteen-day schedule of night shifts does not appear to result in changes in 
sleep parameters over the period of the tour except that sleep latency, the time it 
takes to fall asleep, improves over the tour duration. The high intra and inter­
individual variations mask any differences on other study days. The variance 
between subjects is reduced over the tour duration, which probably reflects a 
combination of subjects’ adaptation rate and the cumulative fatigue that is 
anecdotally reported by offshore workers. Sleep efficiency in a normal onshore 
environment can be over 90%, yet here the mean sleep efficiency falls to 83.8%, 
with one individual falling as low as 61%. The sleep of night shift workers may 
be expected to be less efficient due to disturbances during daytime sleep. The 
offshore environment aims to reduce external disturbances to sleep by providing 
light-tight, sound proof accommodation at a distance from the noisiest parts of 
the installation, and limiting sleep interruptions by third parties.
Previously physical activity or exercise has been cited as a possible zeitgeber for 
entrainment of circadian rhythms (see section 1.2.) In this study the active 
periods coincided closely with the periods of light exposure and are a largely a 
function of the shift duration, thus the variability in subjects’ activity levels is 
likely to reflect the demands of their work role on the installation. Activity may 
be contributing to the adaptation process but as the two zeitgebers occur together 
it cannot be considered independently of light.
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The actiwatch-Ls record data in one minute epochs worn on the non-dominant 
hand and provide an objective measure of general activity. The watches can be 
deceived by unusual or isolated movements, such as an exercise cycle where the 
limited hand movement would result in an underestimation of activity, or 
monitoring of control panels where the hands move frequently to monitor 
equipment yet the overall activity is sedentary. However in this study the 
primary use of the data was for light and sleep analysis which is less subject to 
deception unless the watch is covered or removed. The analysis of the actiwatch 
sleep data is subject to some interpretation bias as the time of sleep onset and 
waking is estimated from periods of stillness, thus sleep latency could be 
underestimated in insomnia.
3.4.4 Metabolic responses to meals
In this study we investigated the response to meals at night on three occasions, 
one when subjects were unadapted to nightshift, a second when the subjects were 
expected to have adjusted to their shift, and a third for comparison with other 
shift schedules.
The significantly higher postprandial TAG and total cholesterol on night 2 
(unadapted) in comparison with night 6 (adapted) suggests that postprandial lipid 
metabolism and particularly TAG clearance is compromised during night shift. 
The raised cholesterol on night 2 is most likely to be a knock-on effect of the 
slow TAG clearance. The recovery of postprandial metabolism on night 6 (i.e. 
not significantly raised from fasting levels) suggest that circadian 
resynchronisation confers a beneficial effect on normalising the night-time 
postprandial TAG and cholesterol.
Postprandial responses of the other metabolic and hormonal parameters assessed 
have normally passed their peak levels at 6-hours postprandially, and if they have 
returned to near baseline by that time, any difference between the samples will 
have been missed. The postprandial glucose results suggest that this was the case
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as all four samples fall with the normal fasting range. Furthermore there was no 
statistically significant difference in the postprandial insulin or C-peptide levels, 
and the NEFA results reflect the insulin levels.
In light of the significantly raised TAG in unadapted subjects, it is recommended 
that a postprandial metabolism study in night shift workers is undertaken with 
blood sampling throughout the postprandial period to establish if there are 
disturbances to other metabolic parameters. It would also be of interest to 
investigate the size and density of the LDL particles if the metabolic responses 
are indicative of insulin resistance.
In this study subjects were requested to consume the same meal prior to all three 
postprandial blood sample occasions, and to avoid snacks in between. The aim of 
this request was to reduce the confounding effect of a totally free dietary choice 
on the measures of hormonal and metabolic responses to those meals. The request 
for equality in dietary intake prior to each blood sample was not well complied 
with, and it is recommended that a test meal be applied in further studies. 
However, the fact that these metabolic effects persisted in spite of poor dietary 
compliance, indicates that the observed effects are robust and likely to persist in a 
totally free-living shift-working population.
3.4.5 Dietary intake
The offshore habitat offers fully catered meals even to night shift workers and 
there is no cost incurred by food requirements, other than for confectionery. This 
removes some of the possible cause of differences in night workers’ intakes in an 
onshore environment and less affluent industries, where pre-prepared foods and 
snacks may contribute more to night shift diet intake, and disposable income or 
poverty are more likely to restrict or alter food choice. This survey of offshore 
shiftworkers found no difference in overall macronutrient intake across the tour, 
but a small swing in the ratio of carbohydrate to protein consumed during the 
early versus later part of the tour. It is not clear at the present time why this 
should be, but it may be that the change in appetite and food choice is associated
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with night shift, comfort food, or snacking to stay awake, and may alter as a 
person becomes adapted to their schedule. As diet intake was partially restricted 
by the environment and catering, and similar foods are available to the worker 
throughout the tour, the change in macronutrient ratio seen may be due to a 
physiological affect of adjustment to the shift.
3.4.6 Conclusions and Further study.
On this schedule of fourteen night-shifts, offshore shiftworkers’ circadian rhythm 
of melatonin production adapted to night shift by a delay of the rhythm timing.
During the autumn season there was no significant variation in light exposures 
over the tour period, but there was a clear relationship between the time of light 
exposure and phase shift of the acrophase peak during the early (adaptive) part of 
the tour. Rate of adaptation in individuals appears to be associated with the 
individuals’ normal acrophase time and relationship to light exposure.
There is no significant change in most sleep parameters over the period of the 
tour, however there is a reduction in sleep latency period over the tour. No 
correlation between sleep latency and adaptation was found, so this is likely to be 
associated with cumulative fatigue over the 14 shifts.
The postprandial metabolic response to a meal, measured by plasma 
triacylglycerol, is altered detrimentally at the beginning of 14N schedule. 
Adaptation to this night shift is associated with an improvement in that response.
This shift schedule does not affect dietary intake in terms of energy but may 
induce a small but significant change in food choice to alter macronutrient 
composition. The provision of a fully catered environment is likely to minimise 
any differences in dietary intake between day and night shiftworkers.
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This study confirmed that shiftworkers on the 14N schedule can adapt their 
circadian rhythm to the night shift, and has shown that there are consequences for 
sleep and postprandial metabolism associated with the circadian desynchrony.
The protocol used here was applied to three other commonly operated shift 
schedules in the offshore industry; the ‘swing’ shift of 7 nights (18:00h to 
06:00h) and seven days (06:00h to 18:00h), the day shift (06:00h to 18:00h), and 
the ‘drill’ shift of 7 days (12:00h to 24:00h) and 7 nights (00:00h to 12:00h). 
These studies are reported in the following three chapters.
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Chapter 4 : 7-Night. 7- 
Day offshore shift 
schedule
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4 CONSEQUENCES OF A 7-NIGHT, 7-DAY OFFSHORE
SHIFT SCHEDULE
4.1 In tr o d u c t io n
4.1.1 The 7-nights, 7-days shift schedule
The offshore petrochemical industry operates an alternative schedule to the 14N 
schedule reported in chapter 3, which despite reservations of its relative safety, is 
popular amongst the workforce. The 7-nights (1800h-0600h) and 7 days (0600h- 
1800h) schedule (7N7D) is usually operated continuously, so that each week as a 
new crew arrive they commence their tour on nightshift then change to days after 
the first week when the next night crew arrive. The change over day or ‘swing- 
shift’ consists of three 8 hour periods (rest, work, then rest again) as opposed to 
the 12-hours rest and 12-hours work, facilitating the crew change from a night 
shift to a day shift. The reverse shift of days first, then nights is also operated, 
but mostly as a drill shift (see chapter 6).
The fatigue and reduced alertness associated with circadian desynchrony in night 
shift work (Akerstedt and Landstrom, 1998; Akerstedt, 2003) are a major health 
and safety concern in this industry that operates in such a remote and hazardous 
environment. Here, where the consequences of a mistake could have far reaching 
effects, any way of improving night-shift fatigue or reducing accident risk is 
given serious attention. On this schedule the workers are subjected to two periods 
of desynchrony, the first as they commence night shift, and then, if they have 
adapted to the night shift, a second period of desynchrony when they change over 
to day shift in the second week. The first week of this schedule is in effect 
identical to the first week of the 14N schedule. Therefore based on the results of 
the 14N schedule and those of Barnes et al (1998a) it was predicted that subjects 
on this schedule would adapt their aMT6s rhythm to synchronise with the timing 
of the night shift.
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This schedule is popular amongst the workforce as, despite having to undergo a 
change of shift (and therefore a circadian disruption) twice in each tour, they 
perceive that all of their readjustment occurs offshore and that having worked a 
week on dayshift they feel they will be returning home adjusted to normal clock 
time. Bames et al (1998b) reported on circadian adaptation in the reverse swing 
shift with different work hours (7 days, 7 nights, 1200-2400h), finding that 
adaptation was only partially achieved in workers with the benefit of spring 
daylight, and that adaptation did not occur during the shorter, darker days of 
winter. Thus it was hypothesised that on this schedule adapted night workers 
would not fully re-adjust when they change back to days in week two of the tour.
Perhaps surprisingly, given its popularity, circadian adaptation to this schedule 
had not previously been studied, so its inclusion was a fundamental aspect of the 
project. The study was undertaken to measure the circadian adaptation, sleep, 
dietary intake, and hormonal and metabolic responses to meals during a 14-day 
offshore tour of 7 nights (1800h-0600h) and 7 days (0600h-1800h). The aim 
was to establish whether this schedule induces a phase shift of the circadian 
system to the night shift and the day shift, and to monitor any effects of the 
schedule on parameters of sleep, hormones and metabolism.
4.2 St u d y  d esig n  a n d  M e th o d s
The methods and analysis protocols common to all studies have been detailed in 
methods chapter 2 and cross-referenced. Aspects of study design and 
methodology specific to the study of this schedule are detailed here.
Prior to the commencement of this project a pilot study of the 7N7D schedule 
was undertaken to develop and test the methodology and feasibility of a 
multidisciplinary field study protocol. Following the pilot study the protocol was 
amended to include the use of the Actiwatch-L for assessment of sleep and light 
exposure. This amended protocol was then used in all of the studies included in 
this report. Where appropriate, the results of the pilot study have been combined 
with the results of the present study as the schedule and season were common to 
both.
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4.2.1 Subject recruitment
Two offshore oil and gas operators provided access to two offshore installations 
for the pilot study and a further two operators gave access to three installations in 
the North Sea for the main study. The installations’ medical officers were 
recruited to co-ordinate the sample and data collection offshore.
Twenty-six male subjects were initially recruited from three offshore installations 
(Geographical positions: 53:2°N, 2:0°E; 53:0°N, 1:5°E; 53:3°N, 3:3°W). Of the 
twenty-six recruited, twelve subjects were studied, seven were excluded due to 
shift schedule changes and seven withdrew. A further eleven male subjects were 
studied on the same schedule from two North Sea oil installations (59°N, 01°E 
and 60°N 04°W) in the pilot study. The data from all 23 subjects, age 40.2±10.4 
years (mean ±SD), BMI 26.3±3.3 kg/m2 (range 22.1-33.8 kg/m2) is reported 
where possible, however AWLs were not available at the time of the pilot study, 
so light and sleep parameters were not recorded in the pilot study subjects. Data 
exclusions are cited within specific results sections and the subject numbers 
included in each result are quoted.
Subjects were studied for a 14 day period offshore on a swing shift of seven 
nights (1800h- 0600h) followed by seven days (0600h-1800h). The studies were 
undertaken during autumn or spring months (September to November or 
February and March, the main study was undertaken during August to 
November) to avoid the extremes of light conditions that occur in summer and 
winter. Work times were scheduled, but sleep or recreational activities were not. 
The study period was preceded by two weeks off work.
Over the 14 day tour subjects were required to provide 3 to 4 hourly (and 
oversleep) continuous urine collections and 4 blood samples. Dietary intake was 
recorded on blood sample days only (or for 9 of the 14 days on the pilot study), 
together with a questionnaire about diet and lifestyle on shore. They were
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required to wear an Actiwatch-L. Table 4.1 shows a summary of the study design 
for a schedule of 7-nights (1800h-0600h), 7-days (0600h-1800h).
Table 4-1 Study design for a 7-night (1800h-0600h), 7-day (0600h-1800h) shift 
schedule.
Day 1 2 3 4 5 6 7 8 9 10 11 12 13 14
Shift N N N N N N N S D D D D D D
Urine U U U U U U U u U U U U U U
Blood P4 P4 P4
F*
Diet D D D D D D D D D
AWL L L L L L L L L L L L L L L
KEY
U = Urine collection 
F4 = Fasting blood sample 
P4 = 6h Postprandial blood
D = The dietary intake record (full study days 2,6,13 only)
L = subjects wear an Actiwatch-L (light and activity monitor)
Shift: N = Nightshift, S = swing shift, D = day shift
4.2.2 M easurem ent o f  shift adaptation
The direction and extent of circadian rhythm adaptation was assessed via the 
urinary melatonin metabolite 6-sulphatoxymelatonin (aMT6s) in sequential 3-4 
hourly (or 8-12 hours over sleep) urine collections for the 14 day period of study. 
aMT6s was measured by radioimmunoassay (Arendt et al 1985 adapted by 
Aldous and Arendt 1988) as described in section 2.2 and appendix ii. Interassay 
coefficients of variation were 8.2, 10.8 and 7.7% at 3.5, 20.4 and 45 ng/ml 
respectively. The rhythmicity and 24 hour acrophase times were determined by 
cosinor analysis, and the phase shift in aMT6s acrophase was calculated. This is 
described in methods 2.2.2. as are the criteria for adaptation.
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4.2.3 Assessment of Sleep and light exposure
Light and activity (sleep) data were collected using the Actiwatch-L, as in the 
previous study and analysed as described in methods 2.2.9. These data were not 
collected in the pilot study.
4.2.4 Measurement of hormones & metabolites.
4.2.4.1 Sample collection
Fasting and postprandial blood (25ml) venous blood samples were drawn and 
separated according to the protocol in appendix iii. Plasma was transported to 
shore in ice and returned to the University of Surrey in dry ice to maintain the 
frozen state.
Sample 1 was a fasting sample, taken on study day 13, in the morning after an 
overnight fast of at least 8 hours. Day 13 was chosen as it was considered to be 
the most likely time that subjects would be day-adapted. Samples 2, 3, and 4 
were taken 6 hours post-consumption of a mid-shift main meal on nights 2 
(unadapted to night shift), 6 (potentially adapted to night shift), and 13 
(potentially re-adapted to day shift).
In the previous study (14N schedule) subjects were asked to self-standardise their 
meal (to consume the same meal on each occasion) prior to each blood sample. 
The compliance with this was inadequate and some data had to be rejected. In 
the present study a test meal was introduced to reduce the confounding effect of 
diet on postprandial metabolism. The meal consisted of a cheese baguette, an 
apple and a 2-finger kit-kat. The foods were selected to achieve reproducibility 
across all study sites.
4.2.4.2 Sample analysis
Glucose, insulin, C-peptide, TAG, NEFA, total cholesterol and HDL cholesterol 
were measured on all samples, as described in materials 2.1 and methods 2.2.
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4.2.5 Assessment of dietaiy Intake
4.2.5.1 Dietary Data collection
Dietary intake, by a record of all meals and portions consumed, was recorded for
3-day periods at the start of the night shift, over the swing shift period and at the 
end of the day shift in the pilot study subjects only. The diet record is described 
in 2.2.6 and the diary can be found in appendix iv.
4.2.5.2 Dietary record analysis
Dietary records were analysed using dietary analysis program Diet Plan 5 as 
described in methods 2.2.6, to establish 24-hour total energy intake and 
macronutrient consumption, 24h patterns of dietary intake and differences in 
content and timing of food consumption on day and night shifts.
4.2.6 Statistical measures
Graphpad Instat and Statistica were used to perform the statistical tests as 
described in methods 2.2.7.
Difference in daily aMT6s rhythm amplitude between adapting and non-adapting 
subjects was assessed by unpaired t-test, P values of <0.05 were accepted as 
statistically significant.
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4.3 R esults
4.3.1 Circadian Adaptation
A significant difference was found between the mean acrophase at the start, day 
2, 05:32h ± 2.42 (mean ±SD) and the mean acrophase at the end, day 7, (10.95h ± 
3.34 ) o f  the night shift week (p=0.0004). There was no significant difference 
between the start, day 8, (11:04h ± 4.05 ) and end, day 13, (12:59h ± 8.83 ) o f  the 
day shift week. Figure 4-1 shows the mean daily acrophase o f  the circadian 
rhythm as assessed by measurement o f  urinary 6-sulphatoxymelatonin (aMT6s) 
in sequential samples throughout the 7N7D schedule and the change in phase 
position o f  the acrophase. The data suggest that as a group the subjects did adapt 
to the night shift, but not back to day shift.
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Figure 4-1 Mean daily acrophase (calculated peak time) o f the circadian rhythm as 
assessed by measurement o f urinary 6-sulphatoxymelatonin (aMT6s) in sequential 
samples throughout 7 days night shift (1800-0600h), followed by day shift (0600- 
1800h). Adaptation to the schedule is indicated by the change in phase position o f  
the acrophase (n=23 [meant SEM]).
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Eighteen o f  the twenty-three subjects demonstrated adaptation o f  the aMT6s 
rhythm to the night shift schedule by delay o f  the acrophase. Thirteen o f  these 
subjects did not substantially change their night shift phase position on return to 
the day shift. Figure 4-3 shows the change in phase o f  individuals’ melatonin 
rhythms o f  those subjects who adapt to the night shift but have no further 
significant phase shift adaptation back to normal time for the day shift.
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Figure 4-2Acrophase times o f individual subjects (n=13) who adapted to nightshift, 
but did not re-adapt to day shift on the 7N7D schedule (pilot study subjects are 
denoted by a ‘p’).
129
O f those subjects who adapted to nights, six underwent further phase shifts o f  the 
aMT6s rhythm in adaptation back to ‘normal’ time. Two subjects continued to 
delay their rhythm further, while four reversed the adaptation by an advancing 
phase shift, all six subjects thereby resynchronised to the day shift. The aMT6s 
acrophase changes o f  these dual adapters are presented in Figure 4-3.
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Figure 4-3 Acrophase times o f subjects who demonstrated adaptation to night shift 
and day shift on the 7N7D schedule (n=6, pilot study subjects are denoted by a ‘p’).
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Three subjects showed no significant phase shift o f  the aMT6s rhythm, thus they 
did not adapt to nights and were therefore in the appropriate phase o f  the 
circadian clock during the dayshift week. A  further subject (subject p i)  appeared 
to be pre-adapted to night shift on day 2 and thereafter did not significantly 
change phase during the night shift, and furthermore did not demonstrate any 
phase shift during the day shift. Figure 4-4 shows the aMT6s acrophase times o f  
these non-adapting subjects.
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Figure 4-4Acrophase times o f non-adapting subjects on 7N7D schedule (pilot study 
subjects are denoted by a ‘p’).
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4.3.1.1 Rate of adaptation
The mean adaptation rate to night shift, calculated as hours o f phase shift per day, 
was 2.15± 0.38 hours/day (mean ± SEM ) from day 2 until the subject was 
considered to be adapted. ( for criteria for adaptation refer to methods 2.2.) 
Adaptation rate was significantly correlated with initial acrophase time (r = 0.62, 
p=0.01). Seven subjects were excluded from the correlation due to missing or 
adapted initial acrophase data (n=3) or no adaptation (n=4). This relationship is 
shown in Figure 4-5 and supports the data reported in the 14N schedule 
suggesting that subjects with late acrophase adapt to a night shift more rapidly 
than those with early acrophase.
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Figure 4-5 Correlation o f starting acrophase time and adaptation rate (n=16, r=
0.62, p=0.01).
4.3.1.2 aMT6s rhythm amplitude
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The aMT6s rhythm amplitude, calculated by cosinor analysis, is an indicator o f  
melatonin synthesis and suppression. There was no significant change in the 
mean amplitude over the study duration (p=0.05). However as there was 
variation in the subjects’ adaptation, amplitude was compared in dual-adapters 
(n=6), night only adapters (n=13) and non-adapters (n=4). The non-adapting 
subjects had a significantly higher rhythm amplitude (p=0.01), this is shown in 
Figure 4-6 and suggests that aMT6s rhythm amplitude is a factor in adaptation. 
However this does not necessarily indicate a suppression o f  total melatonin 
synthesis in the adapting subjects, as there is a large individual variation in 24h 
production. The lower amplitude could reflect a dampening or squashing o f  the 
rhythm peak as the rhythm phase-shifts, investigation o f  24h melatonin 
production could elucidate this.
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Figure 4-6 Amplitude o f the aMT6s rhythm in non-adapting (n=4), night only 
adapting (n=13) and dual adapting (n=6) subjects on the 7N7D schedule. Dual 
adapters and night-adapters both have significantly lower amplitude than non 
adapters (p= 0.01)
4.3.2 Light exposure
4.3.2.1 Total light
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Repeated measures ANOVA failed to find a significant change in the total light 
exposure over the tour. However 2 way RM-ANOVA (factors: time and shift) 
comparing days 2 to 7 (night shift) with days 8 to 13 (day shift) found 
significantly higher light exposure on the day shifts (p= 0.02). This data is 
represented in Figure 4-7. One subject was excluded as his watch recorded 
virtually no light during the day shift, and it is likely that the watch was covered 
by clothing. Individual light exposure was not recorded in the pilot study, so 
light data refers only to the main study.
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Figure 4-7 Total 24-h light exposure by lux recorded at 1 minute epochs, averaged 
each hour and summed each 24hrs (n = ll, mean t SEM).
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4.3.2.2 Pattern of light exposure
A temporal change in light exposure timing related to the sleep/wake cycle can be 
seen in Figure 4-8, this shows the difference in timing o f  light exposure between 
the night and day shifts.
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Figure 4-8 Mean light exposure (lux per minute, averaged per hour) during the 
night (blue, n=12) and day shift (yellow, n = ll)  o f the 7N7D schedule.
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4.3.2.3 Light exposure and adaptation of circadian phase
Figure 4-9 shows the mean acrophase position in relation to the light exposure on 
each day o f  the tour. The daily pattern o f  light exposure is indicated by the red 
line and the aMT6s acrophase is shown as the vertical black bar within each 24- 
hour period. The acrophase can clearly be seen to delay from occurring during a 
light phase when the subjects first commence the night shift tour, into the dark 
phase as they adapt to the shift. After the mid-tour shift change the crew’s mean 
acrophase, newly adapted to nights, is once again out o f  synchrony with their 
light exposure and sleep periods.
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Figure 4-9 Mean (n=12) acrophase position in relation to the pattern o f light 
exposure over the 7N7D schedule 14 day tour. Each day of the tour is represented 
in 13 vertical bands with the aMT6s acrophase position in each 24-hour period 
indicated by a vertical black bar. The height o f the bar indicates the amplitude o f  
the rhythm and the position o f the bar within each day indicates the acrophase 
time. The red line indicates the daily pattern o f light exposure.
As subjects on this schedule have a varied response in terms o f  circadian 
adaptation, three subjects representative o f  the variants (non-adapters, night 
adapters, and night/day adapters) are also shown in Figures 4-10, 4-11, and 4-12. 
Subject 1 (Figure 4-10) does not adapt to the night shift, the vertical marker o f  
acrophase time appears at a similar time o f  day throughout the tour. It is 
interesting to note that this subject has an unusually large light exposure on day
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nine (explaining the day 9 mean peak), this is likely to be associated with an 
increase in natural light exposure for example by an unusual amount o f  time 
spent outside. For this day and the following day the aMT6s rhythm, that is 
indicative o f  melatonin production, was suppressed to the extent that the 
acrophase could not accurately be calculated. The subject otherwise has a higher 
aMT6s amplitude than the mean and has lower light exposure. These 
observations suggest his usual low light exposure is insufficient to suppress his 
melatonin production, or at least the rhythm amplitude. 24h melatonin production 
was not calculated, but might indicate whether the synthesis o f  melatonin was 
suppressed or the rhythm dampened while maintaining the overall production.
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Figure 4-10 Acrophase position of a non-adapting subject in relation to the 
pattern of light exposure over the 14-day tour. Each day of the tour is 
represented in 13 vertical bands with the aMT6s acrophase position for each 
24-hour period indicated by a vertical black bar. The height of the bar 
indicates the amplitude of the rhythm and the position of the bar within each 
day indicates the acrophase time.
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Subject 5 (Figure 4-11) does adapt to the night shift, the vertical marker o f  
acrophase time appears later each day during the night shift so that it falls in the 
subject’s sleep period. The acrophase then remains in a similar position despite 
the shift change, occurring during the work period throughout the week o f  day 
shifts, indicating that he does not re-adapt to the day shift. In contrast to the non­
adapters subject 5 has a greater than the mean light exposure and an aMT6s 
amplitude lower than the mean. However the high light exposure on days 9 and 
10 has also disrupted the melatonin rhythm in this subject, so that it could not be 
calculated by the cosinor analysis.
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Figure 4-11 Acrophase position o f a night-adapting subject in relation to the 
pattern o f light exposure over the 7N7D tour. Each day of the tour is represented in 
13 vertical bands with the aMT6s acrophase position for each 24-hour period 
indicated by a vertical black bar. The height o f the bar indicates the amplitude o f  
the rhythm and the position o f the bar within each day indicates the acrophase 
time. The daily light exposure is indicated by the red line.
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Figure 4-12 (Subject 3) is representative o f  those subjects who adapted to the 
night shift and back to the day shift. The vertical marker o f  acrophase time 
appears later each day during the night shift so that it falls in the subject’s sleep 
period. Then following the shift change the acrophase time becomes earlier again 
to resynchronise the melatonin with the dark period. In this subject the light 
exposure is higher than that o f  the non adapting subject and the light/dark periods 
fall either side o f  the acrophase rather than over the acrophase, suggesting that the 
light level and timing promote adaptation.
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Figure 4-14-2 Acrophase position o f a dual-adapting subject in relation to the 
pattern o f light exposure over the 7N7D tour. Each day of the tour is represented in 
13 vertical bands with the aMT6s acrophase position for each 24-hour period 
indicated by a vertical black bar. The height o f the bar indicates the amplitude o f  
the rhythm and the position o f the bar within each day indicates the acrophase 
time. The daily light exposure is indicated by the red line.
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4.3.3 Effect of schedule on sleep
4.3.3.1 Sleep parameters
The sleep duration, sleep efficiency, sleep latency and sleep fragmentation was 
calculated (using the manufacturer’s software, see Methods 2.2.) from actigraphy 
and light data each day in the 7N7D schedule subjects; they are shown in Figure
4-13. There were no significant changes in the mean sleep duration or sleep 
fragmentation over the period of the tour (ANOVA p>0.05). There was no 
change in sleep efficiency during the night shift, however 2-way ANOVA 
(factors time and shift) compared night shift with day shift and indicated an 
increase in sleep efficiency following the changeover to day shift (p= <0.02). It is 
apparent from the graphs that sleep is disturbed for the night that follows the shift 
change, as sleep latency is increased while sleep duration and efficiency both 
decrease, however these differences fail to reach significance. Examination of the 
error bars indicates that the between subject variance increases following the shift 
change. Day 8 sleep was excluded as the swing shift allows for two shorter rest 
periods to facilitate the shift change, consequently the sleep during this day is not 
comparable to the other days.
It was not possible to compare sleep in non-adapting and adapting subjects, as 
only one subject of the 11 that provided sleep data, did not adapt to the night 
shift.
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Figure 4-13 Mean sleep duration, efficiency, latency and fragmentation (n = ll, 
[mean± SEM]) on the 7N7D schedule. Day 8 is excluded as it is the swing shift of 
two short sleep periods therefore not compatible for analysis with the other days.
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4.3.4 Metabolic responses to night time meals during the 7N7D schedule
4.3.4.1 Plasma TAG
Blood samples were collected from twenty-three subjects, one set o f  plasma 
samples was lost during transit from the installation, twenty-two are reported. 
Figure 4-14 shows the mean (± SEM) plasma TAG for all subjects. The night-2 
sample, when subjects were the most unadapted to night shift, provided the 
highest mean level o f  plasma TAG, but the differences in TAG between day 2 
and day 6 when circadian adaptation may have occurred, just failed to reach 
significance (p= 0.06, 1-way ANOVA)
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Figure 4-14Mean (n= 22 ) plasma TAG in fasting (‘F’) and postprandial plasma 
taken in days 2, 6 and 13 o f the 7N7D schedule (Mean ±SEM)
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When presented as a change from baseline (fasted sample) the plasma TAG on 
night two was significantly higher than on night six and night 13 (one factor 
repeated measures ANOVA p=0.02, n=15, 7 subjects were excluded where 
samples were missing), see Figure 4-15. Interestingly however, when the non 
adapting subjects were considered in isolation, the trend towards an improvement 
between night 2 and night 6 was still present, although not quite significant (p> 
0.05, n=4). This suggests that the metabolic system may adjust to a temporal 
change even when the circadian system does not.
There was no difference between the TAG on night 6 and day 13. This suggests 
that there is a benefit conferred by adaptation that is equal to that o f  daytime, as 
opposed to night-time, meals.
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Figure 4-15 Percentage change from fasting baseline in postprandial TAG, on 
nights 2 and 6, and day 13. (Mean ±SEM, n=15, schedule 7N7D).
4.3.4.2 Cholesterol
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The difference in total cholesterol between night-2 and night-6 expressed as a 
percentage change from the baseline (fasted sample) indicated a significant 
decrease in cholesterol on day 6 from day 2 (paired t-test p= 0.04, n=17, data 
corrected for incompleteness and diet compliance). 1 factor RM ANOVA did not 
support this finding (p>0.05), but found a further significant decrease in 
cholesterol between day 2 and day 13 (Tukeys HSD for unequal n post hoc,
p=0.01).
HDL cholesterol demonstrated similar results in that there was no difference in 
the absolute values. However, when expressed as a change from the fasted value 
HDL cholesterol was slightly, but significantly higher on night 2 (p=0.04) than 
night 6 and night 13. It was surprising to see an increase in the cardioprotective 
HDL on night two o f  the study, however the implications o f  this can only be 
speculative as no measurements o f  lipoprotein particle size were determined. The 
cholesterol results are shown in Figure 4-16 (absolute values) and 4-17 expressed 
as a change from fasted.
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Figure 4-16Mean (n= 17 ) plasma cholesterol and HDL in fasting (‘F’) and 
postprandial plasma on days 2, 6, and 13 o f the 7N7D schedule.(Mean ± SEM)
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study day
Figure 4-17 Mean (n= 17 ) plasma cholesterol and HDL expressed as a percentage 
change from individuals’ fasting values in postprandial plasma on days 2 ,6 , and 13 
of the 7N7D schedule (Mean ± SEM)
4.3.4.3 Other metabolic parameters
Postprandial and fasting NEFA and glucose were also determined, however as 
there were no significant differences between the sample days, in absolute values 
or in % change from fasted, these data are not shown.
4.3.4.4 Postprandial hormonal responses
Insulin and C-peptide were also determined in fasting and postprandial plasma. 
No significant differences were found between the postprandial samples in these 
parameters, however a trend towards increased insulin, or delayed insulin 
clearance is seen in Figure 4-18 (C-peptide not shown). Seven subjects were 
excluded from the results, where samples were missing or diet compliance was 
suspect.
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Figure 4-18 Plasma insulin in fasting and postprandial plasma on days 2, 6, and 13 
of the 7N7D schedule. n=T6 (Mean ± SEM)
4.3.5 Dietaiy Intake
Dietary intake was recorded for three 3-day periods; at the start o f  the night shift, 
over the swing shifts and at the end o f  the day shifts on the pilot study only 
(Dietary records from the full protocol study were used only for checking dietary 
compliance with test meals).
There was a temporal change in the timing o f  food intakes between days and 
nights in line with the change in waking and working hours. The macronutrient 
intake results for night shift and day shift are shown in Table 4-2 along with the 
estimated average requirement (EAR) for energy and reference nutrient intake 
(RNI) for macronutrients, as reference points.
There was no significant difference in the mean energy or macronutrient intakes 
between the night (NS) and day shift (DS). The slightly lower intake seen over 
the three day swing shift (SS) period, where one day is short due to the 
changeover shift, did not reach statistical significance.
Table 4-2 Table of mean (± SEM) macronutrient intake during the night shift (NS), 
swing shift (SS) and day shift (DS) compared to the EAR or RNI
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Mean nutrient 
intake
EAR*
/RNI
NS SEM SS SEM DS SEM
Total k-cals 2550* 2102 132 1967 129 2219 127
CHO as %  energy 50% 43.9 7.26 44.6 1.22 45.7 6.98
Fat as % energy <35% 35.3 6.67 34.9 1.43 33.8 6.74
Protein %  energy 15% 20.9 5.03 20.5 1.03 20.4 4.73
4.4 D isc u ssio n
4.4.1 Adaptation to shift schedule
In entrained conditions a variation of less than ± 3 hours is considered to 
represent a normal variation in circadian phase (Lockley et al, 1999), this was the 
basis for using a phase shift of 3 hours or greater as the criterion for individual 
adaptation. A highly significant correlation is seen between aMT6s acrophase 
and melatonin acrophase (r=0.86, p<0.001) using the same sample protocol (Ross 
et al, 1995) thus aMT6s can be considered a reliable estimate of the timing of 
melatonin secretion.
Most onshore shift workers do not adapt to the night shift and this is thought to 
be due in large part to bright light exposure in the early morning following the 
night shift acting counter to adaptation. Yet of the twenty-three subjects who 
took part in this study, only four showed no adaptation at all to night shift. This 
suggests that the offshore environment is more conducive to circadian adjustment 
than onshore shiftwork and is supported by previous studies that have reported 
adaptation in offshore work (Barnes et al 1998a).
It is evident that most subjects adapt to night shift on this schedule taking up to 6 
days to do so, however the majority do not adapt back to dayshift during the time 
offshore and thus spend nearly all the period offshore out of synchrony with their 
work and sleep schedule. Clearly, given more time, all subjects will presumably 
adapt to dayshift, however the time course of the period offshore was too short to 
observe complete adaptation in all subjects. For example, subjects 20 and 23 
appear to be advancing their circadian phase and subject pi 1 could be continuing
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to phase delay through days 9 to 13, but the phase shifts were insufficient to be 
considered as adaptation, by the end of the tour.
A previous study of a 14-day schedule of 7 days and 7 nights working 2400h to 
1200h (Barnes et al 1998b) showed no, or partial adaptation to night shift by 
advance of the aMT6s rhythm in contrast to the delay seen here. This difference 
indicates that the work hours within the schedule may be critical in determining 
the direction of adaptation as it will determine when light is received. The results 
of this study show that even within a schedule there is considerable variation in 
adaptation between the subjects.
The correlation between adaptation rate and initial acrophase supports the data 
reported in the 14N schedule suggesting that subjects with late acrophase are 
better equipped to adapt to a night shift than those with early acrophase. The data 
suggest that one factor determining the initiating adaptation to night shift is the 
phase position of the circadian clock at the start of the tour. This will dictate 
what phase of the melatonin rhythm that the light exposure coincides with. Thus 
the phase shift is most likely to be due to the timing of the light and dark (sleep) 
in relation to the acrophase position.
4.4.2 The effect of light on adaptation
It might be expected that the day shift would receive more light than the night 
shift, and although there was a trend in this direction it was not statistically 
significant. Night shift workers offshore share the same environment as dayshift 
workers during non-working daylight hours and if their work environment is 
similarly lit during night work, the light exposure may indeed be similar. It is 
only subjects who work outside who will have a substantial increase in light due 
to daylight.
The different patterns of light exposure show that the timing of light exposure 
changes on the two shifts and the figure of light and circadian phase position over 
the tour shows light to be the probable catalyst for initiating the adaptive phase 
shifts.
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Looking at the timing of the light in relation to the circadian phase of the three 
representative subjects it is clear that the timing of the light is related to the 
adaptation and to the direction of the phase shift, but the timing of light exposure 
also offers explanation of the variation between subjects. In the non-adapting 
subject (Figure 4-10) the light exposure period fell before and after the aMT6s 
acrophase, inducing no advance or delay of the rhythm and thus there was no 
adaptive phase shift to nights. In the case of the night adapter (Figure 4-11) and 
the dual adapter (Figure 4-12) the light fell primarily before the aMT6s 
acrophase, thereby encouraging a phase delay adaptation to the night shift. After 
the shift change these two subjects differed in respect of adaptation and the 
timing of their exposure to light. The night adapter, once on day shift, was 
exposed to light before and after the acrophase (in both the delay and advance 
portion of the phase response curve), preventing circadian adaptation in either 
direction. In contrast, the dual adapter received virtually all his light after his 
acrophase, i.e. at the best time to bring about a phase advance adaptation to the 
day shift. Thus the most likely explanation of how adaptation is initiated is the 
timing of light exposure in relation to the circadian rhythm, which is dependent 
on the scheduled work time as well as the individuals’ circadian phase.
The increases in the intensity and variability of light exposure seen on day nine 
are most likely explained by the local weather and light conditions combined 
with work activity. Day-nine probably had a brighter sunlight average, but this 
also indicates that subjects with different work areas or routines will receive 
different measures of light regardless of the environmental conditions.
These findings present options for light treatment (or avoidance) as an adaptation 
or recovery strategy: Light treatment, timed appropriately in relation to circadian 
phase could hasten circadian adjustment to any shift change including the return 
to ‘onshore time’. In order to adapt by delay of the circadian rhythm as is desired 
on the 7N7D schedule, light through the duration of the shift, followed by 
darkness immediately after the shift should delay the rhythm in most subjects. It 
is difficult to generalise with the re-adaptation to days, as the variation in 
responses was so great, so to suggest timed light therapy it must be assumed that
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adaptation to nights was successful (as was the case for the majority of subjects 
in this study). According to the results of this study, a night-adapted shiftworker 
has a circadian acrophase near to midday. To initiate re-adaptation by advance of 
the rhythm the worker should avoid light during the first half of the shift, then get 
plenty of light during the second half. This is supported by the work of Bjorvatn 
et al (1999) who reported that timed light treatment improved recovery 
(subjective measures) when re-adapting to day-life after an offshore night shift.
4.4.3 Actigraphy and sleep parameters
It might be expected that sleep would improve with adaptation, however as sleep 
propensity is the result of fatigue combined with the circadian sleep propensity 
rhythm, the fatigue that results from night shift may result in a level of ‘catch-up’ 
sleep that masks the circadian effect on sleep propensity.
Although there was no statistically significant change in any sleep parameter over 
the tour duration, visual inspection of the sleep data graphs shows that sleep 
duration and sleep efficiency reached their lowest points after the swing shift, and 
sleep latency peaked at that time, thus the change over clearly has a negative 
impact on sleep as was reported in offshore workers by Parkes et al (1997).
It is perhaps not surprising to find no difference in sleep latency and sleep 
duration between day and night shift in view of the very limited adaptation to day 
shift. Sleep efficiency was the only parameter to be significantly improved after 
the change to day shift, this does imply that night-time sleep is beneficial to sleep 
efficiency regardless of the circadian state.
This study was not specifically designed to monitor sleep, subjects were not 
required to schedule or synchronise their bed times and followed their normal 
work and recreational pass-times, thus introducing light and activity as possible 
confounding variables. Studies of sleep offshore, where sleep is scheduled to 
avoid anti-adaptive light exposure, would be useful to determine if this strategy 
impacts on adaptation or sleep parameters.
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4.4.4 Metabolic responses to meals
4.4.4.1 Night shift eating and postprandial lipids
The plasma TAG analysis showed a higher postprandial TAG and cholesterol 
response following a night shift meal (night 2) than a day shift meal (day 13) 
despite the fact that on the day shift some subjects were also maladapted. Similar 
findings of a diurnal difference in postprandial lipids, particularly TAG, has 
previously been reported in simulated shiftwork studies (Sopowski et al, 2001; 
Hampton et al, 1996). These findings implicate night-time eating, via the 
impaired lipid metabolism, in the increased CHD risk associated with shift work.
It was hypothesised in this study that postprandial TAG would be significantly 
improved after an adapted night-time (night 6) meal than after an unadapted 
night-time (night 2) meal. The normalised data support this hypothesis and 
suggest that adaptation to night shift reduces any impairment in lipid metabolism 
associated with night shift meals.
It was most interesting to find that the improvement in postprandial lipids 
associated with night 6 was not confined to the aMT6s adapted subjects, which 
implies that the adjustment in metabolism is not reliant on circadian adaptation. 
This suggests that peripheral clock mechanisms can dissociate from the central 
circadian clock in shift work conditions, this is supported by the findings of 
Morgan et al (1998) where sleep and postprandial metabolic responses were 
desynchronised from the circadian rhythm in a constant routine study. 
Furthermore Stokkan et al (2001) demonstrated a faster adaptation in liver clock 
than in the SCN.
4.4.4.2 Postprandial glucose and insulin responses.
Postprandial insulin and C-peptide follow the same trend as TAG and cholesterol 
of being higher on night 2, falling on night 6 and lowest on day 13, but without 
statistical significance, we cannot draw any conclusions about the effect of 
adaptation. The trend may be explained by the diurnal rhythm in insulin 
resistance (Morgan et al, 1999), where eating during the night is likely to cause
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an increase in insulin output over and above the response of a day time meal. 
This would explain the increased night 2 postprandially raised TAG and 
cholesterol, and the improvement seen in day 13.
Plasma glucose is expected to have returned to baseline 6 hours after a meal with 
normal food intakes, so it is not surprising that were no significant differences 
between postprandial plasma glucose. This is supported by the previous work on 
simulated shift work studies (Hampton et al, 1996; Ribeiro et al, 1998).
The nature of shiftwork involves a repeated cycle of shift and normality that 
imposes frequent periods of maladaptation or desynchrony on the shift worker. If 
this confers a cumulative effect via adverse metabolic changes, long term shift 
workers may be increasingly insulin resistant due to repeated exposure. Karlsson 
et al (2001) support this with epidemiological evidence that markers of metabolic 
syndrome are associated with shift work. This offers a likely etiological route for 
increased risk of CHD in shift workers. A study involving a more tightly 
controlled diet intake and increased blood sampling frequency would be needed 
to determine the postprandial responses to night shift meals more accurately, 
which may not be practical in a working environment.
4.4.4.3 Protocol limitations
Due to the protocol limits on the number of blood samples allowed to be taken it 
was necessary to take a single blood sample at the most appropriate time to see a 
metabolic response to the night time meal. The 6-hour postprandial time point 
was chosen as being the most informative for plasma lipids and CHD risk in shift 
work studies (Hampton et al, 1996; Ribeiro et al, 1998). It was not considered 
feasible to take hourly samples from men during their working night and it is 
unlikely that the installations or the subjects would have given their consent to do 
so. In hindsight it would have been interesting to have taken a postprandial blood 
sample on night 9 of the 7N7D schedule to assess the affect of maladaptation to 
the day shift.
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It is worthy of note that because some subjects did not re-adapt to the day shift 
the fasting sample was taken at different circadian times, and may therefore differ 
from a synchronised or onshore fasting sample and consequently is not 
appropriate for comparison with a non-shift working population.
4.4.5 Dietary intake
Dietary recall diaries were considered to be the most appropriate method of 
recording intakes. Although weighed food records are deemed to be more 
comprehensive and accurate, it was considered that the nature of the subjects and 
the environment would result in a lower compliance.
No overall difference in energy intakes between night and day shift workers was 
found, which is supported by other studies of shift workers in non-catered 
environments (Lennemas et al, 1995). This is attributed to a temporal change in 
meal times, so that night workers intake remains similar to day workers, but is 
consumed at different times, this may be especially true of the fully catered 
environment offshore. The lower energy intakes seen in the mid tour period are 
likely to be the due to the swing shift, where the shortened day and extra sleep 
period of the swing shift results in a meal being missed.
The protocol required that the subjects consume the same meal prior to each of 
the three postprandial blood samples. This was a necessary development of the 
pilot study protocol where free diet choice (to determine the usual dietary intake 
of these shiftworkers), may have contributed to the high inter-subject variance in 
the metabolic and hormonal responses to meals. There was only partial 
compliance with this aspect of the protocol.
The diet consumed by these subjects may be considered to be a ‘healthy diet’ in 
terms of macronutrient ratios, especially the percentage of fat as a source of 
energy (<35%), which is in line with recommended intakes. The protein intake 
was a slightly above recommended (COMA, 1991), however this is not unusual 
in a male population. It should be noted that dietary intake was significantly
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under reported by 27% of subjects and that analysis methods can contribute to 
this error by underestimating portion sizes.
4.4.6 Conclusions and further study
It is clear that circadian adaptation can occur on the 7N7D offshore shift 
schedule, but with considerable individual variation. This study reinforces the 
hypothesis that light, dictated by schedule, and individuals’ routine, in relation to 
circadian phase is a major influence on circadian adaptation. The study also 
confirms the metabolic abnormalities previously shown in simulated and real 
(Lund et al, 2001) shiftwork studies and suggests that a proportion of the 
improvement associated with adjustment to night shift may be independent of the 
circadian adaptation.
The study protocol was subsequently applied in a study of offshore day shift and 
the drill (reversed swing) shift.
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5 A STUDY OF THE 14-DAYS OFFSHORE SCHEDULE
5.1 In tr o d u c t io n
5.1.1 Offshore day shift
The offshore petrochemical industry recognises that night work is associated with 
increased sleepiness during work hours, and sleepiness is related to reduced 
performance and safety. In this safety conscious industry that operates 24-hour 
production for economic reasons, wherever possible work is carried out during 
the day and night work is kept at the safe minimum to maintain operations. Thus 
the 14-Days (14D) shift schedule is probably the most widely operated work 
schedule in the industry. Day shift might not be considered to be shiftwork, 
except that the shift often starts at 0600h and is of twelve hours duration. It 
therefore meets Akerstedt’s criteria for defining shiftwork as consisting of work 
involving two or more shifts to cover a work period that extends beyond that of 
normal office hours (Akerstedt, 1990). It is possible therefore that even a day 
shift schedule offshore might require some adjustment, if not strictly circadian 
then in terms of wake up time, sleep habits, communal living, and to the 12-hour 
working day after being in the home environment for two weeks or more.
The schedule is operated in rotation with a tour of 14 (or 21) nights and 14 (or 
21) days leave between each tour, however some workers may be on dayshift 
continually each tour if their job does not require night work.
5.1.2 The 14-Days study
This schedule was included in this series of studies to provide an offshore 
baseline measure of the study parameters during 14 days offshore, in effect 
monitoring the adjustment from home life (onshore days) to the controlled 
environment and long working hours of the offshore days schedule. The aim was 
to establish if this shift schedule induces a phase shift of the circadian system in a 
population of offshore day workers and to monitor any effects of the schedule on 
parameters of sleep, hormones and metabolism for comparison with the other 
schedules studied.
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5.2 STUDY DESIGN AND METHODS
The experimental procedures used in this study are summarised below, however 
for further detail of this methodology please refer to the cross-referenced 
materials and methods chapter 2 and appendices.
5.2.1 Subject Recruitment
Two offshore oil and gas operators provided access to installations in the North 
Sea (geographical positions: 60:5°N, 01:2°E and 60:5°N, 01:3°E). The 
installations’ medical officers co-ordinated the sample and data collection and 
recruited subjects from their workforce. Twenty-six subjects were recruited, 6 
withdrew for undisclosed reasons. Twenty subjects were studied over the first 
14-day shifts (1800h-0600h) of a 14 or 21 day tour. Subjects were men, aged 
between 19 and 55 years (42.9 ±10.5 mean ± SD), with mean BMI 27.1 kg/m2 
(range: 22.7-38 kg/m2). They were free of medications indicated in the protocol 
exclusion criteria, and gave informed consent.
5.2.2 Study Design
The study was designed to run in 14-day study periods. Over the 14 days subjects 
were required to provide 3 to 4 hourly (and oversleep) continuous urine 
collections and 4 blood samples, together with a record of their dietary intake and 
completion of a questionnaire about diet and lifestyle on shore. They were 
required to wear an Actiwatch-L (wrist worn activity and light recorder, 
Cambridge Neurotechnology Ltd). Table 5.1 shows a summary of the study 
design for a schedule of 14 days.
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Table 5-1 Study design for a 14-day shift
Day 1 2 3 4 5 6 7 8 9 10 11 12 13 14
Shift D D D D D D D D D D D D D D
Urine U U U U U U U U U U U U U U
Blood PA PA PA
FA
Meal M M M
AWL L L L L L L L L L L L L L L
KEY
D = day shift
U = Urine collection
FA = Fasting blood sample
PA = 6h Postprandial blood
M = test meal and dietary intake record
L = subjects wear an Actiwatch-L light and activity monitor
5.2.3 Measurement of Shift Adaptation
Circadian status and phase shift were determined from sequential urine 
collections collected as described in section 2.2.2 and analysed by cosinor 
analysis.
5.2.4 Assessment of sleep and light exposure
Light and activity (sleep) data was collected using an Actiwatch-L, and analysed 
using Sleepwatch 2001 (Cambridge Neurotechnology Ltd, Cambridge UK) as 
described in section 2.2.9.
5.2.5 Measurement of hormonal & metabolic changes
5.2.5.1 Blood sample collection
The installations’ medical officers took venous blood samples (25ml) on four 
occasions during the study as follows. A fasting sample after an over-sleep fast of 
at least 8 hours was taken on study day 13 to provide a baseline measurement.
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Samples 2, 3, and 4, postprandial samples, were taken 6 hours post consumption 
of a mid-shift main meal on nights 2, 6, and 13 to monitor any change from the 
first day offshore and days once accustomed to the schedule. The plasma was 
separated, stored and transported as described in the blood handing protocol, 
appendix iii.
5.2.5.2 Plasma analysis
Glucose, TAG, cholesterols and NEFA, were assayed by automated 
spectrophotometer, see 2.2.3. Insulin and C-peptide were assayed by specific 
radioimmunoassays see section 2.2.4.
5.2.6 Statistical measures
Statistica and Instat were used to perform statistical tests as described in section 
2.2.7. P values of <0.05 were accepted as statistically significant.
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5.3 R esults
5.3.1 Circadian adaptation
At the start o f  the tour the mean (n=16) aMT6s acrophase time was determined to 
be at 03:03h, there was no significant change in acrophase timing over the 14 
days (RM ANOVA p>0.05), suggesting that no circadian adaptation has taken 
place on this schedule. Two subjects were excluded from the analysis as they 
withdrew part way through the study, a further two were excluded due to 
acrophase timing abnormalities (one was excluded from the adaptation data due 
to low and irregular aMT6s excretion, and one was excluded for an acrophase 
time more than two standard deviations away from the mean). Figure 5-1 shows 
the mean daily aMT6s acrophase time as assessed by measurement o f  urinary 6- 
sulphatoxymelatonin (aMT6s) in sequential samples throughout 14 day shifts 
(0600h-1800).
16.00 .
£, 14.00 - 
o
£ 12.00
«  10.00 -
V)flj
^  8.00Q.
°  6.00o
CB
4.00WCOI-
S 2.00 -
0.00
2 3 4 5 6 7 8 9
day of tour
Figure 5-1 Circadian phase position on day shift; Mean (+/- SEM) acrophase time 
of shift-workers on a schedule o f 14 days (n=16).
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5.3.2 Actigraphy and light.
Actiwatch-L’s were worn by all but one subjects. A further three did not wear 
the monitor continuously for the tour duration, these four were therefore excluded 
from this aspect o f  the data analysis.
5.3.2.1 Light
There were no significant changes in total light exposure (p=0.59) over the period 
o f  the tour. Figure 5-2 shows the (mean n=16) total light exposure per day o f the 
shift (calculated from 1-min epochs averaged per hour).
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study day
Figure 5-2 Total light exposure (n = 16, mean ±SEM) on 14D schedule, measured in 
lux at one minute epochs, averaged per hour and expressed as accumulation per 
24h.
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The pattern o f  light exposure over 24 hours on this schedule can be seen in Figure 
5-3. The light levels rise before 06:00h (shift start time) coinciding with wake 
and get-up time, and fall from mid afternoon onward. The lowest light level 
occurs during the night and the peak occurs between 10:00h and 14:00h, as 
would be expected for day work.
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Figure 5-3 Pattern of light exposure over 24-hours on 14-days schedule. Light is 
expressed as a 2h mean o f per-minute measures.
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5.3.2.2 Circadian phase position of acrophase in relation to light
Figure 5-4 shows the mean acrophase position in relation to the light exposure. 
The acrophase marker positioned at approximately 04:00h can clearly be seen to 
occur during the dark phase and remain there for the duration o f  the tour. The 
light exposure peak is seen to occur daily after the acrophase.
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Figure 5-4 Mean (n=T6) acrophase position in relation to the pattern o f light 
exposure (red line) over the 14 day tour. Each day of the tour is represented in 13 
vertical bands with the aMT6s acrophase position for each 24-hour period 
indicated by a vertical black bar. The height o f the bar indicates the amplitude o f  
the rhythm and the position o f the bar within each day indicates the acrophase 
time.
5.3.3 Sleep
There were no significant changes in sleep duration, sleep efficiency, sleep 
latency or sleep fragmentation over the period o f  the tour (ANOVA p>0.05), 
shown in Figure 5-5. This shows that the 14D schedule has no impact on these 
parameters o f  sleep while offshore.
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Figure 5-5 Mean sleep duration, efficiency, latency and fragmentation (n=16, [mean 
± SEM]) on the 14 days schedule.
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5.3.4 Metabolic responses to meals
Blood samples were collected as described from all subjects, and dietary intake 
was checked for dietary compliance with the test meal and any other intake. Of 
the 20 subjects who participated in blood sampling, two subjects were excluded 
for poor diet compliance. Further subjects were excluded from each analysis 
where that parameter sample was missing, the n for each parameter is cited with 
the result.
5.3.4.1 Triacylglycerol
Postprandial plasma TAG was significantly raised from fasted levels, however 
there was no significant difference in TAG between the three postprandial 
samples (ANOVA p=>0.05), this is shown in Figure 5-6.
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Figure 5-6 Mean fasting and postprandial plasma TAG (n= 13, mean ± SEM) on the 
14-Days schedule.
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5.3.4.2 Cholesterol
There was no significant change in total cholesterol or HDL cholesterol between 
day 2 and day 13 (n=12, p>0.05). Cholesterol data is shown in Figure 5-7.
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Figure 5-7 Mean total and HDL cholesterol (n=12 mean±SEM), in fasted and 
postprandial plasma on the 14-Days schedule (corrected for dietary non 
compliance)
5.3.4.3 Other metabo lie parameters
There was no significant difference in glucose or NEFA between the three 
postprandial samples (one factor RM ANOVA p=>0.05), these are represented in 
Figures 5-8 and 5-9 respectively.
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Figure 5-8 Glucose (n=12 mean±SEM) in fasted and postprandial plasma on the 14- 
Days schedule (corrected for dietary non compliance)
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Figure 5-9 NEFA (n=12 mean±SEM) in fasted and postprandial plasma on the 14- 
Days schedule (corrected for dietary non compliance)
5.3.4.4 Postprandial insulin and C-peptide
There was no significant difference in insulin or C-peptide between the three 
postprandial samples, days 2, 6 and 13 (ANOVA p=>0.05), these are represented 
in Figure 5-10 and 5-11.
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Figure 5-10 Insulin (n = ll mean±SEM), in fasted and postprandial plasma on the 
14-Days schedule (corrected for dietary non compliance)
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Figure 5-11 C-peptide (n=13, mean ±SEM), in fasted and postprandial plasma on 
the 14-Days schedule (corrected for dietary non compliance)
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5.4 D iscussion
5.4.1 Circadian status on the 14-Days schedule
Prior to the 14D offshore tour the workers have been onshore at home on leave 
with no work schedule to adhere to and thus more freedom for their circadian 
system to entrain to its natural time. The purpose of this study was to determine if 
any circadian phase shift occurred on a day shift schedule, and if it did not then 
the data provides a baseline for comparison with other schedules. No adaptation 
of the circadian system was expected on this schedule and no significant change 
occurred. Offshore the twelve hour shift schedule and 0600h start are likely to 
result in an earlier bed time, thus despite no circadian change there may be an 
unquantified adjustment in terms of sleep and wake time in comparison to life 
onshore.
5.4.2 Light
As described in the introduction 1.2.1.3, the human circadian system naturally 
cycles with a duration of just over 24-hours and it is the morning light exposure 
that entrains the circadian rhythm of melatonin production to 24-hours. With 
weak time cues the acrophase time may delay for a few days until it reaches a 
critical point on the PRC at which morning light and other non-photic time cues, 
are sufficient to advance the circadian timing of the next oscillation. The 
phenomenon, known as scalloping, is sometimes visible in individual acrophase 
profiles, however it is disguised in the mean data as subjects do not necessarily 
‘scallop’ in synchrony with each other.
The mean total fight exposure across the shift did not change significantly, 
suggesting that subjects received a similar fight exposure throughout their tour. 
The timing of fight exposure in relation to the circadian phase is such that the 
major fight exposure occurs, in most cases, after the melatonin peak and thus 
aligned to maintain entrainment to clock time.
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On this schedule the small and consistent standard errors demonstrate that there is 
little variance between the subjects, or over the tour. As the subjects were 
studied in small groups over several weeks, the small daily fluctuations in light 
exposure are likely to be due to local weather and light conditions, while variance 
between subjects is likely to reflect their job type and personal routines as well as 
the environmental conditions.
5.4.3 Actigraphy and sleep parameters
As these subjects do not undergo a significant period of maladaptation and are 
sleeping during the circadian phase appropriate for sleep it is not surprising that 
the 14D schedule does not appear to result in any disturbances in sleep pattern 
over the period of the tour.
The offshore environment aims to reduce external disturbances to sleep by 
providing light excluding accommodation, with sound proofing and distance 
from the noisiest parts of the installation, and limiting sleep interruptions by third 
parties. Despite these precautions sleep duration and sleep efficiency in this 
study were lower than that reported by Leger et al (2002) in a normal non- 
shiftwork population (duration: 6h:16m compared to 7h:4m, efficiency: 83.6% 
compared to 92.3%). Sleep efficiency was marginally, but not significantly better 
than the other shifts, this data is presented in chapter 7, wherethe schedules are 
compared. This may be a consequence of the offshore environment and 
accommodation facilities, as the beds are narrow single bunks, with lightweight 
mattresses and thin pillows. This probably represents a change from the home 
environment for most subjects, thus contributing to reduced overall sleep quality.
5.4.4 Metabolic responses to meals
In this study the postprandial response to meals were investigated on three 
occasions, at the same point during the shift as in the other schedules, i.e. six 
hours after the mid shift meal on days two, six and thirteen. However as this was 
a day shift, the meals were consumed during day-time. As in the previous study 
subjects were requested to consume the same test meal prior to all three
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postprandial blood sample occasions, and to avoid snacks in between. The 
purpose of this request was to reduce the confounding effect of a totally free 
dietary choice on the measures of hormonal and metabolic responses to those 
meals. The request for equality in dietary intake prior to each blood sample was 
not fully complied with, and data from non-compliant samples was excluded.
There were no differences between the postprandial samples in any of the 
hormonal and metabolic parameters, which confirms that the day shift schedule 
confers no significant effect on metabolic activity of the workers on this shift.
5.4.5 Conclusions.
The offshore day shift schedule induces no maladaptation and therefore no 
circadian adjustment in response. The naturally timed light/dark exposure 
maintained normal circadian synchronisation. As all subjects followed a regular 
sleep wake pattern of day time wakefulness and night time sleep, the schedule 
does not impact on sleep, but reflects any impact of the offshore environment. It 
is concluded that this study provides a valid baseline for comparing the other 
offshore research parameters.
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Chapter 6 : 7-Days, 7- 
Nights drill schedule
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6 STUDY 4: 7-DAYS, 7-NIGHTS DRILL SCHEDULE
6.1 In tr o d u c tio n
6.1.1 The drilling installations’ schedule
Drilling rigs have a reputation for being harsher, noisier and dirtier, than the 
production platforms studied in previous chapters. The 24-hour operation of 
drilling installations is run to a different time schedule than those previously 
reported. They usually operate a schedule that consists of seven days followed 
by seven nights (7D7N drill) and timed from 12:00h to 00:00h (days) and 00:00h 
to 12:00h (nights). The schedule is run on a continuous rotation so that each week 
as a new crew arrive they commence their tour on day shift then change to nights 
after the first week when the next day crew arrive.
Workers on this schedule arrive offshore from a period at home without 
shiftwork and commence the tour with a week of day shifts, although in 
comparison to other day shifts, this is operated late with a 12:00h start. At day 8, 
the changeover day they work an 8-hour work period between two 8-hour rest 
periods to facilitate the change in shift.
At first glance, the appeal of this schedule is uncertain as workers return to shore 
after a week of nights and thus are likely to feel, as the 14-nights schedule 
workers do, that they have to spend their own time in recovery. However the 
timing is interesting as the schedule allows both shifts to be working in daylight 
hours, so that even the night shift has a feel of day work. During the day shift the 
workers are unlikely to undergo a change in circadian phase as the night-time 
sleep and day-time light would maintain normal entrainment, as demonstrated in 
Barnes et al (1998b). The day light exposure in the latter part of the night shift 
could induce adaptation to the night shift by circadian phase shift in the advance 
direction, however Barnes reported inconsistent and incomplete adaptation on 
this shift (Barnes et al, 1998b). This lack of adaptation suggests that workers 
could be returning to shore/home requiring little readjustment. It also implies that 
the entire period of night shifts is undertaken maladapted to the schedule.
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The consequences of this schedule and maladaptation on sleep and metabolism 
have not previously been investigated and identifying the timing of light exposure 
could elucidate the role of light exposure. Thus the schedule was included in this 
series of studies.
6.1.2 The study of the drill schedule
This study was undertaken to determine changes in circadian phase on this 7D7N 
drilling schedule, and identify the role of light as a determinant of adaptation. Via 
the same protocol that had been applied to the other studies in this project, this 
study would also elucidate any associated consequences with regard to sleep and 
postprandial metabolism. The timing of this schedule was different from the other 
studies and thus provides an opportunity to compare circadian adjustment at 
different clock times and investigate the effects of light at different times on 
circadian adaptation.
6.2 St u d y  d esig n  a n d  M eth o d s
Methodologies specific to the study of this schedule are outlined here, for frill 
details see chapter 2, Materials and Methods. Individual methods are cross- 
referenced.
6.2.1 Subject recruitment
An offshore oil and gas operator provided access to three offshore installations in 
the North Sea, where this drilling schedule was operated. One installation 
declined to participate. The paramedical staff on the other two were recruited to 
co-ordinate the sample and data collection offshore.
Twelve male subjects were initially recruited from the two participating offshore 
installations (Geographical positions: 56:58°N, 001:53°E and 57:22°N, 
001:59°E). One installation declined to provide the demographic data requested, 
but the paramedic confirmed that all subjects were well and fit to take part and
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complied with the inclusion criteria. Of the twelve subjects recruited, nine 
subjects were studied, and three withdrew completely. The data recorded was not 
complete for all subjects, due to errors in data collection at the installation, 
therefore the subject numbers included in each result are quoted with each result.
6.2.2 Study protocol
Subjects were studied for a 14 day period offshore on a schedule of seven days 
(12:00h- 00:00h) followed by a swing shift day then seven nights (00:00h- 
12:00h) during February to May. The study period was preceded by two weeks 
off work. Work times were scheduled, but sleep or recreational activities were 
not.
Over the 14 day tour subjects were required to provide 3 to 4 hourly (and 
oversleep) sequential urine collections and 4 blood samples. Dietary intake was 
recorded on test meal and blood sample days only. They were required to wear an 
Actiwatch-L (wrist worn activity and light recorder, Cambridge Neurotechnology 
Ltd). Table 6.1 shows a summary of the study design for this 7D7N drill 
schedule.
Table 6-1 Study design for the 7-day 7-night (12:00h-00:00h, 00:00h-12:00h), drill 
shift schedule.
Day 1 2 3 4 5 6 7 8 9 10 11 12 13 14
Shift D D D D D D D S N N N N N N
Urine U U U U U U U U U U U U U U
Blood F*
P* P* P6
Diet M M M
AWL L L L L L L L L L L L L L L
KEY
U  = Urine collection
D = day shift, S = swing shift rollover day, N = night shift 
F4 = Fasting blood sample 
P4 = 6h Postprandial blood
L = subjects wear an Actiwatch-L (light and activity monitor) 
M = Test meal and dietary intake record
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6.2.3 Measurement of shift adaptation
The direction and extent of circadian rhythm adaptation was assessed via the 
urinary melatonin metabolite 6-sulphatoxymelatonin (aMT6s) and cosinor 
analysis of the data, as described in methods 2.2.2.
Full instructions were sent to the installations in the same way as with previous 
studies. On previous studies no complications had arisen in recording the urine 
sample data, but on this study, despite communications with the installation, 
urine collection data was not recorded as requested. Consequently, although 
samples were collected, the recorded data was insufficient to calculate the 
duration of each collection for rhythm analysis. This reduced the number of 
viable subjects for rhythm analysis to n=2.
6.2.4 Assessment of sleep and light exposure
Light and sleep data was recorded using the Actiwatch-L, and analysed via 
Sleepwatch 2001 (software provided by Cambridge Neurotechnology Ltd, 
Cambridge UK) as described in methods 2.2.9.
6.2.5 Measurement of hormones & metabolites.
6.2.5.1 Sample collection
Venous blood samples (25ml) were taken from each subject on four occasions 
during the study. The plasma was separated by centrifugation and immediately 
aliquoted and stored at -20°C. Sample 1 was a fasting sample, taken on study 
day 2, in the morning after an overnight fast of at least 8 hours. This was used as 
a baseline against which postprandial responses could be measured. Samples 2, 
3, and 4 were taken 6 hours post-consumption of a mid-shift main meal on days 2 
(day shift), 9 (unadapted night shift), and 13 (potentially adapted night shift). 
Plasma was transported to shore in ice and returned to the University of Surrey in 
dry ice to maintain the frozen state.
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6.2.5.2 Sample analysis
Glucose, insulin, C-peptide, TAG, NEFA, total cholesterol and HDL cholesterol 
were measured on all samples. Glucose, TAG, NEFA and cholesterols were 
assayed by enzymatic spectrophotometric methods using Alphawasser SPACE 
analyser with Randox reagents as described in methods 2.2.4.
Insulin and C-peptide were assayed by specific radioimmunoassay developed at 
the University of Surrey. See methods 2.2.6 and 2.2.7 for assay protocols.
6.2.6 Statistical tests
Graphpad Instat and Statistica were used to perform the statistical measures as 
described in methods 2.2.10. P values of <0.05 were accepted as statistically 
significant.
6.3 R e su l t s
6.3.1 Circadian Adaptation
The day shift crew changed shift pattern to a night shift on day eight. Although 
nine subjects provided urine samples, only two sets of samples (subjects 6 and 8) 
were supplied with complete and accurate records of sample volume and timing. 
The phase shift was calculated individually due to the small subject number 
(n=2).
The mean acrophase time on day two was 4:30h, and 5:27h on day nine. The 
small changes in acrophase time that occurred fell within the limits of natural 
fluctuation and were insufficient to be considered an adaptive phase shift, thus no 
significant phase shift occurred during the day shift period.
The data suggest that both subjects adapted to the night shift by advance of the 
acrophase time, although subject 6 phase shifted more rapidly and to a greater 
extent than subject 8. Although the data pool here is very small the results are 
supported by data previously reported by Barnes et al (1998b). Figure 6-1 shows 
the change in phase position of the subjects’ daily acrophase as assessed by 
measurement of urinary 6-sulphatoxymelatonin (aMT6s) in sequential samples
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throughout day shift (1200-2400h), followed by night shift (0000-1200h). The 
acrophase (calculated peak time) o f  the rhythm is shown.
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Figure 6-1 Adaptation o f the aMT6s acrophase for subjects 6 and 8 on the 7D7N 
drill schedule.
6.3.1.1 Adaptation rate
Subject 06 adapted at a rate o f  3.95h/day and took two days to phase shift more 
than three hours from his acrophase time on day shift (day nine), with a total 
phase shift o f  7.9 hours. Subject 08 adapted by 0.64/day and took 5 days to phase 
shift a total o f  3.2 hours.
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6.3.2 Light exposure
6.3.2.1 Total light
The only statistically significant change in the total light exposure over the tour 
was on day 7, where total light received by subjects was higher than on other 
days (1-way ANOVA p=0.009). Investigation o f  the individual light data showed 
that for 5 o f  these 6 subjects the majority o f  the light was received over a period 
o f  one to two hours anytime between ll:00h  and 16:00h. However one subject 
on day 7 received a high level o f  light for the whole period o f  5 hours. The level 
o f  light recorded suggests that he spent these hours outside in sunlight, thus 
increasing the total light exposure on that day. The apparent trend towards more 
light on the day shift than the night shift failed to reach significance due to the 
increased variance in light exposure between subjects on this shift. Total daily 
light exposure is shown in Figure 6-2.
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Figure 6-2 Mean total 24-h light exposure by lux recorded at 1 minute epochs, 
averaged each hour and summed each 24hrs (n=6 ± SEM) on the 7-day 7-night, 
12:00h-00:00h, 00:00h-12:00h) drill schedule. The day shift, changeover period and 
night shift are indicated by the white arrow, hatched arrow and back arrow 
respectively
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Pattern of light exposure
There was a temporal change in light exposure timing related to the altered 
sleep/wake cycle. The pattern o f light exposure over a 24-hour period during day 
shift was different to the 24-hour light exposure pattern on night shift as the work 
force receives light mainly during the work period regardless o f  whether it is day 
or night. The difference in light provided by artificial light and daylight is clearly 
displayed in Figure 6-3 showing the 24-hour light exposure pattern on day and 
night shift on the 7D7N drill schedule.
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Figure 6-3 Mean light exposure pattern on day and night shift, 7-day 7-night 
(12:00h-00:00h, 00:00h-12:00h) schedule, n=6
6.3.2.3 Light exposure and adaptation o f  circadian phase
The two subjects for whom adequate data were available to calculate circadian 
phase shifts had a varied response in terms o f  circadian adaptation, thus no mean 
has been calculated and their individual light exposure and phase shift data are 
shown separately in figures 6-4, and 6-5. Neither subject shows any circadian
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adaptation to the day shift schedule (see also Figure 6-1); the vertical marker of 
acrophase time appears at a similar time of day throughout the day shift period of 
the tour. The light exposure occurred entirely after the aMT6s acrophase, and 
thus maintains the day-entrained circadian status.
The change-over to night shift occurred on day 8, so that the first full night shift 
was on day nine of the tour. After the shift change, the aMT6s acrophase was out 
of synchrony with the light exposure and sleep period. Due to the 00:00h to 
12:00h timing of this night shift the light exposure occurred both before and after 
the acrophase but with the peak light immediately after the acrophase, thereby 
encouraging a phase advance of the circadian rhythm. In both subjects, during 
the night shift part of the tour the acrophase time can be seen to phase advance 
from occurring during a light phase when the subjects first commence the night 
shift tour, to nearer to the dark/sleep phase as adaptation to the shift occurs. 
Subject 6 (Figure 6-4), following a complete loss of the circadian rhythm, adapts 
to the night shift rapidly by an advance of 7.9 hours over two nights, however as 
phase position data is missing for days 7 & 8 this can only be taken as an estimate 
of the phase shift. Subject 8 (Figure 6-5) demonstrates adaptation to the night 
shift by an advance of the acrophase time by 3.2 hours, but takes five days to 
reach this and from a day shift acrophase time of 05:00h. This phase shift was 
insufficient to move the aMT6s acrophase into the subject’s sleep period.
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Figure 6-4 and Figure 6-5 aMT6s acrophase position o f subject 06 (above) and 
subject 08 (below) in relation to the pattern o f light exposure over the 7D7N tour. 
The days o f the tour are represented in 13 vertical bands with the aMT6s acrophase 
position for each 24-hour period indicated by a vertical black bar. The height o f  the 
bar indicates the amplitude o f the rhythm and the position o f the bar within each 
day indicates the acrophase time. The red line indicates the pattern and lux o f  the 
light exposure. 7-day 7-night (12:00h-00:00h, 00:00h-12:00h) schedule
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6.3.3 Effect of schedule on sleep
6.3.3.1 Sleep parameters
Sleep parameters are reported for four subjects, including subjects 6 and 8 for 
whom adaptation data was reported. The remainder were excluded as subjects 
removed the Actiwatches overnight, or withdrew from the study part way 
through. The sleep duration, sleep efficiency, sleep latency and sleep 
fragmentation are shown in Figure 6-6.
An overall trend to reduced sleep duration was seen in the second half of the tour, 
after the change over to night shift (p=0.07), and the sleep on day 8 was 
significantly shorter than on other days or nights (p<0.01). There were no 
significant changes in sleep latency, sleep efficiency or sleep fragmentation over 
the period of the tour (ANOVA p>0.05).
A greater variance was found in the subjects’ sleep fragmentation (p<0.01) 
following the shift change, suggesting that some subjects were more affected by 
the disturbance of the shift change than others.
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SEM), 7-day 7-night drill schedule
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6.3.4 Metabolic responses to night time meals
Blood samples were collected from nine subjects, only full data sets were 
included in the analysis. All samples were checked for dietary compliance, and 
data were excluded where non-compliant.
6.3.4.1 Plasma metabolites
There were no significant differences in postprandial plasma TAG between day 2 
(unadapted days), day 9 (unadapted nights) and day 13 (adapted nights), and no 
difference from the fasting sample at 6-hours postprandial, shown in Figure 6-7.
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Figure 6-7 Mean TAG in fasted and postprandial (pp) plasma on the 7D7N drill 
schedule (n=5, ± SEM)
6.3.4.2 Other metabo lie parameters
No differences were found between the postprandial plasma samples in respect o f  
cholesterol (total and HDL), glucose or NEFA, on the 7D7N drill schedule. 
These data are shown in Figure 6-8. If this schedule has an effect on postprandial 
metabolism it was not elucidated in this study, however the timing o f  the study 
and blood samples may have confounded any effect, as discussed in section 6.4.4.
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Figure 6-8 Mean total and HDL cholesterol (top), glucose (middle) and NEFA 
(bottom) in fasted and postprandial (pp) plasma on the 7D7N drill schedule (n=5, 
SEM).
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6.3.4.3 Insulin and C-peptide
No difference was found between fasting and postprandial insulin or C-peptide, 
and there was no difference between each o f  the postprandial samples. These data 
are shown in Figure 6-9.
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Figure 6-9 Mean insulin and C-peptide in fasting and postprandial plasma on the 
7D7N drill schedule (n=5, SEM).
6.4  D is c u s sio n
6.4.1 Circadian adaptation on the 7D7N drill schedule
A shift o f  3 hours or greater was used as the criterion for individual adaptation as 
previously described in methods section 2 .2 .2 3 . As there were only two subjects 
for whom acrophase could be calculated, and these two differed in their circadian 
behaviour on the schedule, it is difficult to discuss the typical circadian response 
to the schedule. However the responses found here are consistent with the 
findings o f  Barnes (Barnes et al, 1998b) in a study o f  the same shift schedule, 
although the individual variation in circadian adaptation amongst subjects was 
not reported. In a study o f  a 14-day schedule o f  7 days and 7 nights working 
2400h to 1200h, Barnes showed that either no adaptation, or only partial 
adaptation by advance o f  the aMT6s rhythm occurred during the night shift 
period. As previously suggested the most likely factor determining the initial 
adaptation to night shift is the timing o f  light exposure in relation to the initial 
phase position o f  the circadian clock. In this case as there was no circadian
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phase-shift on day shift, the circadian acrophase maintained its position in the 
early hours of the morning. The artificial light of the night shift occurred at 
conflicting times (before and after the acrophase) and is thus unlikely to instigate 
any adaptation. However the bright day light that the night shift workers are 
exposed to during the last hours of the night shift is well timed to induce an 
advance phase shift.
The two subjects presented on this schedule showed very different rates of 
adaptation, despite a similar acrophase time at the day of changeover from days 
to nights, and similar although not identical light exposure (see Figure 6-4 and 6- 
5). It is possible that subject 6 received more light during the phase advance 
region of the light PRC. However this also raises questions as to what other 
parameters might have an affect on the rate or extent of phase shifting the aMT6s 
rhythm, such as light sensitivity, individual melatonin amplitude, and diurnal 
preference.
6.4.2 Light
It might be expected that the day shift would receive more light than the night 
shift and although (as was found in the schedule of 7-nights and 7-days) there 
was a trend in this direction, the mean total light exposure across the shift did not 
change significantly. Workers on this (drill) schedule receive a different light 
exposure pattern due to the shift timing, as the schedule operates from 12:00h to 
24:00h (days), and 00:00h to 12:00h (nights). Despite this, both the day and night 
shift workers were exposed to a number of hours of natural daylight and had a 
similarly lit work environment, thus they received a similar amount of light in 
total, just at different times. On the day shift they received natural daylight from 
late morning to mid afternoon, which is at a circadian time unlikely to cause a 
circadian phase shift, then artificial light (low in comparison the daylight) until 
they retire to bed. On the night shift, the light exposure was composed of 
artificial light through the night, and daylight from early morning to midday 
when, at the shift end, subjects retired to a darkened room. Thus the light 
exposure is mostly after the aMT6s acrophase and therefore timed to cause a 
circadian phase advance. On the changeover day, light is received for shorter
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periods, between the sleep periods to coincide with the rollover shift. Thus the 
light exposure could be timed to advance and/or delay the circadian phase, and as 
occurred in subject 6, the changeover may result in an overall reduction in light 
exposure on that day.
During the period of adaptation to the night shift (tour days 8-14) the aMT6s 
acrophase occurred prior to the greater proportion of light exposure, consequently 
subject 6 demonstrated an advance of his acrophase time to occur closer to his 
dark/sleep period (Figure 5-4). This supports the supposition that the timing of 
light exposure in relation to the circadian phase is clearly related to the adaptation 
and to the direction of the phase shift. The loss of circadian rhythm in this subject 
at a time of shift change and increased light exposure may have allowed for more 
rapid resetting of his circadian clock. Despite a similar day shift acrophase 
position at day eight and a similar timing of the light in relation to the phase 
position, subject 8 phase shifted to a much lesser extent. This suggests that the 
two subjects have a different response and could be the effect of individual light 
sensitivity. It is known that people differ in light sensitivity in terms of melatonin 
suppression (Bojkowski et al, 1997), but as yet the effect of individual light 
sensitivity on phase shifting has not, to the authors knowledge, been assessed.
6.4.3 Consequences of the 7D7N drill schedule on sleep
Bearing in mind the small number of subjects (n=4) that could be included in the 
sleep analysis, there was no statistically significant difference in the sleep 
parameters over the tour duration, although there was a trend towards reduced 
sleep duration on the night shift consistent with the findings of Barnes et al 
(1998b). Thus from the limited data it is not possible to make any links between 
sleep duration and adaptation to shift as there were insufficient subjects with 
complete adaptation data to make any correlations. However it was noted that the 
variance between subjects increased during night shift sleep, suggesting that 
some subjects sleep is more affected by night shift or at least by a change in shift, 
than others.
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6.4.4 Metabolic responses to meals
The protocol, applied to this schedule and the previous studies, was designed to 
assess the postprandial responses to a meal taken during the night shift when the 
circadian system was either unadapted or adapted to the shift (with an additional 
sample taken on a day shift and a fasting sample as a baseline measure). It was 
hypothesised that the postprandial metabolic and hormonal responses to a night 
time meal would be significantly higher after an unadapted night time (night 2) 
meal than after an adapted night time (night 6) meal, or a day time meal. 
However the timing of this schedule is different to the previously studied night 
shift schedules.
The outcome of no significant difference in hormonal and metabolic responses to 
meals on these shifts is not surprising. On this schedule, day shift meals were 
consumed at approximately 1800h when insulin resistance would be increasing , 
and metabolic responses could be impaired by the evening insulin resistance. As 
blood was sampled at midnight, this would not represent a normal daytime 
metabolic response. On the night shift the meal was consumed at 0600h and the 
blood taken at midday. On day 9 (first full night shift, 00:00-12:00h) the subjects 
circadian rhythm is still day-adapted, thus the postprandial period (PPP) is at the 
most insulin sensitive time and so the night shift postprandial metabolic 
responses may resemble that of a normal day time response. Thus the shift timing 
on this schedule may act as a confounding factor in respect of metabolic and 
hormonal consequences of the shifts. Furthermore, Hampton et al (2002) 
reported that light treatment during the postprandial period improved metabolic 
responses, yet here the day shift PPP was in low light and the night shift PPP was 
in full day light. Thus the light exposure could have further influenced the results.
The day shift, due to its timing of 12:00h-24:00h, could impart a negative impact 
on postprandial metabolism as meals may be consumed during the evening and 
after midnight. However the night shift of this schedule may afford some 
metabolic protection as two meals are consumed during daylight and at a 
metabolically efficient time. Of course adaptation to the night shift could 
theoretically shift the period of insulin sensitivity too, in which case the situation
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would change as adaptation occurred. Moreover, natural individual variation in 
metabolic profiles combined with only partial compliance with the test meal is 
likely to have contributed further to confounding factors. On this basis the 7D7N 
drill schedule could be detrimental to postprandial metabolism on both the day 
and night shifts, but this requires further confirmation via a more controlled 
metabolic study.
The mid shift meal was chosen as it is usually considered to be the main meal of 
the day. In hindsight it may have been more appropriate to study the responses to 
the pre shift meal, however this would not reflect the late meals of the day shift. 
Ideally a study of each meal on both shifts with several postprandial samples 
would be undertaken, but this would not be practical to implement in offshore 
workers, and would be unacceptably invasive in physically active workers.
6.5 C o n c lu sio n s
6.5.1 Conclusions
This offshore shift schedule has shown only partial circadian adaptation, however 
the phase shift, even when insufficient to constitute adaptation, was in the 
advance direction.
The data was limited by a small subject number, but is consistent with Barnes et 
al (1998b), who reported similar partial adaptation by advance of the circadian 
rhythm on this schedule.
The timing of light exposure differs on this schedule from the others studied. The 
light exposure timing relative to the subjects’ circadian phase is such that if 
adaptation to night shift occurs it is likely to be in the advance direction.
Sleep on this schedule was not significantly different between the night and day 
shifts but sleep duration was significantly disturbed by the changeover shift. 
Moreover increased variance in sleep parameters during the night shift, suggests 
that sleep is more likely to be compromised than when working a day shift.
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The variance in circadian adaptation on this schedule and the limited data make it 
difficult to draw conclusions regarding any relationship between adaptation and 
postprandial lipid metabolism on this night shift. Further study is required to fully 
ascertain if there are metabolic consequences on the day as well as night shift 
during this schedule.
6.5.2 Further work
A study of a schedule that follows this timing (12:00h-24:00h-12:00h) but with 
the night shift first, followed by the dayshift would be interesting. This shift 
pattern would theoretically be advantageous in that the adaptation to night shift 
might be easier and faster if it did not follow a late day shift. Also the predicted 
adaptation back to day shift would be in the natural direction of the human 
circadian tau (by delay). In the same vein a study of nights only on this schedule 
timing would demonstrate the potential for adaptation without the mid shift 
disruption. If, as in the 14N schedule on 18:00h-06:00h, the crew adapt with 
greater unity than on the swing shift, this may be a preferable schedule as a 
unified crew is a better cohort for testing strategies to assist adaptation or 
improve postprandial metabolism, than a group with individual variations in 
response.
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7 A DISCUSSION OF CIRCADIAN RHYTHMS AND
HEALTH IN SHIFTWORK
7.1 In tr o d u c t io n
Shift work is essential in the petroleum industry as it cannot economically 
function without a 24-hour continuous operation, and running only day shifts is 
not considered an option. Night-work leads to an increased risk of heart disease 
(attributed in part to impaired postprandial metabolism, introduced in 1.5) and is 
associated with an increased risk of errors and accidents via fatigue (see section 
1.4.4). On this basis, the Health and Safety executive would like to ensure that 
only the safest and least disruptive schedules are operated.
The aims of this project were essentially to study a range of shift work schedules, 
investigating their effects on the circadian system and consequences with regard 
to circadian status, sleep and postprandial metabolism. The hypothesis was that 
these schedules would differ in these parameters, so that a ‘best’ and/or ‘worst’ 
might be identified for the benefit of the industry.
This chapter will first compare the schedules studied, highlighting where they 
differ in their effects on circadian status and health consequences, followed by a 
discussion of the findings. Strategies for improving adaptation or reducing the 
consequences of maladaptation will be presented and supported by suggestions 
for further study.
7.2 C o m pa riso n  o f  sc h edu les
7.2.1 Impact of shift on circadian adaptation
7.2.1.1 Circadian adaptation -  effect of shift
The circadian phase shifts during the different schedules studied, and the degree 
of adaptation calculated from these data,, are compared in Figure 7-1 and 
summarised in table 7-1. The circadian adaptation to each schedule is shown as 
hours of phase-shift (change in timing of the aMT6s rhythm) by delay or advance 
(negative figures represent an advancing phase-shift).
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All subjects adapted to the night shift by day seven o f  the 14N schedule (n = ll) , 
and the majority adapted to the nights on the 7N7D rotation schedule (n=23, 20 
adapted) by delay phase shift. However while only minor further adjustment 
occurs after day seven on 14N, the 7N7D workers are subjected to a second 
change o f  work time. The majority o f  previously adapted workers did not re- 
adapt (4 re-adapted, 16 did not) to the second abrupt phase shift o f  work/sleep 
time. The highest individual variation in the extent o f  adaptation occurred on the 
7N7D schedule.
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Figure 7-1 Adaptation by phase shift o f the aMT6s circadian rhythm on four 
offshore shift schedules. Adaptation is shown in hours o f phase shift (mean ± SD) 
over the fourteen days o f study.
The 7D7N drill schedule (1200h to 2400h, 2400h to 1200h) produced no 
significant adaptation to day shift despite the distorted day. The two subjects (for 
whom complete data sets were obtained) then adapted to the following seven 
days o f  night shift by a circadian phase advance. The 14D (0600h-1800h) 
schedule also requires no significant circadian adaptation, and none was observed 
(n=14). However these subjects arrived offshore from a day time ‘home’ routine
195
where there was no scheduled work to initiate an early wake time, once offshore 
the early shift-start (06:00h) may still require a small adjustment to be made.
The 14D schedule was significantly different from the 14N (2 way ANOVA  
factors: schedule and day o f  tour p=0.005) and the 7N7D schedule (p=0.003), 
showing that there is a significant circadian response to these two shift schedules 
in comparison to the day shift. No statistically significant difference was 
apparent in phase shift over tour duration between the 7D7N drill shift and any 
other schedule (p= >0.05), almost certainly due to the small number o f  subjects 
with large inter-subject variability. The overall trend is similar to the 14D 
profile.
Table 7-1 Circadian adaptation (indicated by hours of phase shift ± SD) and 
desynchrony load (hours desynchronised from ideal (see text for explanation), 
cumulative over the tour) for each shift schedule. Data referred to in the text is in 
red
Shift Schedule Phase shift ±SD Phase shift + Desynchrony
schedule time (h) days 2-7 (h) days 9-13 SD Load (±SD)
14 N 1800h-0600h 5.05 (n=Tl) 3.05 0.3 1.6 27.98(16.86)
7N7D N 1800h-0600h 6.73 (n=20) 4.15 7.13 (n=4) 1.3
night adapters D 0600h-1800h 0.63 (n=16) 2.3 61.7(13.87)
7N7D -1.5 (n=3) 1.2 0.43 (n=3) 3.8
(non-adapters)
14 D 0600h-l800h 0.8 (n=14) 1.06 0.19 (n=13) 1.24 13.95 (6.57)
7D7N D 1200h-2400h
N 0000h-1200h 0.95 (n=2) 0.21 -5.18 3.75 31.51 (7.88)
7.2.1.2 Desynchrony load
In order to attempt to quantify the difference in terms o f  how adapted or 
unadapted the workforce might be on these schedules, the time span (hours and 
minutes) that each person’s circadian phase was positioned from the shift ideal 
phase position was calculated as described in chapter 2, methods 2.2.2.4. The 
mean adapted acrophase position (all adapted subjects, week 2 o f  14N schedule) 
was taken as ‘ideal’ for the night shift (14N and nights o f  7N7D). The day shift
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□ 7N7D
group mean was taken as the ‘ideal’ baseline for the 14D, days o f  7D7N drill and 
for re-adaptation to day shift on 7N7D. On the OOOOh -1200h schedule the small 
study size prevented the use o f  a group mean, so the ideal was calculated as the 
aMT6s acrophase position that would be required for it to fall within the subjects’ 
sleep period. The area under the curve (Figure 7-2) was calculated to give a 
quantified measure o f  the desynchrony that occurred on each schedule. This 
‘desynchrony load’ (cumulative hours desynchronised from day-time normal 
phase or fully adapted night shift) is a novel approach to quantifying the effects 
o f  maladaptation and was used as an indicator o f  the disruption that the schedule 
causes to the circadian system over the tour duration. It is reported for each 
schedule in table 7-1 and is graphically represented in figure 7-2.
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tn©■a
day of tour
Figure 7-2 Desynchrony load on four offshore shift schedules between days 2 and 
13 of the study tour. Desynchrony is measured by the time in hours and minutes 
that acrophase position differs from the calculated ideal. (14D n=18,14N n=10, 
7N7D n=23, 7D7N drill n=2)
Total Desynchrony load was 61.7h on the 7N7D schedule, significantly higher 
than night shift or day shift schedules (2 way repeated measuresANOVA, factors: 
shift, day o f  tour, with Tukey HSD for unequal-n post hoc test: 14D 13.95h, 
p=0.0002; 14N 27.98h p=0.0002), and with a trend towards being higher than the
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7D7N drill (31.51h, p=0.06). This suggests that the 7N7D swing shift confers a 
greater level of maladaptation overall, and that this is spread over a greater 
number of work days. This schedule is the one that workers claim to prefer 
because they feel they readjust to ‘day’ time during work hours and return to 
shore adjusted. Clearly this is not the case, at least in terms of circadian 
adaptation. The 7D7N drill shift desynchrony load, although not significantly 
different from the 7N7D swing shift during the offshore tour (p=0.06), was not 
significantly different from the 14N either. However as the Drill schedule had a 
small number of subjects (n=2) it is not possible to say with any clarity that the 
data represent a true reflection of the desynchrony associated with this schedule, 
although a similar level of adaptation was shown by Barnes et al (1998b) on the 
same schedule.
The 14N desynchrony load was also significantly worse than the 14D (ANOVA 
as above, p=0.02) but very similar to the 7D7N drill schedule as would be 
expected with a single period of desynchrony each. These two schedules still 
require resynchrony (i.e. from nights back to days) once the workers return to 
shore. It is the rate at which the subjects adjust to the change that leads to the 
level and duration of desynchrony.
The maladaptation, particularly in the initial stage of desynchrony, is a 
consequence of shiftwork. If the desynchrony affects fatigue or performance 
(cognitive performance, recorded concurrently in the same subjects is to be 
reported by the HSE) it is clearly undesirable in a high hazard work place. 
Detrimental health effects could be reduced if the desynchrony were reduced in 
frequency and duration. Its impact on health is discussed further in section 7.3.
7.2.2 Light exposure and shift schedule
7.2.2.1 Impact of shift on light exposure
Since light is the major controlling zeitgeber of circadian rhythms, the difference 
in light exposure during the schedules needs to be considered. Here light 
exposure is compared, to identify differences between the schedules.
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It might have been predicted that day workers would get more light overall than 
night workers, but there was no significant difference in total light exposure 
between the day-shift and night-shift or within either swing shift. There was 
greater light exposure on the 7D7N drill schedule operating 1200h-2400h-1200h 
than on the schedules operating 0600h-1800h-0600 (p=0.002), shown in figure 7- 
3. This was attributed in part to the operational nature o f  the installation in that it 
is a drilling rig and a greater amount o f  time is likely to be spent outside than 
inside. Also the timing o f  the schedule (i.e. each shift overlaps daylight and 
night-time darkness), means that the workers o f  both shifts receive natural day 
light as well as artificial light.
+— 14D
800000 i
7IM7D
700000 * — 7D7N drill
600000
500000
400000
300000 -
200000
100000
T T 1
2 3 4 5 6 7 8 9 10 11 12 13
day of study
Figure 7-3 Mean total daily light exposure (24 hour accumulation o f lm in epoch 
lux) on four offshore shift schedules. 14D (n=16), 14N (n=12), 7N7D (n = ll)  and 
7D7N drill shift (n=6)
1.2.22 Effect o f  light on adaptation
The pattern o f  light exposure however does vary with shift (these were shown in 
the schedule specific chapters), and it is this, rather than the total light exposure, 
that is related to adaptation. Subjects’ light exposure is dependent on the 
combination o f  work and rest hours spent in day light and the level o f  light 
exposure during the night shift. Thus the timing o f the schedule influences the 
pattern o f  light over the shift and dictates the timing o f  light in relation to the
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circadian clock. This has been upheld on every schedule studied and is 
particularly clear when looking at the light of individual subjects. When light 
exposure occurred before the aMT6s acrophase the subject’s rhythm delayed, and 
when it occurred after the acrophase the subject’s rhythm advanced. When light 
fell on either side of the acrophase, the effect is conflicting and adaptation was 
slower or did not occur. Graphs of light exposure relative to individual acrophase 
position are shown in the results for each schedule (see previous chapters 3 to 6), 
and demonstrate that the timing of the light is a major factor in the extent and 
direction of adaptation.
Where adaptation was found to occur (14N and nights of 7N7D) the rate of 
adaptation was related to the acrophase time at the start of the tour. The 
acrophase starting point (D2) is the closest (of the available data) to the subjects’ 
natural acrophase position. This is likely already to have phase shifted in those 
subjects that adapted rapidly to their night shift, increasing the variability of the 
starting acrophase. Consequently the same light (at the same clock time) occurs at 
a different circadian time for each subject, encouraging adaptation more in the 
late phased subjects than the early subjects. This suggests that diurnal preference 
may be an important factor in shiftwork adaptation, with owls (late phased 
subjects) having adaptational advantage over larks (early phased subjects) in 
night work that requires a phase delay. The larks may have the advantage in re­
adaptation or shifts that require a phase advance.
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7.2.3 Impact of shift schedule on sleep
Sleep parameter results within each schedule have been shown in the previous 
chapters. Here the schedules are compared to determine if there were any 
differences in their impact on sleep.
The 7N7D schedule change-over day (day 8) had two periods of sleep to facilitate 
the shift change. These are both included in graphs (Figures 7-4 to 7-7), and the 
other schedules show a gap in the data at that point. The second sleep period was 
excluded from the statistical analyses as there was no data to compare with other 
schedules. It should be noted that on the drill shift schedule the subject number 
(n=4) was lower than on the other schedules and thus is not representative of the 
schedule population.
/
Mean sleep duration and efficiency was lower on all schedules studied, including 
14D, than in a normal non-shiftworking (Non-SW) onshore population (n = 24, 
age 44.4 ±11, non shiftworking, healthy mixed gender population, Leger et al 
2002) as shown in Table 2. This suggests an effect of the offshore environment 
on sleep that is mildly detrimental, irrespective of schedule. However there were 
no differences between different shifts for any parameter.
Table 2. Sleep duration and efficiency (± SD) for each shift schedule and a non- 
shiftwork onshore population (Leger et al, 2002).
Shift schedule Sleep duration 
h:min
(± SD mins) Sleep efficiency % (±SD)
14 D n=16 6:16 (±70) 83.6 (±8.5)
14 N n=ll 6:22 (±62) 85.1 (±7.3)
7N7D n=ll 6:20 (±60) 85.0 (±7.5)
7D7N drill n=4 5:33 (±76) 82.6 (±8.1)
Non-SW n=24 7:04 (±51) 92.3 (±3.6)
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7.2.3.1 Sleep duration and shift schedule
Two-way rmANOVA comparing all shifts found no difference in sleep duration 
between the schedules, but indicated a significant interaction between shift and 
day o f tour. Tukey HSD test for unequal-n identified the difference as as shorter 
sleep on day 8 o f  the 7N7D and the 7D7N drill schedules. This is shown on the 
graph o f  sleep duration in all shifts (Figure 7-4) as the two points o f  shortest sleep 
duration.
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Figure 7-4 Sleep duration on four shift schedules: 14D, 14N, 7N7D, and 7D7N drill- 
shift. The additional sleep period taken on the 7N7D swing shift is shown between 
days 8 & 9, where the other schedules show no data point.
Despite little significant difference overall, the 7N7D and 7D7N tours have 
shown a negative impact on sleep which is attributed to the changeover schedule. 
The night after the swing or change-over day on these schedules has reduced 
sleep duration compared to previous sleep periods on the same schedule. On the 
7D7N drill shift schedule the reduced sleep duration continues throughout the 
remainder o f  the tour, but was not statistically different from the other schedules.
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7.2.3.2 Sleep latency
Figure 7-5 shows sleep latency in the four schedules, no significant difference 
was identified between the schedules. It is curious to note that although sleep 
latency is increased for the main sleep periods at the change-over from night to 
day shift (Days 8 & 9 on 7N7D schedule), the same does not apply on the drill 
schedule. Sleep duration post-shift change is lower on the drill schedule and the 
resulting sleep deprivation could have the effect of improving sleep latency. This 
might also explain the short latency on the extra sleep period of day 8 (7N7D 
schedule).
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Figure 7-5 Sleep latency (h:m) on four shift schedules: 14D, 14N, 7N7D, and 7D7N 
drill-shift. The additional sleep period taken on the 7N7D swing shift is shown 
between days 8 & 9, where the other schedules show no data point.
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7.2.3.3 Sleep efficiency
There were no differences in sleep efficiency (Figure 7-6) between the four 
schedules, but a significant interaction between schedule and tour (p<0.01), 
attributed by Tukeys test to a significantly reduced sleep efficiency on night 11 of 
the drill schedule. Investigation of the individuals’ sleep data on that schedule 
indicated that two subjects on the same installation had increased sleep latency 
and fragmentation, with reduced sleep duration and efficiency on that night. The 
two subjects on a different installation had no unusual sleep disturbances. 
Without further evidence it is not possible to report a conclusive cause, however 
a ‘rough night on the rig’ although not specifically reported here, can be the cause 
of isolated disturbances.
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Figure 7-6. Mean Sleep efficiency (%) on four shift schedules: 14D, 14N, 7N7D, and 
7D7N drill-shift. The additional sleep period taken on the 7N7D swing shift is 
shown between days 8 & 9, where the other schedules show no data point.
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7.2.3.4 Sleep fragmentation
The increased fragmentation that occurred on night 11 of the drill schedule as 
discussed above is clearly visible in Figure 7-7. Despite this no statistically 
significant differences in sleep fragmentation were found between the shift 
schedules.
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Figure 7-7. Sleep fragmentation index (%) on four shift schedules: 14D, 14N, 
7N7D, and 7D7N drill-shift. The additional sleep period taken on the 7N7D swing 
shift is shown between days 8 & 9, where the other schedules show no data point.
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7.2.4 Impact of schedule on postprandial metabolism
7.2.4.1 Schedule and postprandial metabolism
Postprandial metabolic and hormone responses were compared for differences 
between the schedules by 2 way ANOVA (factors schedule and day). This 
showed no significant difference between the four schedules for TAG (p=0.06, 
Figure 7-8), glucose (Figure 7-9), NEFA, insulin or C-peptide (all p>0.05). Total 
cholesterol was significantly higher in the 14D subject group than the 14N or 
7N7D schedules. The difference is not present when the data is expressed as a 
percentage change form the basal (fasted) sample which confirms that it is 
unlikely to be attributed to the schedule and simply reflects a difference in the 
populations studied. The cholesterol in all groups is shown in Figure 7-10.
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Figure 7-8 Mean fasted and postprandial TAG on four offshore shift work 
schedules (7N7D, 14N, 14D, 7D7N drill).
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Figure 7-9. Mean fasted and postprandial glucose on four offehore shift work 
schedules (7N7D, 14N, 14D, 7D7N drill). No significant difference between 
schedules was found
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Figure 7-10 Mean fasted and postprandial cholesterol on four offshore shift work 
schedules (7N7D, 14N, 14D, 7D7N drill).
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7.2.4.2 Effect of desynchrony and adaptation on postprandial lipids
Postprandial TAG was found to be higher on the unadapted night-time sample 
than the other samples on the 14N and 7N7D schedules reported in chapters 3 
and 4. As stated in section 7.2.4.1 , no overall difference was apparent between 
the four schedules but an ANOVA on the combined night shift data (combined 
data from 1800h-0600h 14N and nights of 7N7D) indicated a difference over the 
sample days for TAG and cholesterol. Tukeys post test (for unequal n) attributed 
this to a difference between night 2 and night 6 (p=0.01, n=24) for TAG, shown 
in Figure 7-11 and for cholesterol (p<0.01, n=26) shown in Figure 7-12. -
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Figure 7-11 Postprandial plasma TAG on day 2 and day 6 o f night shift (n=24) from 
schedules 14N and 7N7D combined (p=0.01, N=24)
The night 2 and 6 mean TAG responses are both above 1.5mmol/1 reported by 
Griffin et al (1994) to be the level at which small dense LDL cholesterol are 
formed, and thus represent an increase in CVD risk. The total cholesterol, 
although significantly higher on night 2 than 6 does not represent an increase 
above the normal range.
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Figure 7-12. Postprandial plasma total cholesterol on day 2 and 6 o f night shift 
(n=26) from schedules 14N and 7N7D combined (p=0.01, n=26).
Significantly lower lipids on night 6 of night shift when significant adaptation has 
occurred compared with night 2 of a night shift when circadian desynchrony was 
greatest, suggests that adaptation confers a metabolic benefit. This in turn 
implies that the schedule associated with the most desynchrony, will confer the 
greatest increase in CVD risk.
The picture is less clear with other metabolic and hormonal parameters (insulin, 
C-peptide and glucose) as the six-hour postprandial sample was too late to assess 
the peak of the response. Thus even when parameters remained significantly 
different from fasting levels, there was no difference between the sample days or 
the schedules.
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7.3 Discussion
7.3.1 Methods and protocols
7.3.1.1 Offshore field research
The environment of the offshore installation provides almost ideal research 
conditions. The isolation provides a controlling mechanism for external 
confounding factors and all subjects are exposed to an almost identical 
environment. The only variations will be individual differences in routine or job 
requirements. Intrinsic differences between subjects are of course still present in 
these conditions, as they would be in a simulated study environment for example 
using a constant routine protocol.
The management of a research site from a distance is less than ideal. The 
disadvantages of such a distant field research site are that it is more complicated 
to administer and set up, and once in place is constrained by an agreed protocol. 
Despite the willingness of participants and the commitment of the medical 
officers as on-site data collectors, the relinquishing of direct daily monitoring of 
adherence to the protocol inevitably results in some reduction in quality control. 
If errors do occur, the problem may not be apparent until it is too late or too 
expensive to repeat. Subjects are limited by the offshore population size and 
losses are not easily replaced, thus resulting in small subject numbers.
It is unusual in circadian studies not to have an acclimatisation period: a period 
prior to the actual investigation in which the subjects’ circadian status can be 
entrained or at least established. This valuable aspect of the ideal protocol could 
not be met in the field research environment as workers arrive offshore on the 
day that they commence work, thus there is no free day to acclimatise. Given the 
huge expense of transporting and maintaining personnel offshore it was not 
deemed possible to commence the tour a day early. Thus day 2 of the studies was 
the first day on which there was a complete 24-hours of data available for 
analysis and day 13 was taken as the last day for inclusion of rhythm analysis, as 
some subjects gave incomplete collections on day 14.
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7.3.2 Consequences of shift work with regard to circadian rhythms
7.3.2.1 Circadian desynchrony and adaptation to shift schedule
The main consequence of the night shift, or a mid tour shift change, was that of 
an increased period of desynchrony, and initially an increased state of 
maladaptation, requiring several days for recovery. Such desynchrony was 
recently shown in a phase disturbance of clock gene expression within the 
mammalian (rat) SCN, and similarly recovery or resynchrony was shown to 
extend over a period of up to 13 days (Nagano et al, 2003). In the present studies, 
circadian desynchrony was shown in a previously unstudied schedule of 7N7D. 
Moreover the desynchrony was quantified in all four schedules to allow a 
between schedule comparison. A direct relationship between timing of light and 
circadian adaptation was also shown in this shift work population.
Of the schedules studied here, the 14N involves the least circadian desynchrony 
and results in the best adaptation (most concerted in entrainment, with the least 
total desynchrony other than 14D). This finding is in accordance with adaptation 
of the aMT6s rhythm in the same schedule described by Barnes et al (1998a). 
The 7D7N drill schedule (1200h-2400h, 0000h-1200h) offered a similarly low 
desynchrony load as the 14N, with no significant difference between these two 
schedules.
The 7D7N drill schedule (D: 1200-2400h, N: 0000-1200h) also leaves most 
workers returning home still synchronised, at least in circadian terms, to the night 
shift, however in theory the adaptation that is required on returning home is the 
equivalent of adapting by delay to nights offshore, shown here and by Barnes et 
al (1998a) to be both robust and reproducible. It is probably easier to recover at 
home from this schedule than the 14N, as only a small phase delay (the natural 
direction of the human circadian clock) is needed, in contrast to a longer and 
more difficult phase advance required to re-adjust after the 14N schedule (1800h- 
0600h). However desynchrony was only calculated within the offshore tour 
period, and as these two schedules require a re-adjustment in the home 
environment, there is an element of desynchrony that has not been accounted for.
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A study of the phase shift adjustment at home after the tour would be required to 
establish the effect of the complete desychrony-resychrony cycle. In this project 
phase shifts were measured between summer and winter to avoid the extreme 
seasonal light conditions, however the adaptation might vary with season, as was 
shown in the 7D7N drill schedule by Barnes et al (1998b).
The 7N7D schedule (N: 18:00-06:00h, D: 06:00-18:00h) has not been previously 
studied. The day shifts that follow a week of nights (7N7D) are particularly 
difficult to adapt to, because the phase advance required is against the natural 
direction of the human clock and day-light is present over the full duration of the 
shift, i.e. at a time which can counter adaptation. The lack of adaptation to day 
shift on the 7N7D schedule was responsible for the greater part of the schedule’s 
desynchrony load. If the adaptive phase shift is successful offshore then there is 
no further adjustment required at home, however the data here demonstrate that 
this is not always the case.
The adaptation back to days on the 7N7D schedule was the poorest of all and the 
variance in the subjects phase position increased during this time. The evidence 
suggests that light exposure caused phase delays, phase advances or no change 
depending on the time of the individual’s circadian acrophase at the beginning of 
the dayshifts. Bougrine also found these individual differences in response to 
light in fast rotating shiftworkers attempting to adapt (Bougrine et al, 1998). This 
lack of homogeneity would make it difficult and possibly ineffective to apply a 
unified circadian adaptation strategy to workers on the 7N7D schedule, unless a 
more harmonious adaptation to night shift were achieved first.
7.3.2.2 Individual differences
The first week of the 14N and 7N7D schedules, i.e. until the change over day on 
the 7N7D swing schedule, are in practical terms identical and yet there is greater 
variability amongst individuals in the extent of adaptation that occurs on the 
7N7D tour. The variation found in the pilot study was confirmed in the second 
study of the schedule. There is natural variation amongst people depending on 
their circadian timing at baseline. Their individual tau (periodicity or duration of
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circadian oscillation) and possibly an individual sensitivity to external factors 
such as light, might explain some of the variation found by Bougrine et al (1998). 
However these factors do not explain the difference between the schedules (i.e. 
some subjects on 7N7D did not adapt at all) as they would apply to both 
schedules. There was no difference in schedule timing or light exposure, and thus 
no obvious reason why adaptation should occur more cohesively on the 14N, 
however it is possible that there is a difference in the attitude or behaviour of the 
individuals that instigates a subconscious ‘coping strategy’. On the 14N tour the 
workers know that they have a full two weeks to work the night shift and 
resisting the change in sleep time for two weeks is not a comfortable strategy 
even if it were possible. However on the 7N7D the change to day shift is only 7 
days away at most and workers may be tempted, consciously or not, to resist the 
adaptation, for example by trying to stay awake after the shift instead of sleeping. 
Examination of the individual AWL data did indeed show differences in chosen 
sleep period. This would have the effect of increasing light exposure at the time 
when light will prevent the phase delay needed to adapt to the nights. Resisting 
adaptation is unlikely to work well when there is light during the nightshift, but 
strong light exposure after the shift could prevent adaptation occurring. If  some 
subjects follow this tactic it would explain the greater individual variation seen 
on the 7N7D schedule.
7.3.3 Correcting circadian disruption
7.3.3.1 To adapt or not to adapt
To adapt or not to adapt was discussed in section 1.6.1, however whether the 
physiological adaptation to night shift is of benefit to the worker should not be 
assumed. The workers of the offshore 7N7D schedule were maladapted to their 
schedule for up to 6 days of the night shift and most of the day shift. If a phase 
shift is encouraged in a fast rotating schedule onshore, where night work is 
occasional or only a short number of consecutive nights, the worker could end up 
in a continuous state of desynchrony as he tries to adapt to an ever moving target. 
In the situation where there is no choice of schedule the worker might be better 
off remaining unadapted for the short duration of the night schedule and adopting 
other strategies to minimise the discomfort of the disturbance.
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Slower rotations such as the offshore 14 or 21 night shift schedules offer a 
situation where physiological adaptation is likely to occur (due to for example, 
strong environmental zeitgebers and sufficiently long schedule duration). Here it 
is futile to attempt to resist the adaptation process just to avoid the 
resynchronisation later. In such circumstances the most logical action would be 
to hasten the adaptation so as to spend the greater portion of the schedule adapted 
to the shift, and to adopt coping strategies to minimise the discomfort and 
disruption that the period of desynchrony causes.
7.3.3.2 The effects of light
When considering the effects of light on adaptation it is useful to be reminded of 
the controlling effects of light on the human circadian system (see 1.2.4): The 
timing of circadian rhythms is entrained by light exposure and can be phase 
shifted (earlier or later), to synchronise with a change in environment and 
behaviour. It is the timing of light exposure in relation to an individual’s 
circadian rhythm that is associated with phase shift or adaptation; Light exposure 
before the peak of the melatonin (aMT6s) rhythm will delay the next peak to a 
later time, and light after the peak will advance the next peak to an earlier time.
These rules of light and timing explain the phase shifts seen in the schedules 
studied in this project. On the 18:00h-06:00h shift, early night-shift light occurs 
before the circadian acrophase and thus usually enhances a phase delay. On 
schedules that include this shift, circadian rhythm timing at tour start was 
positively correlated to the rate of adaptation. The later the acrophase the more 
light is received before it, thus encouraging the phase shift. Night workers on 
this shift with an early acrophase would have received a substantial amount of 
light after their acrophase. This conflicting light has the opposite effect, 
encouraging an advance of the rhythm. The outcome in these subjects was a slow 
adaptation or no significant phase shift at all. This effect is in line with the 
circadian responses to different 24h light exposure profiles reported by Dumont 
et al (2001)
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The poor re-adaptation to the day-shift (after nights on a 7N7D schedule) may 
also be explained by the timing of light exposure. After 7 night shifts, the aMT6s 
peak occurred at ll:35h (±1.9h) thus during dayshift, shiftworkers received light 
before and after the peak, one exposure countering the effect of the other, so that 
no significant phase shift occurred in many subjects. Four subjects did adapt to 
this day-shift and in each case the light exposure was more suitably timed to their 
individual phase position to encourage adaptation.
The 7D7N (drill) schedule timing is such that the dayshift workers receive light 
prior to the aMT6s peak (12:00h up to OOOOh - 0200h) which could encourage a 
slight delay, although this was not significant here. A circadian phase delay on 
this day shift would be likely to result in a later waking time, which is not 
problematic in a crew that has a shift start of midday. The nightshift (OOOOh- 
1200h) received bright (day) light after waking, i.e. mostly after the aMT6s peak, 
encouraging a phase advance of the rhythm peak back into the sleep period 
before the shift starts, and thus aiding nightshift adaptation. Similar phase 
advances in response to light after circadian peak and after wake time were 
reported by Boivin et al (1996) and Warman et al (2003) respectively.
7.3.3.3 Adaptation by advance or delay
There is no right or wrong direction of adaptation, the circadian system can be 
advanced or delayed to synchronise with a new schedule as described in section 
1.2.4.2. It is more a question of the direction in which adaptation is most easily 
achieved, or most appropriate given the schedule. The easiest and fastest way to 
adapt will depend on a combination of factors interacting with the schedule 
timing and individual phase position. Combinations of timed light and scheduled 
darkness/sleep have been reported by Czeisler et al (1990), Eastman et al (1994), 
Horowitz et al (2001) and Yoon et al (2002) to induce advances and delays of the 
circadian system which probably best represent the interacting factors in offshore 
adaptation. Burgess et al (2002) and Crowley et al (2003) included the use of 
melatonin to further facilitate adaptation in night workers, this has not, to the 
author’s knowledge, been assessed in offshore shift workers. To advise on the 
best strategy to encourage adaptation in the most appropriate direction, one must
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consider the timing o f the schedule and light exposure in relation to the circadian 
phase of the worker, and any other confounding or conflicting zeitgebers. A 
phase response curve can be used to predict the likely direction of an adaptive 
phase shift in response to different zeitgebers (see Khalsa et al 2003; Burgess et 
al 2003).
7.3.3.4 Natural circadian timing and diurnal preference
Diurnal preference (not recorded in these studies) can dictate the timing of the 
sleep period and is related to individuals’ natural acrophase position. In fact 
Farbos found that diurnal preference and individual’s preferred sleep times 
explained the capacity to adjust to night work (Farbos et al 2000). Normal day- 
adapted acrophase could not be established offshore as initial acrophase position 
had to be taken at day 2 when some adaptation would have occurred, which 
exaggerated the variance in circadian phase. If offshore workers selected variable 
sleep times, this would have exacerbated the variance in phase position and, 
similarly to Farbos, individual phase position time was related to shiftwork 
tolerance via adaptation rate. This suggests that if initial acrophase could be 
harmonised at the start of a tour, by a combination of light and sleep scheduling, 
a more unified adaptation would follow. Furthermore Burgess and Eastman 
(2004) demonstrated phase advances and delays following early or late bedtimes, 
despite identical early morning light exposure, supporting the theory that 
scheduled sleep could enhance phase shifts. Determination of diurnal preference 
was not undertaken in these studies, however larks and owls have been shown to 
differ in their adaptation and response to shift work, Dumont et al (2001) reported 
that ‘momingness’ and ‘eveningness’ were strongly associated with phase 
advance and phase delay respectively. A study of diurnal preference and 
shiftwork tolerance is suggested in the section on further work.
Individual preferences, combined with unscheduled zeitgebers and the 
irregularity of daily routines, means that adaptation in any direction is difficult in 
a home and family environment, while the more isolated and controlled 
environment offshore confers a huge advantage as adaptation strategies can be 
implemented more readily.
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7.3.4 Consequences of schedule and desynchrony
7.3.4.1 Consequences of schedule on sleep
Disturbed sleep is a common complaint amongst shift workers and there is 
evidence here to support this. In this project a mid-tour change of shift was found 
to have effects on total sleep, and a return to day shift after a week of nights 
significantly improved sleep efficiency.
The limited improvement in sleep latency over a 14N tour, suggested some 
benefit of the stable 14N schedule over the disturbance of the 7N7D swing shift, 
although no conclusive advantage in adaptation was identified for sleep, whereas 
Parkes reported that ‘adaptation was evident’ in self reported sleep by week 2 of 
a stable 14 night schedule (Parkes et al, 1997). Impairment of sleep as a result of 
desynchrony can be difficult to determine as sleep propensity on the first nights 
(or day sleep periods) of desynchrony is a battle between the circadian rhythm of 
wakefulness and the fatigue due to sleep debt accrued and long work hours. Thus 
the impaired sleep expected on night shift may be overridden by fatigue, as a 
rebound decrease in sleep latency often follows in the subsequent sleep. 
Furthermore Smith et al (unpublished) showed an increase in fatigue over the 
14N tour, measured by cognitive performance data collected concurrently and in 
the same subjects as for the data of this project. This work-associated fatigue, 
accumulated over the tour despite no reduction in sleep, is offered as explanation 
for even a small improvement in sleep latency.
The schedules involving a changeover had the shortest sleep (shortest duration 
and longest latency) on the changeover and the first night following the 
changeover shift, indicating that the mid-shift change impairs sleep duration. 
Both of the swing shifts studied induce a desynchrony that would be rectified by 
an advance of the circadian rhythm. This forces the shiftworker to attempt sleep 
before the circadian rise in sleepiness and explains the increased sleep latency as 
described by Guilleminault as a delayed sleep phase insomnia (Guilleminault et 
al, 1982). Thus the sleep consequence of a swing shift schedule versus single 
shift schedules (14 nights or days) is that sleep is disturbed for the day of change
217
and at least one day after the change, this is consistent with the work of Parkes et 
al (1997), who reported sleep impairment in offshore workers on a ‘rollover’ shift 
compared to a stable day or night shift schedule. This will predictably jeopardise 
alertness and, unless sleep is made-up in the following nights, will also contribute 
to a cumulative fatigue. Bonnet and Arand (1995) suggested that a sleep debt as 
little as 1.3 hours in a night, a level that falls within the range of variation 
amongst the subjects studied here, could impair performance the next day by up 
to 32%.
Sleep efficiency was significantly improved on the day shifts following the 
change over shift on the 7N7D schedule and may be increased at this time to 
compensate for the cumulative fatigue and sleep debt accrued as a result of tour 
duration. The improvement in sleep efficiency seen after the change over on the 
7N7D schedule suggests that returning to normal clock time was associated with 
better sleep, despite the desynchrony. Perhaps the sleep wake cycle is restored 
more rapidly than the circadian system especially when fatigue overrides the 
circadian signals.
Whether improvements in sleep parameters can be attributed to circadian 
adaptation, independent adjustment of the sleep wake cycle, or attributed to the 
cumulative fatigue that is reported in these subjects as above, is not clear. 
Borbely’s review of models of sleep regulation suggests that sleep propensity is 
an interaction of a sleep homeostat and the circadian rhythm of sleepiness 
(Borbely and Achermann 1999). Thus the sleep impairment is likely to be due to 
the circadian desynchrony and the sleep improvement that follows is likely to be 
a response of the somnostat. Whatever the reason, the 14N schedule has less 
sleep disturbance than the schedules containing a swing shift and showed an 
improvement over tour duration and is therefore the ‘best’ schedule to operate in 
terms of sleep.
As all schedules studied, including day shift, had a lower mean sleep efficiency 
than was reported by Leger et al (2002) in non-shift workers onshore, it seems 
that the offshore environment impacts mildly on sleep. This is consistent with 
Parkes (1999) who reported that sleep problems were associated with shift work, 
but also with physical environment in offshore workers.
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It should be noted that sleep latency and duration are difficult to assess by 
actigraphy alone as periods of stillness can be misinterpreted as sleep. This can 
contribute to error in sleep assessment, which may be reduced by concurrent 
sleep diaries to support the objective data. However maintaining such records 
adds an additional workload to the subject that was undesirable in this protocol. 
An operator difference can confound the analysis of the sleep data. To remove 
this error all sleep analysis was completed by one person.
7.3.4.2 Consequences of schedule on CHD risk
The most important consequence of night work on CHD risk was the finding of 
increased postprandial lipids on night 2, the unadapted night (night 2 of 14N and 
of 7N7D) compared with postprandial night time lipids on night 6. The night 2 
raised 6h postprandial plasma TAG level represented an increase higher than 
1.5mmol/l, the level at which the atherogenic small dense LDL cholesterols are 
formed (Griffin et al 1994). This shows that the desynchronisation of night work 
is associated with an impairment of postprandial metabolism resulting in raised 
TAG, and thus associated with an increase in CVD risk. Intermediate sampling 
points throughout the postprandial period would be required to determine the 
peak TAG and thus whether the 6h value is a result of a raised response, delayed 
clearance or a combination of both. Further study with greater sampling 
frequency is suggested in the recommendations for further work.
It was unexpected to find no overall significant difference between the 14D and 
14N schedules in terms of postprandial metabolism, as differences have 
previously been shown between day and night (Hampton et al 1996; Ribeiro et al 
1998). In the current studies the numbers in each were relatively small, the 
subjects were different for each schedule and were on different installations, 
which is very likely to have introduced an undesirable level of variance. It would 
have been preferable to study one population repeatedly on each schedule, 
however such a protocol was not compatible with the voluntary input of the 
installations and subjects.
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The night shift postprandial metabolism results of the 7D7N drill schedule did 
not support the findings of increase night time TAG found on night 2 of the 
18:00h-06:00h night shifts. This schedule does not reach the same level of 
desynchrony as the 7N7D and due to the timing of the start of night shift (2400h), 
the night shift test meals are consumed at 0600h thus the postprandial period was 
(probably) relatively insulin sensitive. This is in line with Al-Naimi et al (2004) 
who recently showed impairment of lipid metabolism after an 01:00 meal 
compared with a 07:00 meal. For a meal consumed at this insulin sensitive time 
there is the added potential benefit of daylight occurring during the postprandial 
period. Hampton et al 2002 demonstrated that light treatment during a simulated 
night shift constant routine protocol, had beneficial affects on TAG and insulin, 
thus it is not surprising that no significant difference was seen in night shift 
metabolism.
Contrastingly, on a day shift of 12:00h to 24:00h the test meal was consumed at 
18:00h and postprandial blood samples were drawn after the midnight shift-end. 
Therefore the postprandial period was probably more insulin resistant than on the 
night shift and with only limited ambient light exposure. Thus there was 
predictably (in retrospect) no difference between night and dayshift postprandial 
responses on this schedule. Furthermore day shift workers finishing at midnight 
consume a post shift meal when insulin resistance is greatest, thus a further 
disturbance to metabolism may be present. This could not be measured in these 
studies as it would require blood sampling during the sleep period, which would 
be inappropriate. However, it is possible that this day shift schedule may be 
equally as detrimental to postprandial metabolism as the night shift. However the 
study of the 7D7N drill schedule involved a smaller than desirable subject 
number and the lack of significant findings could also be due to this.
7.3.4.3 Consequences of offshore schedules on dietary intake
Offshore industry differs from most shiftwork environments in that it is fully 
catered. Diet provision offshore includes healthy choices and, in contrast to 
virtually all onshore workplaces, fully catered night-shift meals are often
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available, certainly a wide variety of snacks in addition to meals are freely 
available.
Dietary intake on the 14N and 7N7D shift showed that energy consumption was 
constant in offshore shift schedules, but with the temporal redistribution of foods 
within the 24-hours. This is in agreement with the findings of Lennernas in 
onshore shiftworkers that total daily energy intake was not significantly different 
between shift and non-shift workers (Lennernas et al, 1994,1995).
In the offshore situation diet is less likely to suffer as a full catering service is 
available to night workers as well as to day workers. The small change in the 
ratio of protein and carbohydrates consumed that occurred after night-6 of the 
14N schedule (see section 3.3.) suggests that macronutrient composition appears 
to change with adaptation or tour duration. This could be an artifact caused by 
the catered environment, rather than differences in food choice, however this 
difference was not found on the 7N7D schedule where adaptation was 
inconsistent and many subjects were in a state of desynchrony for most of the 
schedule. Furthermore no such difference has been reported in onshore or fester 
rotating shiftworkers and the appetite disturbance associated with desynchrony 
would naturally improve with re-synchronisation. Further study of dietary intake 
in shiftwork could identify if there is any effect of desynchrony or adaptation on 
food choice or diet quality.
We have reported that intake of dietary polyphenols differs between day and 
night shift workers (Woods et al, 2003). Certain classes of polyphenols (eg 
cinnamates and flavanones) increased during night shift, attributable to an 
increase in consumption of coffee and fruit juices. This difference in intake of 
drinks is most likely to be a strategy (conscious or subconscious) to promote 
alertness or wakefulness. Interestingly in fast rotating shift workers, who suffer 
reduced sleep duration on morning shifts, Lennernas reported no difference in 
caffeine intake across shifts, but that workers consumed more coffee at work than 
at home on days off (Lennernas et al, 1995). Furthermore, higher intake of 
polyphenols associated with vegetable intake and tea on the offshore day shift
221
suggests there may be a difference in the quality of diet between day and night 
work that needs to be pursued. Stewart and Wahlqvist (1985) reported a shift 
work variation in food intake associated with the food provision facilities 
available at the work site supporting the findings here that there may be a 
difference in macronutrient intake if not total energy intake. In contrast however, 
Lennernas et al (1993) found no differences in meal type (i.e. snacks versus full 
meals and number of eating episodes), in non-catered shiftworkers.
Whether dietary choices alter over the duration of a tour offshore, or are affected 
by circadian adjustment to the shift schedule is uncertain. These may be 
important factors if the choices exacerbate the detrimental effects of disturbed 
postprandial metabolism. The nocturnal diet of shift workers is especially 
important in this respect, a reduction in dietary quality especially in cardio­
protective antioxidants adds to the other shiftwork factors to confer an overall 
increased CVD risk. In view of the aspects of diet quality that contribute to CVD 
risk and cardio-protection (see section 1.5.5) and the metabolic impairment of 
shiftwork desynchrony shown by impaired postprandial lipid metabolism, 
analysis of diet quality in shiftworkers is essential in determining the impact of 
diet on CVD risk in this population group.
As diet is amenable to modification, this may provide a way of reducing diet 
related CVD risk in shiftworkers. The catered environment and health promotion 
activities offshore provide a route for advice to be made available or strategies to 
be implemented for improvement of diet in offshore shift workers. Advice could, 
for example, include suggestions for foods to avoid during the ‘insulin resistant’ 
times.
7.3.4.4 Repeated episodes of desynchrony
Single or occasional episodes of desynchrony are unlikely to have any long term 
detrimental effect on health. Similarly, infrequent trans-meridian travel (e.g. 
foreign holidays) is not generally associated with increased risk of damaged 
health. Epidemiology suggests that changes in CVD risk in migrants is related to 
their inherent risk and the additional risk of the environment and lifestyle they
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move into, not the move per-se. One assumes then, that once resynchronised with 
the new environment any metabolic disruption is normalised and sleep debt is 
recovered. However the situation is different for shift workers: firstly, as 
previously discussed, most shift workers do not undergo circadian re-synchrony, 
and even in those who do the disruption is repeated time and time again, thus 
inducing a repeated cumulative exposure to the risk.
The schedules studied here incur increased desynchrony episodes with each 
change of shift. A 14N schedule incurs a single desychrony-resychrony cycle 
once in an 8-week schedule rotation, and with adaptation only a few days are 
spent maladapted. The schedules combining days and nights incur double the 
desynchrony episodes over the same period, and a greater number of days 
maladapted each time. Each incident of desynchrony is associated with a loss of 
sleep and impaired metabolic function. Repeatedly raised postprandial TAG and 
cholesterol when insulin resistance is high represent a situation not dissimilar to 
type II diabetes and the metabolic syndrome, impacting correspondingly on CVD 
risk.
Shift work may contribute other components to the shiftwork-CVD risk recipe, 
that were not studied here, yet also present in a dose response manner. Dinges 
suggests that stress and sleep loss, as occurs in shiftwork, may impact on CVD 
risk and morbidity via promotion of inflammatory responses (Dinges et al 2002). 
The sleep loss seen in shift schedules here was small and as Dinges also proposed 
that sleep recovery reversed the effect, it is likely to be a transient symptom. 
However the effect is repeated with every period of desynchrony. It would be a 
valuable exercise to measure inflammatory markers in shiftworkers, thus a study 
is suggested in the section on further work. One cannot help but wonder if the 
physiological adaptation to a night shift would normalise inflammatory response 
as it does the metabolic responses.
A summary of the effects of the circadian system, sleep, diet and metabolism as 
consequences of shiftwork, and possible interactions providing mechanistic 
pathways for an increased risk of CVD in shift workers is presented in Figure 7- 
13.
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Figure 7-13 Schematic of factors relating shiftwork to CVD risk.
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7.3.5 Beneficial consequences of adaptation.
7.3.5.1 Adaptation and sleep
The small improvement in sleep latency during the 14N schedule (that was not 
found in the other night shifts with less complete circadian adaptation), was 
statistically significant only at the end of the tour. Yet adaptation was 
substantially achieved between days 4 and 6, thus it is difficult to attribute the 
improvement entirely to the circadian re-synchrony. An improvement in sleep 
latency was also reported in just one week of simulated night shift by Lamond et 
al (2003) who associated the improvement with circadian adaptation and 
suggested that in optimal sleeping conditions, as provided offshore, the 
cumulative sleep debt is minimal. Fatigue is a strong signal for sleep and 
seemingly allows an adjustment in the sleep wake cycle in spite o f the circadian 
desynchrony. Morgan et al (1998) also demonstrated a dissociation of the sleep 
wake cycle and the circadian rhythm in a study that phase shifted the sleep period 
while the aMT6s phase position was maintained. Unexpectedly no clear sleep 
improvement was found to be associated with circadian adaptation as was 
reported by Dawson and Campbell (1991) and Barton et al (1995), however the 
impact of fatigue and the optimal sleeping conditions may have masked the effect 
of desynchrony.
13.52  Metabolic adaptation
Adaptation is clearly advantageous in terms of postprandial lipid metabolism, as 
demonstrated between the unadapted and adapted nights of the 14N and 7N7D 
schedules. The normalised postprandial TAG on night 6 (significantly lower than 
on night 2 and not significantly different from fasting) suggests that there is an 
improvement in postprandial metabolism associated with acclimatisation to the 
schedule. A similar recovery was reported by Ribeiro et al (1998) following a 
simulated night shift study where a partial recovery (but not a complete return to 
baseline) was seen 2 days after a phase shift. Orth-Gomer (1983) also reported 
lower serum TAG and glucose in shiftworkers on a clockwise rotating schedule 
(adapting) than an anti clockwise (nonadapting) schedule, suggesting that the 
maladaptation confers a negative effect. The improvement in postprandial TAG 
and cholesterol that occurred concurrently with circadian phase shift suggesting a
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beneficial effect of the circadian adaptation in the current studies, cannot be 
attributed entirely to the phase shift as even the non adapting subjects showed a 
trend towards improvement by night 6. This suggests that there may be a 
physiological adaptation in terms of postprandial metabolism that is independent 
of circadian adaptation. This is in agreement with Morgan et al (1998) who 
demonstrated that rhythms in TAG and glucose could desynchronise from the 
circadian rhythm. Circadian desynchrony is clearly detrimental to normal 
postprandial metabolic responses and this constitutes a route for shiftwork to 
impact on CVD risk. The data here and in the literature suggest that a recovery 
occurs over a period of days in line with circadian adaptation, but that may also 
occur independently of adaptation. This suggests that where a shift schedule is of 
sufficient stability and duration circadian and metabolic adaptations offer a route 
for reducing the impact on CVD risk associated with the desynchrony.
13.53 Uncoupling of circadian oscillators
In a recent review of clock mechanisms Balsalobre (2002) proposed that while 
the SCN is recognised as the central controlling oscillator of circadian rhythms, 
tissues throughout the body express clock genes. Thus there are peripheral 
oscillators that may depend on the SCN for their innate rhythmicity, but that 
respond to local stimuli. The independent recovery of metabolic processes and 
sleep cycle in the non adapting subjects suggests that these rhythms are indeed 
controlled separately from the central circadian oscillator in the SCN. Nagano et 
al (2003), demonstrated that a change in day/night cycle caused a desynchrony in 
clock gene expression in the SCN, and that different genes and regions of the 
SCN recovered at different rates. This may explain why the suppression of 
melatonin by light is rapid yet the resynchrony takes days. Furthermore Hastings 
et al (2003) suggested that peripheral clocks were more sensitive to non-photic 
zeitgebers and respond rapidly to local stimulus. This uncoupling of central and 
peripheral clock mechanisms may explain why sleep and endocrine function may 
adjust to a change in day/night cycle independently o f the circadian rhythm.
In shiftwork a rapid adjustment in peripheral clocks is a benefit where schedule 
duration is long and consists of a single shift pattern, as once the adjustment is
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made no further disruption will occur until the worker adjusts back to day-time. 
This supports the recommendations made here: that a schedule of night-shift only 
has a less severe consequence on health than a schedule causing more episodes of 
desynchrony.
7.4 St r a t eg ie s , r e c o m m e n d a tio n s  a n d  fu t u r e  w o r k
7.4.1 Strategies for improving adaptation and health benefits
Several strategies for coping with shiftwork and encouraging adaptation to night 
work by phase shifting the circadian system have been investigated. The use of 
such strategies in relation to shift work and the offshore schedules studied in this 
project is discussed here along with the physiological effects and potential 
benefits to health. These recommendations are thus compiled from findings in 
this study and the relevant literature.
7.4.1.1 Light treatment and darkness in circadian adaptation
The idea of using light as a treatment to induce a phase shift is not new (see 
section 1.3 and 1.6). In recent years light has been suggested as a strategy to 
alleviate maladaptation to shift work (Horowitz et al, 2001; Bjorvatn et al, 1999) 
and to encourage re-adjustment of the sleep pattern after returning from an 
offshore tour (Bjorvatn et al, 1999). This project has further contributed to this 
field by identifying the adapted phase position in the most commonly operated 
offshore schedules, thus allowing for the development of schedule- specific light 
treatment strategies.
The benefits of appropriately timed light treatment for shift workers goes beyond 
promoting circadian resynchronisation. Campbell and Dawson (1990) proffered 
the suggestion that an improvement in performance seen with light treatment at 
night is independent of phase shift as it occurred immediately in direct response 
to the light. In this case the light was timed over both the phase delay and 
advance portions of the human PRC to light, so that no phase shift was expected. 
Thus light can be used as a coping strategy in shift workers whether or not 
adaptation is required. In offshore night workers working 14 nights or more, who
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do adapt and might gain benefit from that adaptation, the light treatment could be 
utilised to aid night work performance and hasten the circadian adjustment. Foret 
et al (1998) suggested that users of bright light treatment for improved alertness 
during night work should be aware of a possible shift in rhythm timing during 
subsequent nights. This is wise advice for fast rotating shift workers who do not 
normally adapt, nor want to adapt to their shift schedule.
However in view of the more recent reports of an association between night time 
light exposure and increased incidence of cancers (for reviews see Swerdlow 
2003 and Anisimov 2003), the effect of light at night needs investigation before 
any recommendations on light treatment are made. In shift work conditions that 
facilitate rapid circadian adaptation, such as the 14N schedule in this study, 
subjects may gain a further advantage in that once adapted the light they receive 
at night is no longer inappropriately timed. One could speculate that using light to 
achieve a faster adaptation could offset the risk associated with the unavoidable 
night shift light exposure of a non-adapted subject.
7.4.1.2 Light treatment administration
Timed light treatment may be a strategy to implement offshore to encourage 
adaptation rate and direction; this has been successful in alleviating subjectively 
measured maladaptation on offshore workers (Bjorvatn et al 1999). This would 
be most effective if all subjects’ circadian phase is harmonised, but difficult when 
individuals vary. In order to increase the uniformity of the circadian adaptation to 
7N7D, light exposure would either have to be tailored to individuals, having 
previously identified their individual circadian phase and consequently would be 
costly and/or impractical, or combined with supporting strategies. Avoiding 
adaptation-conflicting light during the first nights offshore i.e. during the 
adaptation period (then, on day shift avoiding phase delaying light during the first 
days) is a practical alternative. Light avoidance requires the use of light 
excluding glasses (sunglasses) which may impair performance if used during 
work, or scheduling sleep to bring about the darkness. It is possible that specific 
glasses with a filter for blue light (the most active wavelength for phase shifting),
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may become available but clearly careful evaluation would be required prior to 
promotion of their use.
Advice for timed light exposure/avoidance for enhanced adaptation could be 
given with greater precision to workers on the most homogeneous (14N) schedule 
during their adaptation period. The schedule itself provides light at the right time, 
but light or avoidance of light in free time could also be utilised. Avoidance of 
light immediately after night shift (especially the first few nights) should prevent 
any counteractive effect of light.
The change-over day leads to light exposure countering adaptation in the 7D7N, 
thus if this schedule is operated it is especially important to avoid light and 
schedule sleep between the shift end and midday. Theoretically the change over 
could be staggered over two days, thus reducing the desynchrony as adaptation 
occurs. This would allow the light associated with the schedule to have a pro- 
adaptive, rather than counter-adaptive effect, however there is currently no data 
to support this theoretical strategy.
Timed light treatment to readjust at home could be offered on schedules that 
leave the workforce desynchronised on their return home. After nightshift 1800h- 
0600h the workforce return home with a circadian phase time (melatonin peak) 
near to midday. Light prior to this will be counter-adaptive and should be 
avoided, while light after the circadian peak will hasten the resynchrony back to 
normal. The theoretical ‘milk’ schedule (0300h-1500h) would provide light at the 
most appropriate times to encourage adaptation to both the early and late shifts. 
However subjects with extreme individual variation such as a delayed phase (e.g. 
peak melatonin at 0600-0700h), may find the adjustment to the early dayshift 
start difficult as the phase advance needed is greater and would be countered by 
the early hours of light.
It is clear that getting the timing of the light treatment correct and appropriate for 
the individuals’ circadian phase is paramount, in order to achieve the desired 
phase shift in these offshore workers. This is in agreement with proposals for 
phase shifts by light exposure reported by other shift work research groups
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(Mitchell et al, 1997; Burgess et al, 2002). Moreover, for effective use of light to 
induce adaptive phase shifts, it is preferable to identify indivduals’ acrophase 
time, thus light can then be tailored to shift the rhythm in the direction most 
appropriate to reach the desired new phase position, taking into account any 
other conflicting or judicious zeitgebers. It may be impractical to assess every 
individual’s phase position by objective analysis methods, but establishing 
diurnal preference could provide a quick and cheap alternative method of 
identifying early acrophase from late acrophase subjects.
7.4.1.3 Light and metabolism
This project has shown a disturbance in postprandial metabolic responses to night 
time meals that is in accordance with findings in simulated shift work studies 
(Hampton et al, 1996; Ribeiro et al, 1998). One major difference is that these real 
shiftworkers are not in controlled conditions and are exposed to varying amounts 
of light throughout and following the night shift. Hampton et al (2002) recently 
showed that light treatment may normalise these responses. In a constant routine 
study at 20 lux, with hourly nutrition, bright light treatment during the night 
resulted in lower triacylglycerol and a trend towards lower insulin levels than 
without bright light. These subjects were not phase shifted from clock time and 
this suggests that light treatment confers an improvement on night-time hormonal 
and metabolic responses to meals independently of circadian adaptation. If this is 
the case then the disturbed responses seen in the current studies may be even 
more disturbed than the data revealed, as subjects had the benefit of night time 
light. Research to establish the full extent of the disturbance as it occurs in a shift 
working environment is suggested in the section on further work 7.4.3.
7.4.1.4 Sleep strategies
In the studies reported here sleep was not scheduled, subjects were free to sleep 
according to their preference within the off-work period. Sleep scheduling may 
be an important and currently underused strategy to improve adaptation to night 
shift and has the effect of light exclusion to ameliorate timed light treatment in 
accordance with light and darkness combination treatments (Boivin and James, 
2002). To employ this strategy for adaptation to the 18:00h-06:00h night shift,
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light after the shift should be avoided as it would counter the phase shift. Timing 
the sleep period to coincide with the light avoidance (immediately after shift for 
1800h-0600h, or immediately before a shift for OOOOh start) would therefore 
encourage the adaptation and may induce better sleep due to the timing of this 
sleep period in relation to the circadian rhythm. This is in agreement with the 
improvements in adaptation and performance found by Horowitz (2001) when 
sleep with light exclusion was scheduled after the night shift.
The times of peak alertness are the most difficult for sleep. A shift worker who 
attempts to start sleep between 09:00h and 10:00h after a night shift may not 
sleep easily. Scheduling the sleep period to occur before the alertness peak, i.e. 
as soon after the shift end as is possible may produce a shorter sleep latency, 
longer duration and a better sleep quality.
The nearer to the work shift that sleep is timed, the less adaptation is required to 
synchronise the circadian rhythm within the new sleep period, thus preferred 
sleep period can impact on ability to adapt and schedule preference. If a worker 
prefers to wake shortly before a 00:00h-12:00h night shift and have free time 
later (after the shift) the rhythm needs to be advanced so that melatonin 
production occurs before midnight in line with the sleep. This advance 
adaptation would work well in a night shift worker who normally likes to sleep 
early and rise early anyway. For a night shift that ends early in the morning or for 
a worker whose diurnal preference is toward eveningness, it may be more 
effective to encourage adaptation by delay and sleep as soon as possible after the 
shift. In order for this to work, light at conflicting times must be avoided as 
strong morning light can negate the rhythm delaying effects of light received 
during the night shift.
Napping during shift is not a strategy currently employed in the offshore 
petrochemical industry. However, as a strategy to help shift workers, 
incorporating a nap into the work schedule may benefit in two ways: by aiding 
the phase shift Buxton et al (2000) and by promoting alertness (Sallinen et al 
1998). Using nap-sleep during night shift, especially the first night of a tour, may 
be a useful strategy in improving immediate alertness, as was recently reported
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by Lowden et al (2004a), but would have to be carefiilly timed to avoid 
countering adaptation. In industries where monitoring of equipment is part of the 
safety procedures, the investment in staff levels that allow for personnel to be 
alert at their stations might be considered an appropriate investment.
7.4.1.5 Exogenous Melatonin and adaptation
The use of exogenous melatonin as a strategy to aid circadian adaptation in jetlag 
and shiftwork was introduced in section 1.6, and as with other zeitgebers used 
therapeutically, the timing of administration is of the utmost importance in 
producing the phase shift in the desired direction. Deacon and Arendt’s study
(1996) demonstrated that exogenous melatonin treatment can outweigh the 
effects of light in inducing an adaptive phase shift, thus melatonin either alone or 
with favourably timed light treatment would clearly be a beneficial strategy in 
shift workers wanting to adapt. However melatonin treatment timed to assist 
sleep without a phase shift might be a preferred option for fast rotating shift 
workers who do not remain on a shift schedule long enough to adapt, requiring a 
complex co-ordination of sleep, light and melatonin treatment.
It is worthy of note that melatonin is reported to have indirect effects on health 
via roles other than that of circadian messenger. Exogenous melatonin, by 
inducing sleepiness, improves sleep parameters in shift workers (Cajochen et al, 
2003; Folkard et al, 1992; Deacon and Arendt, 1995), and better sleep as 
discussed in section 1.6.4 is related to fewer health complaints. Whether or not 
melatonin benefits mood may be argued and may well depend on the timing and 
reason for which it is taken. As the administration of melatonin is often 
associated with conditions where sleep is disturbed, it may be that any changes in 
mood are associated with the worsened or improved sleep.
The potential uses of melatonin for health benefit, aside from circadian 
adjustment and sleep regulation, include utilisation of its antioxidant capabilities 
for possible protection from oxidative damage (Beyer et al, 1998) and its 
oncostatic properties possibly enhancing chemotherapy in lung cancer treatment
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(Lissoni et al, 2003). On the basis of Steven’s melatonin hypothesis in relation to 
light, shift workers and cancer (Stevens et al, 1996; Stevens, 2005 see section 
1.4.2.3), there may be a role for melatonin supplementation in cancer prevention 
that still requires investigation in shift workers and indeed more widely.
7.4.1.6 Strategies for improving diet and reducing CHD risk
In light of the impaired postprandial metabolism during periods of shiftwork 
desynchrony in conjunction with the known effect of diet on metabolic markers 
of CHD (reviewed in 1.5.5), advice to avoid high fat and high sugar food and 
snacks at night, particularly at the start of nightshift, would be prudent. The work 
of Ribeiro et al (1998) and Hampton et al (1996) support this as they demonstrate 
the impact of a variation in the lipid: carbohydrate ratio of a pre-study meal on 
the metabolic responses to a night shift test meal. Additionally research is 
currently underway looking at the effects of consuming foods of high and low 
glycaemic index at night, which may provide further advice for optimal dietary 
intake in shiftworkers.
It may be especially important to follow dietary advice on the first (unadapted) 
nights or days of desynchrony before any circadian or metabolic adaptation has 
taken place. In a study of food source and intake in shift workers Stewart and 
Wahlqvist (1985) reported improved quality of diet (by an increase in the 
consumption of lower energy dense foods) following a dietary education program 
at the workplace. This suggests that a program of education on diet, specifically 
aimed at night time eating and shift workers, could improve the dietary impact on 
CHD risk. In a fully catered environment such as the offshore installations, the 
education program may need to be extended to the catering service.
A parallel, analogous instruction on reducing CVD risk in general (lifestyle 
advice on diet, alcohol, smoking and stress etc) could be allied to the dietary 
education suggested above. Furthermore, where increased CHD risk is known to 
be present via non-modifiable etiology, the cessation of shiftwork could be 
considered on the grounds of health.
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There are foods and nutrients that are associated with fatigue, sleep propensity 
and mood that may be utilised as a strategy to assist a shiftworker in these areas. 
For example it is well known that caffeine taken in food or drinks has a stimulant 
effect and can be used to induce wakefulness, this could be and probably is used 
as a strategy amongst shift workers to aid alertness and performance during the 
night shift, or during a period of adaptation back to days. Wright et al (1997) 
demonstrated that caffeine administered during sleep deprivation improved 
performance, the improvement was greater at 02:00h than 20:00h, and the effect 
was compounded when combined with bright light treatment.
7.4.2 Shift schedule recommendations
As part of the outcome of this project recommendations were made to the UK 
petrochemical industry in respect of shift schedules operated in the field. These 
recommendations are in contrast to those of Knauth (1996) whose design for 
better shift systems was based on the fast rotating systems popular in onshore 
industries. Whilst we are agreed on the recommendation that night work should 
be reduced where possible to avoid the adverse consequences, this seems to be in 
conflict with current economic and sociological development -  the 24h society.
Of those studied here, the schedule which causes the least desynchrony (other 
than day shift) was the 14N operating between 1800h-0600h for a tour of 14 or 
21 days, and as such is recommended as the most appropriate to be operated for 
the offshore industry. In contrast Knauth (1996) recommended that fast rotating 
schedules no longer than 5 days were preferable, to prevent phase shifts that 
cause desynchrony. This is inappropriate offshore where fast rotations are 
logistically inoperable, due to the helicopter transport and living accommodation 
required to facilitate offshore work. Thus if a schedule must rotate over longer 
periods, then adaptation to the schedule is preferable to non-adaptation.
A 14N schedule operating 0000h-1200h is also predicted to bring about a low 
desynchrony load during the tour as only a small advance of the circadian phase 
is required, and easier adaptation after returning home as the re-adaptation is in
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the delay direction that the circadian system naturally favours. Thus one could 
also speculate that a schedule with 0300h shift change could offer the least 
desynchrony of all, as theoretically very little circadian adjustment would be 
required. This would involve an early shift 0300h-1500h and a late shift 1500h- 
0300h and would involve less of a disturbance to sleep as both shifts could have a 
period of sleep close to their normal sleep time. To the author’s knowledge this 
schedule has not been operated, or even tested, and despite a prediction of low 
desynchrony load, it may not be popular as an 03:00h start is unlikely to appeal. 
The literature suggests that early shifts are not easy to adapt to, however this 
refers in general to the onshore shifts with 0600-start as it results in shortened 
sleep period (Knauth, 1996, Guilleminault et al, 1982). However, in the 12-hour 
shifts and isolated environment offshore, sleep on the 0600h day shift was not 
significantly shorter than on other schedules, this is perhaps because it follows on 
from a day time routine rather than a night shift.
In terms of advice to the offshore industry on operational policy, the clear effect 
of the shift change on desynchrony load would suggest that unscheduled shift 
changes and call-outs should be avoided.
7.4.3 Recommendations for further study
The protocol used in this research was constrained to some extent by the 
requirements of the funding body for specified schedules to be included and 
compared. Thus, in order to maintain constancy across the studies, there was 
leeway for only minor changes and developments within the protocol. 
Limitations and suggested improvements or further study have been made within 
the discussion above, and recommendations for a development of the research 
area are made below.
If a new schedule were to be operated, such as the 14N 0000h-1200h, or the 
‘milk’ shift 0300h-1500h, 1500h-0300h, it would be advisable to confirm the 
effect on circadian status in a volunteer group prior to wider implementation, via 
a protocol similar to that used in the reported studies.
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A study of the circadian disruption and resynchronisation that occurs on the 
return to shore after a tour would be a logical development. A project to 
investigate the desynchrony onshore after a tour of nightshifts along with an 
investigation into timed light exposure at home to hasten recovery was suggested 
and is now underway.
To further current knowledge of treatment strategies for circadian desynchrony, 
an offshore study to hasten adaptation in the 18:00h-06:00h night shift is 
desirable. A program of light treatment during night shift prior to acrophase, and 
reduced light after the acrophase, with sleep scheduled immediately following the 
shift is suggested. This would be compared with no treatment at all, light only or 
sleep only. Following the view that a more homogenous circadian group should 
be less variable in their response to a unified adaptation strategy, sleep scheduling 
and light control by sunglasses in the days prior to the study could be instigated 
to entrain their acrophase position. Thus treatment would occur in all subjects at a 
similar circadian time. A similar program of light and sleep could be applied to 
the period prior to a shift change to pre-empt or kick start the phase shift, as a 
recent study by Burgess and Eastman (2004) showed a simple change of sleep 
period could induce a phase shift of one hour.
It would be interesting to establish if diurnal preference impacts on adaptation to 
offshore night shift, with a hypothesis that evening types would have better sleep 
and adapt more readily to a night shift, than morning types. Diurnal preference 
established by Home-0stberg questionnaire (Home and Ostberg, 1976) and/or by 
gene typing (for example Archer et al, 2003) could identify subject groups 
followed by a crossover study of adaptation to night shift with and without 
scheduled sleep.
In terms of measuring the effect of desychrony on markers of CHD risk, a time 
course protocol with a greater frequency of postprandial blood sampling would 
elucidate better the metabolic responses. This was not considered feasible in this 
study that combined circadian, sleep and metabolic markers with performance 
tests undertaken by a collaborative research group (to be reported separately by 
Smith et al via the HSE). A study of postprandial metabolic responses in 14N
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workers, the most robust adapters, is suggested in order to elucidate further the 
effect of maladaptation on metabolism. An increased number of postprandial 
samples would provide a profile of the postprandial response over a period up to 
8 hours at 30 min to 1-hour intervals. This would clarify changes in the 
parameters that respond earlier in the postprandial period. The study would 
require tighter control of pre-meal, test-meal and snacking than was observed 
here and could include a wider array of parameters related to CVD risk, such as 
plasma homocysteine and lipid subfractions. As a study of inflammatory markers 
was suggested in the text, this would be particularly interesting in combination 
with a study of insulin sensitivity in shiftworkers. Therefore analysis of 
inflammatory markers could be incorporated to identify if shiftwork induces an 
inflammatory response in unadapted and adapted night workers, and day shift. 
However, a study of this nature is idealistic and unfortunately impractical to 
implement in a physically active work group with demanding work duties. Given 
the difficulties of recruitment in the offshore environment where no 
compensation was given, consent might be even less forthcoming in a more 
invasive protocol
An intervention study to determine if dietary modification reduces the impact of 
impaired metabolism would be useful in terms of preparing advice for 
shiftworkers. An acute study could determine the effects of a healthy night shift 
diet program in comparison to free diet choice (offering an unhealthy alternative 
would be scientifically interesting but may be rejected as unethical) on night time 
metabolic responses. The longer-term effect could be investigated by introducing 
a program of health promotion centred in night shift diet and healthy diet for 
heart health, with measurement of CVD markers before and after the 
intervention.
The combined outcomes of the suggested studies should further advance 
knowledge of and offer some reduction in the consequences of night shift work 
on circadian rhythms, sleep and health.
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URINE COLLECTION RECORD FORM
Medics will be provided with the following to collect and aliquot urine samples:
1 x Measuring Cylinder
12 x Litre bottle for urine collection (2-days supply, reuse)/subject.
6 x Small labeled plastic bottles, bagged /subject/day.
1 x Book of urine records to fill in volumes & times /subject.
Instructions for urine collection:
1. Collect plastic bottles for urine collections (labeled with your initials or subject 
reference), from the medic. Estimate the time you last emptied your bladder to 
give us a starting point
2. Empty bladder, collecting urine in the bottle provided and note the time of the 
urine collection. Use a new collection bottle for each sample. Note the exact 
time in waterproof ink & return the bottle to the medic. Do not discard or flush 
any urine as we need to measure the full volume even although we only analyse 
a small amount.
3. Collect ai[ urine passed  over 3 - 4  hours, or overnight. It is important to empty 
your bladder before going to bed and then immediately on waking to keep the 
overnight period as short as possible (however we do not expect anyone to wake 
up at 4-hour intervals overnight). Please try to provide frequent samples even if 
they are small as this makes our calculation of your circadian rhythm more 
accurate.
4. Continue collecting each time you pass urine, each time use a separate bottle.
5. Return the bottles to the medic as regularly as your work schedule allows.
PLEASE REMEMBER TO NOTE THE TIME ON THE COLLECTION BOTTLE - IT
IS ESSENTIAL TO CALCULATE YOUR CIRCADIAN RHYTHM
Instructions to Medics:
1. Provide each subject with labeled plastic urine collection bottles. You will receive 
the collection bottles back from each subject, containing that subject’s  urine from 
the previous overnight or 4 hour collection period. Measure the urine volume, 
and enter the volume on the form.
2. The subject will have noted the exact time the urine collection was made, 
record this as ‘end time’ on the form.
3. Retain a 3ml aliquot and pour into the small sample vial, labeled with 
subjects reference, study day and sample number.
4. Freeze the sample at -20°C, in daily labeled bags.
5. Discard the remaining urine, retaining the rinsed (USE WATER ONLY) bottle for 
the next day.
6. Repeat this process for each urine collection and each subject.
Previously passed urine at:: TIME  Subject:
DAY TIME PERIOD END TIME VOLUME COMMENTS TICK
1 Period 1(Over
Period 2
Period 3
Period 4
Period 5
Period 6
Period 7
Appendix ii
STOCKGRAND LTD.
School o f Biomedical & Molecular Sciences 
University o f Surrey 
Guildford, Surrey GU2 7XH, UK  
Tel: (0)1483 689712 
Fax: (0)1483 689712/576978 
VAT Registration no: GB 529 0040 74 
E-m ail: stochgrand@ surrey.ac.uk
INSTRUCTIONS FOR RADIOIMMUNOASSAY OF 6-SULPH AT OXYMEL AT ON IN 
(6-HYDROXYMELATONIN SULPHATE. aMT6S) IN HUMAN URINE USING AN1*5!
LABELLED TRACER.
This method is also suitable for use in ra t hamster, qerbil, guinea-pig and 
other species. The standard curve should be constructed in charcoal stripped 
urine from the same species as the samples.
The RIA of aMT6S has been modified from Arendt et al (1985) to use iodinated 
aMT6S (Aldhous et al (1988)). The technique provides a more sensitive, rapid and 
economical procedure. Results with the iodinated aMT6S correlate well with the 
original 3H aMT6S assay. The diluted urine sample is incubated with a specific 
antiserum to aMT6S raised in a sheep and trace amounts of 125l-aMT6S are then 
added. The free and antibody-bound fractions of aMT6S are separated using a 
dextran-coated charcoal suspension. The free aMT6S fraction is precipitated with the 
charcoal by centrifugation and the radioactivity counted in a gamma counter. A 
standard curve is constructed at the same time from standards made up in charcoal 
stripped urine.
REAGENTS
All water used is freshly double-glass distilled (DGDW) and stored in glass.
Buffer: Tricine (Sigma Ltd. product no. T-0377) is made up at 0.1 M (pH 5.5) with
0.9% NaCI and 0.1% gelatin. It is necessary to heat to 50°C for 30min to dissolve the 
gelatin.
In 1 L of DGDW 17.9g tricine
0.9g NaCI 
1.0g gelatin
Buffer is made up fresh weekly.
Antiserum: Sheep anti-aMT6S antiserum, batch number G/S/1118-23884 is 
supplied freeze-dried in different sized aliquots which should be reconstituted as  
follows:
AB/S/04 - sufficient for at least 10,000 assay tubes.
Reconstitute the contents of the vial with 1 ml DGDW and add 9ml assay buffer to 
give an intermediate dilution of 1:100. Divide into 100pl aliquots which can be stored 
at -20°C for up to 6 months: each aliquot is sufficient for 100 assay tubes. The 
working dilution of 1:20,000 is made up as required by diluting an aliquot to 20ml 
with assay buffer.
AB/S/05 - sufficient for at least 1000 assay tubes.
Reconstitute the contents of the vial with 1ml DGDW to give a 1:100 dilution. 
Aliquots can be stored or diluted for use as described above.
AB/S/06 - sufficient for at least 150 assay tubes.
Reconstitute the contents of the vial with 150pl DGDW and add 29.85ml assay buffer 
to provide the working dilution of 1:20,000.
The working dilution should be prepared on the day of the assay and cannot be 
stored.
Dextran-coated charcoal: suspend activated charcoal (Sigma Ltd. product number 
C-5260) at 2% w/v in assay buffer. Stir for 5 minutes. Centrifuge at +4°C for 5min at 
1000rpm. Discard the supernatant and any fines around the sides of the vessel. 
Resuspend the charcoal in the original volume of assay buffer and add 0.02% w/v 
dextran T-70 (Sigma Ltd. product number D-1390). Stir for at least 1hr at 4°C. Store 
at 4°C and make up fresh weekly.
Radiolabel: instructions for preparing 125l-aMT6S.
This method is adapted from the method of Vakkuri et al (1984). 10pg aMT6S is 
supplied in methanol. This should be evaporated to dryness under nitrogen and the 
residue redissolved in 10pl 0.05M phosphate buffer pH 6.0 (1 mg/ml)
lodogen (Sigma Ltd. product number T-0656) is dissolved at 100pg/ml in chloroform 
and 10pl (1pg) aliquots dispensed into Eppendorf tubes. The chloroform is allowed 
to evaporate at room temperature and the tubes stored at 4°C for up to one year 
prior to use.
5pl of a 1 mg/ml solution aMT6S in 0.05M phosphate buffer pH 6.0 (5pg aMT6S) and 
2jliI Na-125l (0.2mCi) in NaOH are added simultaneously to an Eppendorf tube 
containing iodogen. After mixing for 2 minutes 10Ojul methanol is added: the mixture 
is vortexed for 30sec and left overnight at 4°C.
The MeOH phase is subjected to TLC on cellulose F plastic plates (Merck) using 
butan-1-oI : glacial acetic acid : DGDW, 4 : 1.5 : 1 and allowed to run for 
approximately 12 - 15cm. The plate is then removed from the tank, blown dry with O- 
free nitrogen and re-run to a similar end-point. The plate is then cut into 1cm 
sections to locate the position of the radiolabelled aMT6S. The plate sections 
containing a peak of radioactivity occurring at approximate Rf 0.68 are eluted 
overnight with 5ml MeOH containing 0.1% ascorbic acid.
Each label should be assessed  by standard antiserum dilution and displacement 
curves before use. An average yield for this procedure is 100pCi in the specific 125l- 
aMT6S fraction and the radiolabel can be stored for up to 4 months at 4°C. The plate 
sections and cellulose do not have to be removed for storage.
The working solution is prepared by diluting the stock solution with assay buffer to 
give 8,000 -10 ,000  cpm/100 pi. This is prepared freshly for each assay.
Charcoal stripped (aMT6S-free) urine: This is supplied freeze-dried (100 pL per 
vial). Reconstitute with 25 ml assay buffer to give a dilution of 1:250. Store at -20°C.
Standards: 500pg aMT6S (sufficient for one standard curve) is supplied at 200pg/ml 
in 1:250 diluted, charcoal stripped urine and in this form is stable for up to 12 weeks 
if stored at 4°C. Further dilution with charcoal stripped urine (1:250 in assay buffer) 
provides standards (0, 1, 2, 4, 8, 14, 20, 20, 40 and 100pg) for the standard curve,
i.e.,
aMT6S standard aMT6S-free urine aMT6S aMt6S
200Da/ml 1:250 dilution pq/tube nq/ml urine
0 500jil 0 0
5pl 495pl 1 0.5
10pl 490pl 2 1.0
20jul 480jnl 4 2.0
40pl 460pl 8 4.0
70pl 430pl 14 7.0
100pl 400jul 20 10.0
200|liI 300pl 40 20.0
500pl 0 100 50.0
The standards are treated in exactly the same way as the urine samples in the 
assay.
Urine sam ples: urine samples for analysis are stored at -20°C until assayed. 
aMT6S is stable for at least 2 years in urine stored at -20°C, for at least 5 days at 
4°C or at room temperature. Urine is diluted 1:250 with assay buffer prior to assay.
Urine samples can be diluted directly into the assay tubes using an automatic diluter: 
if this is not available it is suggested that an intermediate dilution (e.g. 1:50) is made 
for each sample.
General:
i) the radioimmunoassay is performed in plastic tubes.
ii) disposable glass or plastic apparatus is used where possible with essential 
glassware being sonicated in methanol (AR grade) before use to eliminate 
contamination. All water used for cleaning and rinsing is DGDW.
iii) the figures given for stability of various reagents are minimum estimates.
METHOD
Duplicate tubes are set up for all samples, standards, totals and NSBs. The volumes 
required in the assay are as follows:
Samples/standards 500jnl
Antiserum 200pl
Radiolabel 100pl
Dextran-coated charcoal 100pl
Total volume 900pl
The volumes can be added with ordinary microlitre dispensers or preferably with 
repeating dispensers. It is necessary to restrict assay sizes to 150 tubes or less in 
order to eliminate assay drift.
ASSAY PROTOCOL.
1. Pipette standards and diluted (1:250) stripped urine to form standard curve.
2. Add 500pl of diluted urine sample to assay tube.
3. Add 200pl of diluted antiserum to all tubes except total count and non-specific 
binding tubes. Vortex and incubate at room temperature for 30 minutes.
4. Add 100(il 125l-aMT6S to all tubes and vortex. Incubate for 15 -1 8  hours at 4°C. 
(For a less sensitive, but more rapid assay, this incubation can be reduced to 2 
hours).
5. Separate antibody-bound aMT6S from the free fraction by incubation for 15min at 
4°C with 100pl dextran-coated charcoal (stirred during and after addition). The 
charcoal should be stirred for 30min prior to use. Charcoal addition and vortexing 
should be done quickly to reduce intra-assay variation.
6. Centrifuge at 3500rpm at 4°C for 15min.
7. Decant supernatant over a mesh and discard. This must be done immediately 
after centrifugation. Blot the tops of the tubes.
8. Count the non-antibody-bound fraction in the charcoal pellet in an appropriate 
gamma-radiation counter. Determine the aMT6S concentration in the samples from 
the dose-response curve.
OTHER COMMENTS: Those workers wishing to use tritiated aMT6S should follow 
the procedure described in Arendt et al (1985)
REFERENCES:
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Protocol for Taking Blood
Set up the blood and sample tubes in the racks ready for each subject and ensure that each 
tube has the correct subject’s initials on it. The vacutainer tubes are NOT labeled, you will 
need to write the subjects initials on these with the waterproof pen provided, in order to 
identify them in the centrifuge. All other sample tubes are pre-labeled.
Withdraw 25ml venous blood from an antecubital vein, using the vacutainer system provided, 
directly into the three blood tubes, containing fluoride-oxalate, EDTA or lithium heparin to 
prevent coagulation, as follows:
> 5ml into the fluoride oxalate blood collection tube.
>  10ml into the EDTA blood collection tube.
>  10ml into the lithium heparin blood collection tube.
Invert twice to mix well, but do not shake. The blood should be centrifuged immediately, or 
placed in ice and centrifuged within 15 minutes.
C entrifuge at 3000rpm  for 10 m inutes.
Remember to balance the centrifuge evenly, use spare tubes filled with water if you do not
have an even number of same sized samples. If  the tube stopper is resting on the rotor the
friction may cause tubes to break at the neck, so adapters to hold the 5ml tubes are provided, 
and should support the tube sufficiently above the rotor to prevent any friction or tube 
breakage. The adapters also raise the 5ml tubes and allow them to be lifted out of the rotor 
without being tipped
Use disposable pipettes to transfer plasma (straw coloured top  layer) from the collection 
tubes as follows, avoid getting any red cells in the samples:
1. From the fluoride oxalate (grey tube) sample:
lml plasma into LP3 tube labeled ‘GLUC’
2. From the EDTA (lilac tube) sample: - 0.5ml plasma into LP3 tube labeled ‘TAG’
- 0.5ml plasma into LP3 tube labeled ‘NEFA’
- 4mls plasma into LP4 tube labeled ‘LDL’
3. From the lithium heparin (green tube) sample:
- 2mls plasma into LP3 tube labeled ‘INS’
- 2mls plasma into LP3 tube labeled ‘C-PEP’
- lml plasma into LP3 tube labeled ‘y-GT’
All sample tubes should be resealed with the caps provided and re-bagged in the subject’s 
resealable labeled bag.
All samples must then be transferred immediately to a freezer at -20°C.
Please dispose of sharps and biological waste in sharps bin and bio-hazard bags respectively.
At the end of the study period the frozen plasma samples will be transported, packed with ice 
packs in an insulated box, back to shore. Please see the sample transport instructions.
DIETARY INTAKE RECORD INSTRUCTIONS
This part of the study is to ascertain your eating habits over the shifts that you do. You are 
asked to complete a dietary intake record for a number of days throughout your tour. The 
information you give is completely confidential, it will not be used for any purpose other 
than research, and you will not be identifiable from any of the data or results that are 
produced.
Please record all food and drink consum ed during each specified day, includ ing any  
agreed test m eals.
♦ Including all elements of a meal, remember the extras; drinks, side orders, salads, bread, 
butter, sauces, dressings, and puddings etc.
♦ Record details of between meal snacks as well as each meal, so at each meal time think 
back and enter the foods/drinks you may have had since the last entry.
♦ The example below demonstrates how to enter your selections and portion sizes.
Example o f completed dietary intake record:
Meal Time Description of all food/drinks
(please be as specific as you can)
Porition
S M L Qty
Evening
meal
(Pre-shift if 
on nights)
1700 Roast beef and gravy
Roast potato
Yorkshire pudding
Carrots/ Broccoli etc
Salad, please list the content
Apple crumble
Custard
Coffee with milk, sugar
✓
✓
✓
✓
2
2
Evening
snacks
2100 Cheese roll, white bread with butter 
Banana
Diet coke/orange juice
✓
2
1
Other 1500 Mars bar/biscuit -  digestive, plain 
Crisps
1
1
For portion size guidance you may wish to refer to the photographic portion guide provided. This
shows photographic representations of portions of a range of foods and will help to ensure that all
subjects have a similar estimation of what is a small (S), medium (M) or large (L) portion.
A selection of foods are represented but you may need to use your imagination for food 
variety, so use the picture most similar to the food you have eaten. For example:
♦ There is a picture of boiled potato portions, which you will need to use for estimating 
roast and mashed potato.
♦ There is a picture of a casserole which will be a guide for curry, mince, and any other 
dishes of a similar ‘plate spread’.
Portions of some foods are easily described by number, such as: rolls, slices of bread/toast, pats of 
butter, sausages etc. in which case you can enter that number in the column marked ‘Qty’ for quantity. 
The analysis of your dietary intake is fundamental to this research so please try to record everything 
you have consumed even if you are not sure about the portion size.
Thank you for you co-operation.
Dietary Intake Record - Day 2 of study
Subject reference/initals____________ Shift times_________ to
Please record ALL your food and drink intake for this 24 hours, including the time and 
quantity. Your sleep period may fall over one meal so enter ‘sleep’. ____________
Meal Time Description of foods/drinks
(Please be as specific as you can)
Portion (see guide)
S M L Qty
Breakfast 
Or Pre-shift 
meal
* please have fasting blood sample taken 
after sleep period but before any food -  
thank you *
a.m. snacks
Midshift
Meal
* please have the agreed test meal as this
meal is 6 hours before your blood sample.
*
Snacks * Please avoid further snacks before the 
blood sample *
Post shift 
/Evening 
meal
Evening
snacks
Night-time 
meal/other 
if on night 
Shift
Night time 
snacks
Others
9
SMALL MEDIUM LARGE
BREAKFAST CEREAL - guide to most cereals incl. porridge, but not muesli (usually eaten in smaller portions) 
Remember to give an indication of how much milk (1/4 pt./125ml, 1/3 pt./170ml etc) and sugar if you have it.
■\ I
PASTA - Use to estimate other pasta shapes, rice, noodles and chop suey. y
f
y1/ <^00 
POTATO - Also use to estimate roast, mashed and jacket potato portions.
I
I A
\ \  -
CHIPS AND FRIES - Please indicate if you have big chips, potato wedges or french style (thin) fries.
T l I
. 1 11
VEGETABLES - Use to estimate most cooked vegetables and salad vegetables.
V, 1 \
1
\v
LASAGNE - Also use this as a guide to other composite foods such as pizza slices, pies, macaroni cheese etc
J i
' J P  y  v  \ 9
CHEESE - Use to estimate cheese if it is as a potato filling, or with salad o* biscuits.
SMALL
V ' '■ 'X \
MEDIUM
“'bXES}.**.: ■ j '.v V
1/
if
MEAT - Use to estimate most meats served in one piece e.g. steak, chops, chicken leg/breast
€7 mm
-■
*
\ .J  I V
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SLICED MEAT - Use to estimate most meats served in slices.
.'m
i a
If ggH H lj
II ~mi y>
CASSEROLE - Use to estimate irfeat or vegetable meals of a similar texture, including curry and mince.
Hr
I 11 
11
i
J
FISH - Use to estimate fish in batter, breadcrumbs or sauce as well as grilled, poached or fried fish steaks.
r~- jA--M, V it 'Mk 7 •#*■
'i \  \ JM3
DESSERTS - Use to estimate pies, sponges,and other puddings, remember to hst custard/ice cream separately. -
1-
T
CUSTARD - Use to estimate other sauces and soft desserts such as chocolate sauce/rice pudding.
ICE CREAM - A different portion may be consumed when eaten alone or as an accompaniment to other desserts.
RECRUITMENT INFORMATION PACK
For Phase Two of the Study:
The Effect o f Night Shift Work on Circadian Adaptation and Markers
of Cardiovascular Disease Risk
in Offshore Oil & Gas Installation Workers.
v' Recruitment information for medics 
S  Study information for volunteers 
S  Subject consent form 
S  Subject participation record
UniS
Recruitment Information for Medics
This pack should provide all the information you need to recruit volunteers to the study, 
providing them with information and recording their consent and personal details.
1. Please provide all potentially interested volunteers with the ‘Information for Subjects’, 
which they should read and understand before confirming their consent to participate. 
Please answer any queries that arise if you can, or refer questions to Michelle Gibbs at the 
University of Surrey: 01483 686387, or e-mail: <m.gibbs@surrey.ac.uk>
2. Those who agree to become subjects in the study must then complete the subject consent 
form, and a participation record to provide the subjects data (weight, height activity etc.).
3. The participation record is also a statement of the subject’s fitness to participate. This is a 
requirement of the University of Surrey Advisory Committee on Ethics. It must be signed 
by the installation medic as confirmation that the medic has sufficient knowledge of the 
subjects health to consider them fit to participate (provide urine samples, blood samples 
and a record of their dietary intake etc).
4. The information recorded on these forms must remain confidential and you are asked to 
return them once completed to the University of Surrey:
Michelle Gibbs
School of Biological Sciences 
University of Surrey 
Guildford 
Surrey GU2 7XH
Once this information is received at the University of Surrey and the number of subjects 
participating is known, transport of the necessary equipment to the installation will be 
arranged, and a convenient study commencement date will be agreed upon.
Please contact me at any stage should queries arise.
Uni
Volunteer/Subject Information
The Study: The Effect of Night Shift Work on Dietary Intake, Circadian Adaptation 
And Markers of Cardiovascular Disease Risk in Offshore Oil and Gas Installation
Workers.
Principle investigator Michelle Gibbs
University of Surrey.
Please read this information sheet carefully before you make up your mind about taking part 
in this study. Ask for an explanation of anything that is not clear to you. The installation 
operators and Medic on your site are fully aware of the study, and the medic has agreed to 
collect the samples and data as required.
If you have read and understood the information sheet and decide to take part in the study, 
you will be asked to sign a consent form which says that you are entering the study 
voluntarily but are free to withdraw at any time. It also says that you have had an explanation 
of the study and that you understood that explanation.
If you have questions or require more information, please contact your on site medic or 
Michelle Gibbs on 01483 686387, or e-mail at m.gibbs@surrey.ac.uk.
Why are we doing the study?
At the University of Surrey, we are a researching the effects of shift-work and diet on health. 
Shift-work results in a mismatch between internal biological rhythms and the external 
environmental and behavioural time cues (e.g. the light-dark cycle, meal times, imposed 
sleep-wake cycle etc.). Your body can normally adjust to such changes in the environment, 
but this process may take several days. The resulting desynchronisation can result in fatigue, 
lowered mood, sleeplessness, reduced performance, indigestion, altered metabolism etc.
This study aims to identify the relationships between adaptation to night shift, altered 
metabolism and your diet, in a variety of shift patterns and a day shift schedule. Eventually 
the aim is to help alleviate these problems and reduce adverse effects on your well being.
This study has been approved by the University of Surrey Advisory Committee on Ethics.
Uni
What the study involves
Pre-study
You will be given the opportunity to familiarise yourself with the questionnaires/diet records, 
and urine collection materials you will be using in the study. You will be provided with a 
study diary to explain the daily progress of the study, and what to do each day. Your name, 
date of birth, height, weight and any medication you take will be recorded on a subject 
participation record, along with confirmation from your installation medic of your fitness to 
participate, all of which will remain confidential.
During the study
You are asked to continue your daily work, leisure and sleep routine as usual.
Urine samples
You are asked to provide urine samples for 14 or 21 days, in order for us to measure the rate 
at which your body adapts to shiftwork. Plastic containers will be provided for urine 
collection.
□ You will collect urine over each 3-4 hour period in a separate container. The easiest 
thing to do is use a separate container every time you need to pass urine.
□ Please collect all urine as we need to measure total volume.
□ At the end of each period please MAKE A NOTE OF THE TIME on the container, so 
that we can calculate the number of hours and minutes between each sample.
□ Give the containers to the medic, and take a container for the next period of collection.
□ Please ensure you provide a sample immediately before sleeping and another on waking 
to keep the overnight sample as short a time as possible. The overnight/sleep period 
sample may be up to eight hours.
Small samples will be taken from the urine and analysed for a specific marker of biological 
rhythms. All urine must be collected in the containers provided and stored until 
retrieval, none should be discarded prior to samples being taken for analysis.
Blood samples
On four occasions during the course of your two/three week tour, a small (25ml) blood 
sample will be taken by a qualified doctor or paramedic on the rig. No more than 1OOML (4 
x 25ml) will be taken in one shift-type study period.
Uni§
Pre Blood Sample Meals
You are asked to take an agreed and specific meal approximately 6 hours prior to each blood 
sample (except the fasted sample, which should be after at least an 8 hour fast eg over the 
sleep period and before the next meal). We ask that you consume the same meal on all 
blood sampling occasions and the same meal as your fellow volunteers, therefore this 
meal will be specified. This is so that any differences in your metabolic responses is not 
caused by differences in the meal you consumed. (I appreciate that the same meal might not 
be everyone’s choice, but it is only on three occasions and it really is important for us to rule 
out the meal as a cause of any results). You are asked to record your food intake on those 
days includes all meals, snacks and drinks along with the time of your meals, on a dietary 
intake record sheet which will be provided.
Activity and light measures
You will be asked to wear an ‘Actiwatch-L’, a wrist watch style motion and light sensor, 
which will measure your activity levels and light exposure, this gives an indication of your 
sleep quality and the effects of light on your circadian rhythm.
Cognitive fatigue/performance measure
You will complete a short fatigue assessment before and after your shift, this is a speed and 
accuracy response computer game/test.
Your rights as a volunteer
You are asked to take part in this study voluntarily. You are therefore free to withdraw from 
the study at any time and the medical supervisor or principal investigator is free to withdraw 
you for medical or administrative reasons, or protocol violations.
Confidentiality
All information, which you give or is collected about you, will be treated as highly 
confidential. None of the documents reporting the study will identify you by name. If the 
results are published in medical journals, your privacy will be maintained.
The results obtained in this study may be valuable in the development of patterns of work and 
lifestyle which will be of potential benefit to you and others.
The Effect Of Nightshift Work On Dietary 
Intake, Circadian Adaptation And Markers 
Of Cardiovascular Disease Risk In Offshore 
Oil & Gas Installation Workers.
Volunteer Consent Form University 
o f Surrey
School of 
biomedical and 
Life S cien ces
Michelle Gibbs
Research Assistant 
01483 686397
Email: m.gibbs@surrey.ac.uk
I, the undersigned, voluntarily agree to take part in the above study.
I have been given a full explanation by the scientific investigators of the nature, purpose and 
likely duration of the study and what I will be expected to do.
I have been given the opportunity to question the investigators on all aspects of the study, and 
have understood the advice and information given as a result.
I agree to comply with any instruction given to me during the study and to co-operate fully 
with all the study staff, informing them immediately of any problems that may have arisen.
All documentation held on a volunteer is in the strictest confidence and complies with the 
Data Protection Act (1984). I agree that I will not seek to restrict the use to which the results 
of the study may be put.
I understand that I am free to withdraw from the study at any time without needing to justify 
my decision and without prejudice.
I confirm that I have read and understood the above and freely consent to participating in this 
study. I have been given adequate time to consider my participation and agree to comply 
with the instructions and restrictions of the study.
If you wish to discuss any aspects of this study contact Michelle Gibbs on 01483 876397 or 
e-mail on m.gibbs@surrey.ac.uk.
Name of volunteer (BLOCK CAPITALS)
Signature of volunteer Date
I confirm that I have explained the nature and purpose of the above study.
Name of Investigator (BLOCK CAPITALS)
Signature Date
Subject Participation Record
The Effect of Nightshift Work On Dietary 
Intake, Circadian Adaptation And Markers 
Of Cardiovascular Disease Risk In Offshore 
Oil & Gas Installation Workers.
University 
of Surrey
School of 
Biomedical and 
Life S c ien ces
Michelle Gibbs
Research Assistant 
01483 686397
Email: m.gibbs@surrey.ac.uk
Subject Name
Subject initials ____________________
(or code for identification of samples only)
Type of work _______  and how physically active is the work
if 1 is sitting fairly still and S is hard labour. 1 2 3 4 5
Date of Birth ____________________
Height _____________________
Weight _____________________
Normal (at home) bed-time ______________ and wake-up time
Current medication
Note: subjects taking medication used for control of blood lipids or diabetes, or taking 
beta blockers will be excluded from this study.
Minor analgesics, other antihypertensives, and topical preparations are acceptable. If in 
doubt please identify the medication and consult the study investigators.
I/we____________________________  (Name of medical officer) Medical officer on
______________________________  (Name of installation)
confirm that the above volunteer is fit to participate as a subject in the above study, and 
there is no known health reason that they should not be able to comply with the study 
requirements.
They are not taking any medication that would preclude them from participation.
SIGNATURE OF MEDICAL OFFICER: DATE:
Appendix
Inter-assay Co-efficients of variation
Assay/parameter Low QC Med/high
QC
aMT6S 7.08 6.75/3.87
TAG 2.08 9.69
NEFA 1.98 0.89
Cholesterol 0.95 6.69
HDL chol 2.5 1.95
Glucose 4.16 3.98
Insulin 8.10 9.93
C-peptide 19.02 14.75
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